Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3009041	p-kardabg	— (—)	4308	4929	100.00%	Distribution not available
3009041	p-kardabg	U/ml (u/ml)	3355	4278	0.00%
3009041	p-kardabg	U/ml______ (u/ml)	129	151	0.00%
3009041	p-kardiolipiini,iggvasta-aineet	U/ml (u/ml)	103	123	0.00%
3009041	p-kardiolipiini,iggvasta-aineet	— (—)	59	61	100.00%	Distribution not available
3009041	p-kardiolipiini,iggvasta-aineet	U/ml______ (u/ml)	55	62	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

ILD medications: immunosuppressive drugs

1442

4365

3.07

317.78

1.3

1.2

4.30

3.97

u/ml

0.43

722

2065

SLE (Finngen)

266

171

18.85

316.84

1.7

1.2

5.75

4.64

u/ml

0.28

170

Cardiovascular diseases (excluding rheumatic etc)

1882

1884

5.93

307.65

1.3

1.2

4.21

4.10

u/ml

0.08

937

867

Coagulation defects, purpura and other haemorrhagic conditions

773

1232

6.74

307.65

1.7

1.2

7.96

3.66

u/ml

5.13

438

548

Cerebrovascular diseases (FINNGEN)

1179

604

14.58

307.65

1.4

1.1

4.26

3.90

u/ml

0.27

574

266

Other heart diseases

944

1224

5.15

307.65

1.4

1.2

4.17

3.50

u/ml

0.88

476

547

DVT of lower extremities

780

848

9.96

307.65

1.3

1.2

3.72

4.70

u/ml

0.71

349

395

Pulmonary heart disease, diseases of pulmonary circulation

1560

1402

12.20

307.65

1.3

1.2

3.50

4.35

u/ml

1.09

736

666

Pulmonary embolism

1472

1304

12.42

307.65

1.3

1.2

3.49

4.43

u/ml

1.14

687

617

Venous thromboembolism

2469

2251

11.42

307.65

1.3

1.2

3.81

3.88

u/ml

0.07

1121

1094

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

1497

1055

9.41

307.65

1.4

1.2

4.12

3.80

u/ml

0.32

733

455

Hard cardiovascular diseases

1779

3136

3.44

307.65

1.3

1.2

4.33

3.45

u/ml

1.64

871

1426

Diseases of arteries, arterioles and capillaries (FINNGEN)

517

371

9.97

307.65

1.4

1.1

6.18

4.14

u/ml

1.03

268

161

Cerebrovascular diseases

1622

2976

3.89

307.65

1.3

1.2

4.63

3.61

u/ml

1.76

780

1391

Ischaemic Stroke, excluding all haemorrhages

1228

2143

4.35

307.65

1.3

1.2

4.79

3.73

u/ml

1.35

579

987

Other coagulation defects

472

446

12.18

307.65

1.9

1.2

9.79

3.42

u/ml

5.32

271

196

Hypertensive diseases (excluding secondary)

936

1170

4.76

307.65

1.3

1.2

4.33

3.63

u/ml

0.72

432

506

Other and unspecified coagulation defects

429

321

16.45

307.65

2.0

1.2

10.15

3.50

u/ml

4.96

252

130

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

2215

4075

3.53

307.65

1.3

1.2

3.98

3.83

u/ml

0.19

1072

1862

Stroke, including SAH

1307

2480

3.89

307.65

1.3

1.2

4.71

3.58

u/ml

1.69

630

1143

Stroke, excluding SAH

1285

2301

4.15

307.65

1.3

1.2

4.71

3.64

u/ml

1.49

619

1061

Systemic connective tissue disorders

898

2116

4.41

307.65

1.5

1.2

4.56

4.01

u/ml

0.52

477

945

Cardiovascular diseases

1650

1566

5.78

307.65

1.3

1.2

4.08

4.28

u/ml

0.14

813

743

Other embolism and thrombosis

585

572

11.23

307.65

1.4

1.2

4.08

4.90

u/ml

0.38

280

263

STROKE

1560

2066

5.29

307.65

1.3

1.2

4.50

3.65

u/ml

1.24

749

948

Phlebitis and thrombophlebitis (not including DVT)

931

1145

8.78

307.65

1.4

1.2

3.99

4.25

u/ml

0.17

427

522

DVT of lower extremities and pulmonary embolism

2027

1784

12.35

307.65

1.3

1.2

3.68

4.07

u/ml

0.47

926

851

Pulmonary heart disease

1472

1322

12.25

307.65

1.3

1.2

3.49

4.47

u/ml

1.24

687

625

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1941

5088

2.62

298.13

1.4

1.2

5.45

3.47

u/ml

5.27

1031

2294

L04AD Calcineurin inhibitors

465

720

7.05

290.46

1.4

1.3

3.88

4.31

u/ml

0.27

249

327

Systemic lupus erythematosus

266

202

15.92

289.22

1.7

1.2

5.75

4.47

u/ml

0.39

170

Transplanted organ and tissue status

408

589

7.55

271.90

1.4

1.2

3.67

3.98

u/ml

0.19

228

269

SLE, ICD10

261

215

14.84

270.82

1.7

1.2

5.84

4.44

u/ml

0.44

166

SLE, strict definition

261

215

14.84

270.82

1.7

1.2

5.84

4.44

u/ml

0.44

166

Sequelae of cerebrovascular disease

704

1411

4.38

258.53

1.4

1.2

5.16

3.78

u/ml

1.03

335

640

Habitual aborter

218

158

17.71

245.41

1.2

1.3

3.38

6.02

u/ml

0.76

105

Other disorders of veins

814

2261

3.64

241.32

1.3

1.2

3.65

3.86

u/ml

0.22

405

1015

Patent foramen ovale

207

141

18.98

241.22

1.3

1.2

3.26

4.97

u/ml

0.48

Systemic lupus erythematosus, unspecified

229

187

15.03

239.05

1.7

1.2

6.09

4.37

u/ml

0.52

143

ILD medications

2051

4796

2.34

234.77

1.3

1.2

3.86

3.93

u/ml

0.08

985

2301

ILD medications: prednisolone, methylprednisolone, prednisone

1971

4718

2.36

231.50

1.3

1.2

4.12

3.90

u/ml

0.28

926

2251

Anaemias

503

561

5.92

228.92

1.5

1.2

4.17

5.11

u/ml

0.31

284

263

Atrial fibrillation and flutter

469

494

6.26

226.56

1.4

1.1

4.33

4.00

u/ml

0.20

235

220

Other pulmonary heart/vessel disease

192

133

15.96

217.03

1.6

1.2

4.02

7.89

u/ml

0.60

110

Secondary right heart disease

184

120

17.09

215.07

1.6

1.2

4.11

8.69

u/ml

0.63

105

L04AA Selective immunosuppressants

616

1590

4.05

210.57

1.3

1.2

4.79

4.11

u/ml

0.53

316

713

Dialysis, with operation codes

388

706

5.83

204.49

1.5

1.2

3.71

4.39

u/ml

0.48

210

312

Nephropathy related operations

378

696

5.78

196.83

1.4

1.2

3.71

5.10

u/ml

0.89

208

314

Congenital malformations of cardiac septa

287

406

7.49

187.16

1.3

3.85

4.71

u/ml

0.44

143

196

Other systemic involvement of connective tissue (FG)

557

1419

3.97

186.99

1.4

1.2

4.31

4.04

u/ml

0.18

289

649

Congenital malformations of the circulatory system

446

954

4.79

186.70

1.3

4.15

4.31

u/ml

0.09

232

457

Pain in limb

1560

4320

2.33

185.56

1.3

3.96

3.98

u/ml

0.01

744

2081

First line medication for Crohn's disease

1900

4787

2.16

181.86

1.3

1.2

4.05

3.87

u/ml

0.22

892

2331

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

265

208

9.31

180.46

1.4

1.2

5.34

3.81

u/ml

0.51

163

Atrial fibrillation and flutter with reimbursement

347

331

6.75

176.97

1.4

1.1

4.24

3.58

u/ml

0.40

176

142

Lung transplantation

117

41.84

176.13

1.3

3.40

5.37

u/ml

0.48

Transient ischemic attack

811

2139

3.08

175.56

1.3

1.2

4.69

3.56

u/ml

1.11

398

983

Lung transplant status

116

41.43

174.08

1.3

3.41

5.37

u/ml

0.48

Inflammatory bowel disease treatment related agents

1941

5219

2.09

171.74

1.3

1.2

3.92

3.96

u/ml

0.05

905

2510

Septal defects

268

396

7.26

170.42

1.3

3.72

4.87

u/ml

0.60

130

191

Other systemic involvement of connective tissue

581

1661

3.61

170.31

1.4

1.2

4.19

4.25

u/ml

0.03

306

724

Oral corticosteroids

1796

5035

2.12

167.09

1.3

1.2

4.01

u/ml

0.00

831

2398

Other soft tissue disorders, not elsewhere classified

1669

4402

2.19

166.48

1.3

3.73

3.99

u/ml

0.35

779

2129

Heart failure, not strict

1182

3236

2.50

165.38

1.4

1.2

4.51

3.51

u/ml

1.44

596

1503

Dyspnoea

1532

5101

2.20

164.24

1.3

1.2

4.50

3.96

u/ml

0.64

769

2353

Examination and observation for other reasons

1079

2335

2.65

161.99

1.4

1.2

4.41

3.81

u/ml

0.50

525

1105

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

446

1118

4.04

150.97

1.3

4.03

4.33

u/ml

0.19

216

533

Paroxysmal tachycardia

342

568

5.11

150.39

1.5

1.2

3.95

u/ml

0.00

170

255

Other specified/unspecified systemic involvement of connective tissue

220

313

7.65

148.74

1.5

1.2

4.38

4.29

u/ml

0.03

120

129

Statin medication

1181

2788

2.42

147.97

1.3

1.2

4.61

3.66

u/ml

1.12

564

1308

Congenital malformations of heart and great arteries

376

847

4.53

147.30

1.3

4.31

4.04

u/ml

0.15

191

411

Cardiac arrhythmias

950

2351

2.63

146.19

1.4

1.2

4.63

3.80

u/ml

0.92

468

1087

Tramadol

1315

3533

2.27

145.51

1.3

1.2

4.16

3.65

u/ml

0.73

604

1688

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

453

1195

3.84

142.89

1.3

4.26

4.20

u/ml

0.03

219

576

Dental caries

559

1643

3.30

140.93

1.3

3.87

3.95

u/ml

0.05

285

776

General symptoms and signs

1721

4260

2.05

140.90

1.3

1.2

3.86

3.92

u/ml

0.06

819

2021

Abnormalities of breathing

1508

4131

2.11

139.01

1.3

1.2

4.37

3.97

u/ml

0.42

745

1968

Heart failure and antihypertensive medication

484

830

3.89

138.97

1.4

1.2

5.04

3.35

u/ml

1.12

251

391

Diseases of arteries, arterioles and capillaries

992

3007

2.46

137.65

1.3

1.2

4.99

3.59

u/ml

1.67

498

1398

Secondary hypertension

162

170

9.76

136.48

1.2

3.74

3.40

u/ml

0.14

Oedema, not elsewhere classified

567

1796

3.15

134.36

1.3

1.2

3.92

3.73

u/ml

0.09

263

841

Renal failure

707

2191

2.80

131.67

1.4

1.2

4.31

3.89

u/ml

0.28

365

1008

Ulcer of lower limb, not elsewhere classified

310

696

4.62

127.34

1.3

1.2

3.71

4.18

u/ml

0.30

155

316

Other neurological diseases

1096

3835

2.25

126.24

1.3

1.2

4.35

3.64

u/ml

0.79

538

1787

Headache

1138

4033

2.21

125.87

1.3

1.2

4.49

3.95

u/ml

0.49

529

1910

Caries of dentine

495

1485

3.31

125.84

1.3

3.85

3.95

u/ml

0.06

251

710

Reimbursement for rheumatic diseases

959

4178

2.32

124.80

1.3

1.2

4.20

3.86

u/ml

0.37

481

1934

ILD medications: azathioprine

353

895

4.09

123.68

1.4

1.2

4.64

4.09

u/ml

0.26

178

413

Nonpyogenic thrombosis of intracranial venous system

27.50

123.00

1.4

1.1

2.70

2.77

u/ml

0.03

Autoimmune diseases related-to ILD

1386

5816

2.01

122.47

1.4

1.2

4.50

3.80

u/ml

1.25

696

2681

Chronic kidney disease

486

1461

3.27

122.13

1.4

1.2

4.50

3.92

u/ml

0.27

242

654

Opioids

1560

4110

1.98

118.21

1.3

1.2

4.28

3.74

u/ml

0.52

732

1982

Hypothyroidism (congenital or acquired)

408

576

4.04

116.99

1.3

1.2

3.29

4.95

u/ml

0.71

214

274

Purpura and other haemorrhagic conditions

314

764

4.27

116.43

1.5

1.2

5.63

3.93

u/ml

1.18

175

339

Hypothyroidism and >3 levothyroxin purchases

405

573

4.03

116.03

1.3

1.2

3.26

4.97

u/ml

0.74

213

273

Hypothyroidism, levothyroxine purchases

405

573

4.03

116.03

1.3

1.2

3.26

4.97

u/ml

0.74

213

273

Azathioprine

353

946

3.87

114.43

1.4

1.2

4.64

4.14

u/ml

0.24

178

450

Arterial embolism and thrombosis

153

193

8.36

114.01

1.3

1.2

5.36

3.04

u/ml

0.68

Implicit Sepsis

1155

4071

2.12

113.62

1.4

1.2

4.29

3.67

u/ml

0.74

568

1927

Visual disturbances and blindness

870

3815

2.32

113.09

1.3

1.2

4.30

3.79

u/ml

0.42

450

1754

Other bacterial diseases, including avohilmo

1581

5226

1.91

112.78

1.3

1.2

4.36

3.94

u/ml

0.51

765

2457

L04AX Other immunosuppressants

967

4444

2.21

112.30

1.3

1.2

4.16

3.85

u/ml

0.36

476

2070

Care involving dialysis

220

413

5.63

112.20

1.4

1.2

3.81

5.25

u/ml

0.52

110

181

Second line medication for Crohn's disease

992

4616

2.18

111.47

1.3

1.2

4.16

3.97

u/ml

0.19

490

2164

Symptoms and signs involving the circulatory and respiratory systems

1580

4141

1.93

110.67

1.3

1.2

4.16

3.97

u/ml

0.18

758

1974

Implicit viral Sepsis, including avohilmo

516

1783

2.95

109.68

1.4

1.2

4.28

3.87

u/ml

0.32

246

818

Other bacterial diseases

1428

4911

1.95

109.44

1.3

1.2

4.35

3.69

u/ml

0.97

702

2315

Cardiomyopathy

330

869

3.91

109.25

1.4

1.2

3.17

3.39

u/ml

0.20

178

386

Visual disturbances

823

3584

2.34

109.15

1.3

1.2

4.31

3.82

u/ml

0.38

427

1658

Pain, not elsewhere classified

527

1859

2.90

108.43

1.3

1.2

3.78

3.70

u/ml

0.06

240

866

Implicit bacterial Sepsis

608

1953

2.71

107.32

1.4

1.2

4.48

3.70

u/ml

0.53

294

908

Bacterial Sepsis

692

2283

2.54

106.63

1.3

1.2

4.43

3.75

u/ml

0.51

331

1077

Idiopathic pulmonary fibrosis

178

286

6.53

106.50

1.2

5.55

5.53

u/ml

0.00

111

134

Implicit bacterial Sepsis, including avohilmo

664

2164

2.59

106.41

1.4

1.2

4.53

3.69

u/ml

0.63

321

1018

Finngen Rheumatological endpoints

1539

4655

1.90

105.41

1.3

1.2

3.85

3.93

u/ml

0.08

739

2215

Implicit Sepsis, including avohilmo

1245

4505

2.00

104.27

1.3

1.2

4.28

3.80

u/ml

0.55

607

2120

Neurological diseases, wide definition

509

805

3.23

103.02

1.3

1.2

4.33

3.52

u/ml

0.54

236

389

Metabolic disorders

1426

4522

1.91

101.41

1.3

3.85

3.78

u/ml

0.08

722

2090

Pain in throat and chest

1310

3978

1.97

101.37

1.3

1.2

3.94

4.02

u/ml

0.07

621

1879

Other heart diseases, wide

1497

4873

1.88

101.29

1.3

1.2

4.52

3.84

u/ml

0.90

751

2274

Condition for Implicit Sepsis (Organ dysfunction codes)

1286

4603

1.96

101.08

1.4

1.2

4.22

3.83

u/ml

0.42

623

2168

Bacterial infection, other or unspecified

773

2813

2.35

100.98

1.3

1.2

4.83

3.82

u/ml

0.92

404

1312

Codeine

1426

4072

1.91

98.98

1.3

1.2

4.07

3.74

u/ml

0.35

651

1958

Fever of other and unknown origin

870

3454

2.21

98.89

1.3

1.2

4.07

3.95

u/ml

0.10

434

1647

All chronic kidney diseases

801

2813

2.30

98.49

1.3

1.2

4.43

3.67

u/ml

0.68

401

1316

Medical observation and evaluation for suspected diseases and conditions

995

2343

2.20

98.04

1.3

1.2

3.49

3.80

u/ml

0.46

466

1110

ILD, hospital admissions 1, main diag only

261

629

4.29

97.95

1.3

1.2

5.40

4.46

u/ml

0.28

161

275

Any gastric operation

1204

3008

2.03

96.77

1.3

1.2

4.69

3.69

u/ml

1.14

581

1419

GASTRO-related operations

1204

3008

2.03

96.77

1.3

1.2

4.69

3.69

u/ml

1.14

581

1419

Bacterial infection, other or unspecified, including avohilmo

843

3143

2.23

96.45

1.3

1.2

4.71

3.77

u/ml

0.91

433

1477

Other interstitial pulmonary diseases

274

693

4.08

96.21

1.3

1.2

5.28

4.40

u/ml

0.27

167

305

ILD, hospital admissions

273

689

4.09

96.17

1.3

1.2

5.28

4.41

u/ml

0.27

167

303

Coronary revascularization (ANGIO or CABG)

1119

3368

2.04

96.05

1.3

1.2

4.72

3.54

u/ml

1.52

557

1528

Other respiratory diseases principally affecting the interstitium

307

842

3.75

95.94

1.3

1.2

5.02

4.20

u/ml

0.29

183

371

Interstitial lung disease

274

696

4.06

95.64

1.3

1.2

5.28

4.40

u/ml

0.27

167

305

Interstitial lung disease endpoints

274

696

4.06

95.64

1.3

1.2

5.28

4.40

u/ml

0.27

167

305

Percutaneous Coronary Intervention

1115

3363

2.04

95.51

1.3

1.2

4.40

3.54

u/ml

1.31

556

1526

Kidney transplant status

178

322

5.94

95.06

1.3

1.2

3.83

4.55

u/ml

0.26

147

Portal vein thrombosis

14.00

94.55

1.2

1.3

3.66

4.52

u/ml

0.22

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

1364

4956

1.88

94.30

1.3

1.2

4.19

4.02

u/ml

0.16

657

2344

Emergency coronary revascularization (for ACS)

1169

3578

1.99

94.03

1.3

1.2

4.73

3.57

u/ml

1.58

584

1632

ILD, hospital admission 2, with pulmonary infections

201

406

5.14

93.96

1.4

1.2

4.73

3.87

u/ml

0.21

122

180

Heart failure,strict

686

1986

2.44

93.51

1.4

1.2

4.88

3.49

u/ml

1.30

357

903

Asthma, excluding more controls

1133

2880

2.04

93.21

1.3

1.2

3.82

3.96

u/ml

0.13

522

1349

Major coronary heart disease event

1165

3540

1.99

93.03

1.3

1.2

4.70

3.50

u/ml

1.67

583

1613

Autoimmune diseases excluding thyroid diseases

1588

4804

1.81

93.02

1.4

1.2

4.33

3.77

u/ml

0.94

794

2235

Vasculitis limited to skin, not elsewhere classified

110

121

10.05

92.34

1.4

1.2

2.81

5.84

u/ml

0.82

Atrial septal defect

148

229

7.00

91.99

1.3

4.31

4.59

u/ml

0.09

108

Ischemic heart diseases

1165

3539

1.98

91.77

1.3

1.2

4.52

3.51

u/ml

1.33

585

1603

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1342

4202

1.89

91.20

1.3

1.2

4.61

4.01

u/ml

0.68

678

1948

1342

4202

1.89

91.20

1.3

1.2

4.61

4.01

u/ml

0.68

678

1948

Episodal and paroxysmal disorders

1596

4533

1.80

90.97

1.3

4.15

3.87

u/ml

0.28

750

2175

Autoimmune diseases excluding thyroid diseases, strict definition

1541

4672

1.81

90.79

1.3

1.2

4.29

3.72

u/ml

0.97

776

2168

Implicit viral Sepsis

366

1163

3.22

90.72

1.4

1.2

4.78

4.21

u/ml

0.32

174

527

Viral Sepsis

366

1165

3.22

90.45

1.4

1.2

4.78

4.20

u/ml

0.32

174

528

Asthma

1163

3049

1.99

89.21

1.3

1.2

3.89

3.97

u/ml

0.06

534

1433

Depression medications

399

593

3.43

88.63

1.3

1.2

3.23

4.92

u/ml

0.71

175

287

Migraine

901

3393

2.10

87.47

1.3

4.09

3.99

u/ml

0.09

434

1598

Codes for special purposes

864

4157

2.09

87.17

1.3

1.2

4.16

4.13

u/ml

0.02

433

1948

Provisional assignment of new diseases of uncertain etiology

863

4152

2.09

87.11

1.3

1.2

4.16

4.13

u/ml

0.02

433

1946

Hypertensive diseases

1207

3580

1.92

86.12

1.3

1.2

4.39

3.68

u/ml

0.81

569

1662

Disorders of lipoprotein metabolism and other lipidaemias

1148

3637

1.94

85.57

1.3

1.2

3.79

3.71

u/ml

0.07

568

1677

Influenza and pneumonia

1602

5761

1.73

83.50

1.3

1.2

4.37

3.90

u/ml

0.61

822

2684

Persons encountering health services for specific procedures and health care

1624

5597

1.73

83.26

1.3

3.83

4.06

u/ml

0.23

783

2668

Hypertension

1195

3578

1.90

82.88

1.3

1.2

4.41

3.68

u/ml

0.83

563

1661

Other disorders of skin and subcutaneous tissue

1040

4582

1.94

82.73

1.3

1.2

4.29

3.75

u/ml

0.54

516

2122

Acute renal failure

344

1120

3.14

81.82

1.4

1.2

4.78

4.08

u/ml

0.25

178

505

Codeine or tramadol medication

1654

5274

1.72

81.65

1.3

4.15

3.92

u/ml

0.25

753

2550

Preparatory care for dialysis

135

217

6.68

81.33

1.4

1.2

4.04

4.53

u/ml

0.15

105

Pneumonias (Asthma/COPD co-morbidities)

1520

5770

1.74

80.99

1.3

1.2

4.56

3.92

u/ml

0.89

784

2684

Donors of organs and tissues

11.10

80.98

1.1

1.2

2.51

6.05

u/ml

0.74

All pneumoniae

1529

5790

1.73

80.58

1.3

1.2

4.57

3.90

u/ml

0.95

786

2697

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1586

4901

1.73

80.49

1.3

1.2

3.93

3.82

u/ml

0.13

810

2287

Migraine with aura

509

2054

2.53

80.40

1.3

3.89

4.19

u/ml

0.22

253

959

Covid-19 confirmed case

574

2443

2.39

80.15

1.4

1.2

4.38

3.82

u/ml

0.49

300

1127

Congenital malformations, deformations and chromosomal abnormalities

1003

4996

1.93

80.08

1.3

4.36

3.97

u/ml

0.29

480

2398

Asthma (mode)

1122

3085

1.93

79.65

1.3

1.2

3.91

3.95

u/ml

0.03

518

1446

Hypertension, Pulmonary Arterial

24.51

79.40

1.5

1.2

2.31

1.60

u/ml

—

Persons encountering health services in other circumstances, wide

1626

4904

1.72

79.34

1.3

1.2

3.77

3.82

u/ml

0.06

801

2288

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

1075

5272

1.88

79.06

1.3

4.29

3.95

u/ml

0.26

509

2532

Asthma (only as main-diagnosis), excluding more controls

1017

2880

1.97

77.89

1.3

1.2

3.91

3.96

u/ml

0.04

452

1349

Pain in joint

869

2616

2.06

77.21

1.3

1.2

3.50

3.79

u/ml

0.33

408

1267

Heart failure, strict

709

2267

2.20

76.23

1.4

1.2

4.80

3.72

u/ml

0.92

366

1034

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1481

5484

1.72

76.19

1.3

1.2

4.07

4.00

u/ml

0.07

740

2532

Pure hypercholesterolaemia

1004

3320

1.94

75.82

1.3

1.2

3.57

3.70

u/ml

0.15

507

1545

Antihypertensive medication - note that there are other indications

1049

2855

1.94

75.64

1.3

1.2

4.20

3.87

u/ml

0.29

524

1365

Extracorporeal dialysis

162

331

5.17

75.29

1.5

1.2

3.59

6.06

u/ml

0.89

156

All kidney diseases

1453

5717

1.72

75.04

1.3

1.2

4.41

3.87

u/ml

0.71

725

2662

Pneumonia, organism unspecified

1342

5305

1.75

74.43

1.3

1.2

4.76

3.93

u/ml

1.10

686

2451

313

1023

3.15

74.38

1.4

1.2

3.81

3.93

u/ml

0.08

163

461

Thrombocytopenia, unspecified

168

357

4.92

74.27

1.5

1.2

5.08

3.48

u/ml

0.99

101

164

Cardiomyopathies, Primary/intrinsic

222

583

3.92

74.11

1.5

1.2

2.99

3.52

u/ml

0.51

124

267

Heart failure and coronary heart disease

514

1457

2.50

74.03

1.4

1.2

5.03

3.42

u/ml

1.18

272

657

Glomerular diseases

325

1089

3.06

73.83

1.4

1.3

4.17

4.54

u/ml

0.20

171

500

Asthma (only as main-diagnosis)

1037

3049

1.92

73.81

1.3

1.2

3.88

3.97

u/ml

0.07

463

1433

Cardiomyopathy, other and unspecified

171

371

4.80

73.65

1.5

1.2

2.94

3.12

u/ml

0.12

161

Subjective visual disturbances

447

1770

2.58

73.60

1.3

1.2

4.50

3.89

u/ml

0.38

224

803

Malaise and fatigue

719

2688

2.13

73.41

1.3

1.2

4.20

3.57

u/ml

0.51

365

1271

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1457

5774

1.69

71.62

1.3

1.2

4.66

3.90

u/ml

1.07

744

2689

Infections, IBD-co-morbidities

228

405

4.03

71.42

1.5

1.2

4.87

3.83

u/ml

0.61

117

186

ILD, hospital admissions 3, with pneumonia sepsis

162

345

4.86

71.23

1.4

1.2

5.44

4.27

u/ml

0.23

158

Cardiomyopathy (excluding other)

225

614

3.77

71.07

1.5

1.2

2.97

3.55

u/ml

0.50

127

283

Asthma-related infections

888

4557

1.92

70.82

1.3

4.16

4.07

u/ml

0.08

419

2209

Asthma, hospital admission 2, infections

888

4557

1.92

70.82

1.3

4.16

4.07

u/ml

0.08

419

2209

Glomerular disorders in diseases classified elsewhere

232

653

3.67

70.17

1.4

1.2

4.15

4.78

u/ml

0.27

123

300

Renal tubulo-interstitial diseases

1237

5231

1.75

69.29

1.3

1.2

4.37

3.95

u/ml

0.44

610

2443

Septicaemia

550

2223

2.28

68.72

1.4

1.2

4.73

3.86

u/ml

0.54

271

1037

Arterial embolism and thrombosis of lower extremity artery

111

8.56

68.45

1.3

1.2

3.03

3.00

u/ml

0.01

Other septicaemia, including avohilmo

502

2021

2.36

68.16

1.4

1.2

4.63

3.84

u/ml

0.44

251

936

Explicit Sepsis, including avohilmo

602

2519

2.19

68.08

1.4

1.2

4.70

3.65

u/ml

0.77

296

1167

Autoimmune diseases

1569

4826

1.66

67.87

1.3

1.2

4.05

3.79

u/ml

0.31

813

2251

Any reimbursement code in KELA

920

2374

1.96

67.84

1.3

1.2

3.82

4.13

u/ml

0.26

427

1135

Exposure to unspecified factor

1478

6103

1.66

67.67

1.3

3.91

4.03

u/ml

0.13

711

2904

Explicit Sepsis

587

2461

2.20

66.92

1.4

1.2

4.66

3.68

u/ml

0.68

287

1141

Other septicaemia

488

1973

2.36

66.40

1.4

1.2

4.72

3.86

u/ml

0.47

243

917

Sicca syndrome [Sjögren]

181

448

4.20

65.89

1.3

1.2

3.69

4.99

u/ml

0.63

105

174

Haemorrhage from respiratory passages

441

1599

2.47

65.53

1.4

1.2

4.14

3.76

u/ml

0.29

236

749

Continuous positive airway pressure

237

568

3.53

65.47

1.4

1.2

5.42

3.95

u/ml

0.87

109

283

Hypertension, essential

1100

3473

1.81

65.27

1.3

1.2

4.44

3.63

u/ml

0.85

508

1609

Used for control exclusion in common control thyroid runs

1473

4478

1.67

64.91

1.3

1.2

4.20

3.64

u/ml

0.76

756

2086

Other abnormal products of conception

630

1935

2.18

64.64

1.3

4.72

3.87

u/ml

0.42

265

874

Certain infectious and parasitic diseases

1358

4022

1.70

64.23

1.3

1.2

4.17

3.79

u/ml

0.38

651

1894

Idiopathic thrombocytopenic purpura

100

154

6.99

62.90

1.5

1.2

4.73

3.73

u/ml

0.36

Neurological diseases

1216

3531

1.74

62.32

1.3

4.76

3.80

u/ml

1.06

570

1696

Respiratory insufficiency

138

287

4.93

62.08

1.4

1.2

4.35

3.67

u/ml

0.27

126

Symptoms and signs involving the skin and subcutaneous tissue

1039

5650

1.75

61.44

1.3

3.94

4.09

u/ml

0.17

477

2639

711

3624

1.97

61.38

1.3

4.45

4.14

u/ml

0.24

330

1763

Other necrotizing vasculopathies

145

320

4.71

61.22

1.5

1.2

4.24

6.52

u/ml

0.66

143

Spontaneous abortion

738

2512

2.00

60.98

1.3

5.35

3.76

u/ml

0.82

327

1151

Other CVD (FINNGEN)

124

166

5.80

60.67

1.3

1.2

6.92

4.05

u/ml

0.41

Parasetamol

1036

2916

1.81

60.40

1.3

4.39

3.79

u/ml

0.51

490

1461

All-cause Heart Failure

653

2219

2.07

60.37

1.4

1.2

4.82

3.72

u/ml

0.86

336

1012

Asthma, unspecified (mode), excluding more controls

730

2665

1.98

60.27

1.3

1.2

3.92

4.00

u/ml

0.05

337

1241

Soft tissue disorders

1418

4429

1.65

60.09

1.3

4.33

3.99

u/ml

0.27

675

2148

Complications of medical and surgical care

1014

5243

1.75

59.67

1.3

1.2

4.35

3.92

u/ml

0.49

494

2425

Livedoid vasculitis

33.14

59.64

1.4

1.1

3.10

7.80

u/ml

—

Other diseases of blood and blood-forming organs, wide

357

1406

2.59

59.59

1.4

1.3

4.51

4.38

u/ml

0.06

188

650

Complications of surgical and medical care, not elsewhere classified

1378

5667

1.63

59.30

1.3

1.2

4.46

3.92

u/ml

0.60

655

2643

Myocarditis

113

7.68

59.11

1.3

1.2

2.58

2.79

u/ml

0.12

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

513

1108

2.35

58.99

1.3

1.2

4.36

3.48

u/ml

0.68

241

554

Erysipelas, including avohilmo

946

3929

1.80

58.81

1.3

1.2

3.72

3.61

u/ml

0.14

439

1842

Bleeding

1062

4313

1.74

58.35

1.4

1.2

3.86

3.85

u/ml

0.01

546

2013

Polyarthropathies

959

3453

1.80

57.96

1.3

4.67

4.08

u/ml

0.58

448

1664

Other forms of systemic lupus erythematosus

12.98

57.46

1.5

1.1

7.35

10.30

u/ml

0.23

Asthma-related pneumonia

489

2236

2.21

57.35

1.4

1.2

4.64

4.00

u/ml

0.48

242

1065

Asthma-related pneumonia or sepsis

489

2240

2.20

57.09

1.4

1.2

4.64

3.99

u/ml

0.49

242

1068

Asthma, hospital admissions 3, pneumonia

489

2240

2.20

57.09

1.4

1.2

4.64

3.99

u/ml

0.49

242

1068

Mixed connective tissue disease

9.23

56.75

1.7

1.2

5.25

7.35

u/ml

0.25

ILD-related respiratory insufficiency

123

7.33

56.45

1.4

1.2

3.25

5.29

u/ml

0.54

Asthma, unspecified (mode)

743

2819

1.92

56.35

1.3

1.2

3.91

4.01

u/ml

0.07

339

1315

Symptoms and signs involving cognition, perception, emotional state and behaviour

1342

5575

1.62

55.86

1.3

4.37

3.92

u/ml

0.42

627

2632

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

835

4026

1.82

55.60

1.3

1.2

3.32

3.91

u/ml

1.02

409

1870

COPD/asthma/ILD related infections

1363

4202

1.64

55.51

1.3

1.2

4.19

4.01

u/ml

0.15

631

1948

COPD/asthma related infections

1363

4202

1.64

55.51

1.3

1.2

4.19

4.01

u/ml

0.15

631

1948

Disturbances of skin sensation

484

2260

2.18

54.66

1.3

1.2

3.85

3.94

u/ml

0.06

213

1053

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

814

4443

1.81

54.52

1.3

1.2

4.40

3.86

u/ml

0.55

405

2070

Other pulmonary diagnosis

1062

3081

1.74

54.26

1.3

1.2

4.53

3.96

u/ml

0.44

488

1446

Other headache syndromes

614

3128

1.98

53.90

1.3

1.2

4.26

4.02

u/ml

0.12

280

1455

ILD medications: pirfenidone

15.01

53.82

1.2

4.06

3.75

u/ml

0.06

Hypothyroidism, drug reimbursement

175

313

3.96

53.81

1.3

1.1

3.07

3.67

u/ml

0.41

132

Valvular heart disease excluding rheumatic fever

571

1989

2.07

53.44

1.3

1.2

4.84

3.64

u/ml

1.41

294

925

Disorders of thyroid, IBD co-morbidities

259

592

3.04

53.39

1.4

1.2

5.30

3.76

u/ml

1.20

128

274

Dilated cardiomyopathy

199

609

3.36

52.89

1.5

1.2

2.90

4.73

u/ml

1.38

111

295

Other diseases of pleura

517

2164

2.10

52.13

1.3

1.2

4.17

4.08

u/ml

0.06

260

1006

Bronchitis

1484

5733

1.56

52.08

1.3

4.19

3.94

u/ml

0.31

688

2721

Retinal vascular occlusion

178

512

3.56

52.04

1.3

1.2

3.20

4.91

u/ml

1.38

231

Non-rheumatic valve diseases

563

1970

2.06

51.97

1.3

1.2

4.91

3.65

u/ml

1.46

287

916

Other specific joint derangements/joint disorders

1093

4091

1.68

51.52

1.3

3.61

4.04

u/ml

0.60

509

2010

Asthma (diagnoses ohter than nonallergic)

1208

6084

1.62

51.47

1.3

3.69

4.08

u/ml

0.59

546

2909

Excluding asthma or asthma-COPD overlap

1048

3081

1.72

51.14

1.3

1.2

4.47

3.96

u/ml

0.38

483

1446

Other arterial embolism and thrombosis

7.98

50.97

1.5

1.2

7.00

3.03

u/ml

0.69

Chronic ulcer of skin, not elsewhere classified

129

301

4.43

50.76

1.4

1.2

7.41

4.38

u/ml

0.44

139

Follow-up examination after treatment for conditions other than malignant neoplasms

596

1994

2.01

50.73

1.3

1.2

3.23

3.88

u/ml

1.00

287

928

Other peripheral vascular diseases

161

442

3.77

50.69

1.3

3.08

4.09

u/ml

0.91

199

Retinal vascular disorders

178

521

3.50

50.65

1.3

1.2

3.20

4.86

u/ml

1.34

234

Other arthritis (FG)

434

1999

2.20

50.61

1.3

1.2

4.95

3.78

u/ml

0.79

197

947

Endocrine, nutritional and metabolic diseases

1136

3456

1.67

50.40

1.3

4.39

3.96

u/ml

0.35

542

1674

Other and unspecified vasculitis limited to skin

114

7.27

50.30

1.4

1.2

3.03

5.92

u/ml

0.74

COPD differential diagnosis

1044

3086

1.71

49.99

1.3

1.2

4.49

3.95

u/ml

0.41

482

1447

ILD differential diagnosis

1043

3085

1.71

49.82

1.3

1.2

4.49

3.95

u/ml

0.41

482

1446

Complications of procedures, not elsewhere classified

1094

5415

1.64

49.51

1.3

1.2

4.65

3.91

u/ml

0.76

523

2520

Iron deficiency anaemia

556

2789

1.98

48.64

1.4

1.2

4.53

3.81

u/ml

0.77

291

1263

Erysipelas

680

3179

1.86

48.58

1.3

1.2

3.47

3.74

u/ml

0.37

308

1490

Pain (limb, back, neck, head abdominally)

919

2643

1.76

48.47

1.3

1.2

4.71

3.81

u/ml

0.76

450

1290

Obesity related asthma

503

2500

2.04

48.05

1.3

1.2

4.30

3.79

u/ml

0.36

210

1195

Aplastic and other anaemias

532

2457

2.00

47.69

1.4

1.2

4.17

3.93

u/ml

0.19

272

1125

Neurotic, stress-related and somatoform disorders

1276

5624

1.57

47.50

1.3

1.2

3.68

3.99

u/ml

0.53

613

2664

Anxiety disorders

1283

5641

1.57

47.38

1.3

1.2

3.82

3.96

u/ml

0.18

615

2672

Acute upper respiratory infections of multiple and unspecified sites

1090

4920

1.63

47.19

1.3

3.97

4.04

u/ml

0.07

528

2326

Varicose veins

602

2373

1.93

47.12

1.3

1.2

3.16

3.88

u/ml

1.24

290

1056

Diseases of the musculoskeletal system and connective tissue

776

2142

1.83

47.07

1.3

4.28

3.84

u/ml

0.27

373

1058

Drug-induced systemic lupus erythematosus

13.97

47.03

1.7

1.1

8.07

5.07

u/ml

0.39

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

1371

5715

1.55

46.91

1.3

4.46

3.90

u/ml

0.71

637

2746

ILD medications: nintedanib

23.04

46.88

1.1

1.0

2.81

2.63

u/ml

—

Anxiety disorders, excluding more controls

1162

4650

1.61

46.69

1.3

1.2

3.70

3.99

u/ml

0.38

554

2227

Other necrotizing vasculopathies (FG)

111

246

4.67

46.67

1.3

1.2

3.50

6.19

u/ml

0.75

111

1470

4872

1.54

46.61

1.3

1.2

3.94

4.06

u/ml

0.12

660

2302

Haemolytic anaemias

172

5.59

46.33

1.6

1.2

4.43

5.69

u/ml

0.26

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

737

4179

1.78

46.25

1.3

1.2

4.37

3.76

u/ml

0.68

362

1941

Osteopathies and chondropathies

736

3815

1.78

45.90

1.3

1.2

4.38

3.75

u/ml

0.69

333

1807

Procreative management

531

2245

1.97

44.72

1.3

3.38

4.00

u/ml

1.04

273

1127

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

609

2029

1.92

44.57

1.3

1.2

4.13

4.30

u/ml

0.10

276

929

Unspecified kidney failure

148

419

3.61

44.37

1.3

1.2

5.62

4.64

u/ml

0.16

187

Systemic sclerosis (FG)

107

6.99

44.33

1.5

1.3

7.25

6.55

u/ml

0.07

Lupus nephritis

22.61

44.28

1.4

1.1

4.23

2.71

u/ml

—

Adjustment and management of implanted device

223

805

2.82

44.27

1.5

1.2

3.59

4.86

u/ml

0.83

133

363

Special screening examination for infectious and parasitic diseases

430

1484

2.14

44.07

1.3

1.2

5.11

3.74

u/ml

0.61

229

715

Nutritional anaemias

606

3142

1.86

43.75

1.4

1.2

4.53

3.75

u/ml

0.92

319

1439

Other obstetric conditions, not elsewhere classified

614

2072

1.90

43.49

1.3

1.2

4.29

4.25

u/ml

0.03

278

948

Cutaneous lupus erythematosus

116

6.64

43.39

1.4

1.2

3.85

3.29

u/ml

0.21

Other and unspecified anaemias

480

2274

2.00

43.30

1.4

1.2

4.22

3.87

u/ml

0.28

249

1035

Valvular operations

192

649

3.01

43.05

1.4

1.2

5.79

3.32

u/ml

1.61

115

294

Abnormal findings on diagnostic imaging of lung

541

2703

1.91

42.94

1.4

1.2

3.63

4.09

u/ml

0.46

270

1245

Cough

510

2461

1.95

42.87

1.3

1.2

3.79

u/ml

0.00

250

1145

Hernia of abdominal wall, postoperative

237

891

2.68

42.80

1.3

1.2

4.28

3.47

u/ml

0.60

124

408

Other anaemias

483

2297

1.99

42.72

1.4

1.2

4.21

3.88

u/ml

0.26

251

1047

Acquired haemolytic anaemia

115

6.60

42.55

1.7

1.2

4.31

4.98

u/ml

0.12

Amiodarone users

153

456

3.45

42.50

1.5

1.2

3.95

5.43

u/ml

0.64

216

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

211

4.76

42.45

1.3

1.2

5.65

4.13

u/ml

0.41

Non-ischemic cardiomyopathy

360

1299

2.22

41.40

1.4

1.2

3.87

3.39

u/ml

0.46

181

566

Other specified/unspecified arthritis

375

1774

2.14

41.00

1.3

1.2

5.27

3.71

u/ml

1.02

170

856

Diseases of the skin and subcutaneous tissue

1282

4199

1.54

40.97

1.3

1.2

4.05

4.03

u/ml

0.01

614

1991

Asthma, hospital admissions , main diagnosis only

1099

6178

1.56

40.79

1.3

3.93

4.07

u/ml

0.14

490

2974

Dizziness and giddiness

948

4585

1.62

40.75

1.3

1.2

4.23

3.97

u/ml

0.16

440

2163

Acute upper respiratory infections

1337

5331

1.51

40.62

1.3

1.2

3.64

4.05

u/ml

0.64

617

2507

Heart failure and bmi 25plus

390

1216

2.16

40.31

1.4

1.2

3.89

3.85

u/ml

0.03

203

564

Dialysis

199

4.85

40.08

1.3

1.2

2.73

4.98

u/ml

0.78

Heart failure and hypertrophic cardiomyopathy

7.88

39.99

1.5

1.2

4.60

6.38

u/ml

0.27

Hypertrophic cardiomyopathy

200

4.81

39.82

1.3

1.2

3.75

5.90

u/ml

0.65

Myalgia

363

1723

2.14

39.42

1.3

1.2

2.76

3.67

u/ml

2.01

169

807

Other reaction to severe stress, and adjustment disorders

602

3385

1.80

39.41

1.4

1.3

4.63

4.21

u/ml

0.35

303

1594

Other and unspecified iron deficiency

441

2241

1.99

39.38

1.4

1.2

4.19

3.92

u/ml

0.21

227

1015

Abnormal findings on examination of blood, without diagnosis

564

2800

1.84

39.36

1.4

1.2

4.65

3.88

u/ml

0.65

276

1318

Systemic sclerosis

121

6.17

39.32

1.5

1.2

7.25

6.00

u/ml

0.14

Persons encountering health services for specific procedures, not carried out

170

569

3.07

39.06

1.3

2.92

3.95

u/ml

0.74

260

All influenza

349

1644

2.15

38.58

1.3

3.92

3.64

u/ml

0.18

182

756

Intestinal infectious diseases

1254

6243

1.50

38.48

1.3

4.57

3.89

u/ml

0.82

586

2986

Infections of the skin and subcutaneous tissue

827

5014

1.64

38.44

1.4

1.3

3.65

4.10

u/ml

0.60

423

2395

Diarrhoea and gastroenteritis of presumed infectious origin

970

5524

1.58

38.37

1.3

4.69

3.91

u/ml

0.82

459

2656

Other diseases of intestines

1427

5412

1.48

38.24

1.3

4.48

3.94

u/ml

0.51

700

2566

Any operation in hilmo

14.03

38.15

1.3

1.2

5.04

3.45

u/ml

0.53

Other special examinations and investigations of persons without complaint or reported diagnosis

785

2343

1.71

38.02

1.3

1.2

3.94

3.80

u/ml

0.10

366

1110

Cardiac arrest

6.43

37.99

1.5

1.1

4.03

3.37

u/ml

0.20

Chronic lower respiratory diseases

1583

5787

1.45

37.90

1.3

3.87

4.03

u/ml

0.20

756

2778

Diseases of oesophagus, stomach and duodenum

1378

5535

1.48

37.50

1.3

4.05

4.03

u/ml

0.02

679

2572

Bacterial pneumonia, not elsewhere classified

462

2117

1.94

37.49

1.3

1.2

5.56

3.55

u/ml

1.27

231

970

Other disorders of skin and subcutaneous tissue, not elsewhere classified

209

797

2.67

37.48

1.3

6.62

4.28

u/ml

0.56

351

Diaphragmatic hernia

422

2157

1.98

37.31

1.3

1.2

4.30

4.02

u/ml

0.16

223

978

Presence of cardiac and vascular implants and grafts

464

1768

1.95

37.15

1.5

1.2

5.66

3.84

u/ml

1.20

263

807

Other diseases of the respiratory system

243

999

2.47

37.14

1.4

1.2

4.15

4.42

u/ml

0.13

122

455

Other respiratory disorders and diseases

243

999

2.47

37.14

1.4

1.2

4.15

4.42

u/ml

0.13

122

455

Viral pneumonia

200

750

2.72

37.10

1.5

1.2

4.03

4.00

u/ml

0.01

113

335

Liquid cancers

342

1532

2.14

36.95

1.2

1.3

4.02

4.06

u/ml

0.02

161

734

Certain infectious and parasitic diseases, including avohilmo

878

2692

1.64

36.84

1.3

1.2

4.84

3.64

u/ml

1.03

404

1277

Bacterial pneumoniae

483

2262

1.89

36.68

1.3

1.2

5.53

3.54

u/ml

1.32

240

1032

Other dialysis

159

5.19

36.58

1.3

1.2

3.45

5.07

u/ml

0.50

Implicit fungal Sepsis, including avohilmo

126

367

3.53

36.40

1.3

1.2

4.61

5.30

u/ml

0.21

156

Asthma, including avohilmo

1535

5893

1.44

36.28

1.3

3.82

4.03

u/ml

0.27

714

2843

Mood disorders

1350

5909

1.47

36.18

1.3

3.68

4.00

u/ml

0.46

639

2808

Abdominal and pelvic pain

1261

4234

1.50

36.14

1.2

1.3

4.33

3.75

u/ml

0.61

586

2056

Mood [affective] disorders

1348

5911

1.47

36.13

1.3

3.68

4.00

u/ml

0.46

638

2809

Depression

1283

5827

1.48

36.08

1.3

3.81

4.01

u/ml

0.24

597

2771

Embolic stroke

116

5.84

36.03

1.2

2.55

2.85

u/ml

0.27

Aortic aneurysm

245

1003

2.42

36.01

1.3

1.2

5.33

3.57

u/ml

1.27

135

483

Other nutritional deficiencies

948

5584

1.56

35.95

1.3

4.25

3.99

u/ml

0.24

425

2645

Obesity, other/unspecified

531

2967

1.81

35.71

1.3

4.66

4.06

u/ml

0.38

223

1386

Arthropathies

1229

4146

1.51

35.60

1.3

3.87

4.03

u/ml

0.12

557

2045

Cystitis

1067

4141

1.54

35.56

1.3

1.2

3.95

3.87

u/ml

0.08

522

1907

Care involving use of rehabilitation procedures

799

4460

1.62

35.55

1.2

1.3

3.68

3.93

u/ml

0.24

358

2106

Need for other prophylactic measures

119

340

3.63

35.53

1.4

1.2

4.60

4.52

u/ml

0.02

158

Syncope and collapse

505

2299

1.85

35.44

1.3

1.2

3.68

3.65

u/ml

0.02

233

1086

Systemic sclerosis, icd10

130

5.66

35.42

1.4

1.2

7.25

6.00

u/ml

0.14

Gout

299

1164

2.23

35.28

1.3

1.2

3.97

3.73

u/ml

0.15

149

562

Rheumatoid arthritis

385

1712

2.01

35.05

1.3

1.2

4.01

3.86

u/ml

0.09

170

813

General examination and investigation of persons without complaint and reported diagnosis

755

2342

1.69

35.04

1.3

1.2

4.02

3.80

u/ml

0.14

355

1109

Female infertility

462

1446

1.94

34.81

1.3

4.71

4.93

u/ml

0.07

215

672

Diseases of the eye and adnexa

1122

3699

1.53

34.77

1.3

4.26

3.62

u/ml

0.64

525

1765

Nonischemic cardiomyopathy

155

526

3.01

34.67

1.5

1.2

3.54

3.71

u/ml

0.08

257

Female infertility, cervical, vaginal, other or unspecified origin

430

1411

1.98

34.62

1.2

1.3

4.74

4.91

u/ml

0.05

198

652

Peripheral artery disease

408

1648

1.97

34.45

1.3

1.2

6.03

3.48

u/ml

1.44

217

751

Acute bronchitis

515

2821

1.81

34.43

1.3

1.2

4.87

3.89

u/ml

0.96

229

1345

Oxycodone

414

1830

1.95

34.39

1.3

1.2

3.33

3.62

u/ml

0.31

186

877

Intestinal infectious diseases, including avohilmo, including avohilmo

1453

5644

1.44

34.37

1.3

4.40

3.91

u/ml

0.57

663

2702

Mood disorders, excluding more controls

1205

4775

1.49

34.34

1.3

1.2

3.54

4.00

u/ml

0.69

566

2280

Symptoms and signs involving the digestive system and abdomen

1251

4234

1.49

34.19

1.3

4.36

3.75

u/ml

0.66

593

2056

Bacterial pneumonia (organism specified)

514

2597

1.81

34.00

1.3

1.2

5.42

3.50

u/ml

1.34

253

1215

Atherosclerosis, excluding cerebral and coronary sclerosis

373

1463

2.02

33.66

1.3

1.2

6.39

3.47

u/ml

1.49

193

661

All anxiety disorders

917

4599

1.56

33.65

1.3

3.76

4.00

u/ml

0.27

429

2191

Epilepsy

374

1895

1.99

33.64

1.3

1.2

4.35

3.66

u/ml

0.53

181

915

Haemorrhage, not elsewhere classified

143

5.14

33.55

1.5

1.1

7.05

6.71

u/ml

0.04

Glomerulonephritis

160

564

2.91

33.54

1.3

1.2

3.48

5.15

u/ml

0.88

259

Other and unspecified visual disturbances

177

661

2.74

33.24

1.3

3.84

4.09

u/ml

0.10

288

Urinary track infection

858

2688

1.61

33.22

1.3

1.2

3.49

4.11

u/ml

0.76

398

1197

Symptoms and signs involving speech and voice

422

2246

1.90

33.18

1.3

1.2

3.43

4.09

u/ml

0.81

204

1035

Thoracic aortic aneurysm

184

702

2.67

33.02

1.3

1.2

5.60

3.76

u/ml

0.90

331

Migraine with aura and triptan purchases

307

1470

2.13

32.87

1.3

1.2

3.67

4.15

u/ml

0.32

153

666

Pacemaker

354

1646

2.02

32.85

1.4

1.2

3.76

4.01

u/ml

0.18

189

756

Factors influencing health status and contact with health services

324

744

2.20

32.75

1.2

4.81

3.48

u/ml

0.72

151

356

Other joint disorders

1176

4135

1.49

32.75

1.3

3.84

4.04

u/ml

0.15

518

2038

Peripheral arterial reconstruction

177

664

2.70

32.75

1.4

1.2

3.76

5.18

u/ml

0.62

307

Other diseases of the digestive system

352

1771

2.01

32.62

1.3

1.2

3.71

4.16

u/ml

0.35

184

816

Other acute lower respiratory infections

684

3989

1.65

32.53

1.3

4.33

3.85

u/ml

0.52

315

1921

Obesity and other hyperalimentation

890

5460

1.54

32.22

1.3

4.34

3.98

u/ml

0.32

394

2571

Exposure to other specified factors

1084

6307

1.48

32.22

1.3

4.70

3.88

u/ml

0.87

526

2997

Persons encountering health services for examination and investigation

763

2343

1.64

32.06

1.3

1.2

4.81

3.80

u/ml

0.69

349

1110

Gout, FINNGEN

299

1418

2.12

31.95

1.3

1.2

3.97

3.94

u/ml

0.02

149

671

Anxiety (asthma-related co-morbidities)

890

4396

1.55

31.81

1.3

3.54

4.01

u/ml

0.71

413

2124

Supervision of high-risk pregnancy

332

956

2.12

31.79

1.2

1.3

3.66

4.45

u/ml

0.59

154

459

Raynaud syndrome

164

604

2.79

31.74

1.4

1.3

3.86

4.35

u/ml

0.23

269

Convulsions, not elsewhere classified

309

1479

2.09

31.74

1.4

1.2

4.01

3.93

u/ml

0.04

150

707

Certain disorders involving the immune mechanism

273

1266

2.19

31.67

1.3

1.2

4.48

4.26

u/ml

0.08

121

576

Osteoporosis

292

1267

2.14

31.67

1.3

1.2

4.20

4.46

u/ml

0.13

137

563

Obesity

884

5447

1.54

31.60

1.3

4.34

3.98

u/ml

0.32

393

2567

Other and unspecified dermatitis

681

4209

1.63

31.51

1.3

1.2

3.61

4.11

u/ml

0.57

320

1963

Unspecified privation

172

657

2.68

30.93

1.4

1.3

2.57

5.13

u/ml

2.46

295

Non-allergic asthma (mode), excluding more controls

231

1004

2.31

30.52

1.3

1.2

4.56

3.76

u/ml

0.37

104

455

Infarction of spleen

10.93

30.49

1.6

1.2

7.24

4.80

u/ml

0.24

Retinal detachments and breaks

396

2123

1.88

30.45

1.3

1.2

4.50

3.89

u/ml

0.21

202

963

Left ventricular outflow tract obstruction (LVOTO), broad definition

178

698

2.62

30.42

1.4

1.2

5.71

4.05

u/ml

0.73

319

Nausea and vomiting

343

1711

1.98

30.25

1.3

1.2

4.05

3.84

u/ml

0.15

171

815

Diseases of spleen

101

5.94

30.20

1.5

1.2

5.71

4.44

u/ml

0.20

Other disorders of kidney and ureter

183

729

2.56

30.16

1.4

1.3

4.84

4.89

u/ml

0.02

315

Rheumatoid arthritis, including avohilmo

445

2487

1.81

29.94

1.3

1.2

3.93

3.95

u/ml

0.02

200

1146

Fungal Sepsis

200

4.20

29.81

1.3

1.2

4.80

5.34

u/ml

0.10

Soft tissue disorders related to use, overuse and pressure

335

1713

1.98

29.75

1.3

1.2

3.42

3.56

u/ml

0.07

151

809

Speech therapy

322

1625

2.01

29.74

1.2

3.57

4.42

u/ml

0.66

147

745

Dermatitis

789

5008

1.55

29.49

1.3

1.2

3.48

4.13

u/ml

1.02

374

2339

Seropositive rheumatoid arthritis

276

1316

2.11

29.26

1.3

1.2

3.93

4.07

u/ml

0.06

122

613

Dermatitis and eczema

1411

5983

1.40

29.24

1.3

1.2

3.73

4.02

u/ml

0.42

668

2854

Other symptoms and signs involving cognitive functions and awareness

500

2566

1.74

29.11

1.3

1.2

4.19

3.92

u/ml

0.19

226

1219

Dorsalgia

1273

4738

1.43

28.85

1.3

4.45

3.82

u/ml

0.49

578

2317

Sequelae of external causes of morbidity and mortality

323

1650

1.98

28.83

1.3

1.2

3.73

4.11

u/ml

0.21

146

766

Mycoses, including avohilmo

1186

6340

1.43

28.76

1.3

4.72

3.86

u/ml

0.78

580

2997

Non-allergic asthma (mode)

231

1031

2.25

28.68

1.3

1.2

4.56

3.85

u/ml

0.32

104

473

Low back pain

1016

4663

1.48

28.67

1.2

1.3

4.28

3.81

u/ml

0.35

461

2269

Thrombotic microangiopathy

10.83

28.65

2.1

1.1

6.06

4.41

u/ml

0.23

Caries of enamel

1253

5792

1.42

28.64

1.3

4.41

3.85

u/ml

0.51

599

2737

GI-bleeding

339

1764

1.94

28.55

1.3

1.2

3.73

4.21

u/ml

0.37

179

815

Aortic valve malfunction, age under 60 years

167

657

2.61

28.41

1.4

1.2

5.85

4.15

u/ml

0.69

298

Other and unspecified vascular occlusions

120

395

3.10

28.41

1.3

1.2

3.11

5.38

u/ml

1.52

173

Acute sinusitis

738

4318

1.57

28.41

1.3

3.85

4.01

u/ml

0.15

350

2045

Chronic Coagulation defects

162

4.58

28.29

1.4

1.2

4.12

5.00

u/ml

0.20

Hyperlipidaemia, other/unspecified

389

1900

1.86

28.13

1.3

1.2

4.57

3.90

u/ml

0.32

184

869

Gout, idiopatic and unspecified

262

1252

2.12

28.09

1.2

3.53

4.22

u/ml

0.45

130

593

Early onset COPD, excluding more controls

223

1000

2.25

27.98

1.3

1.2

3.63

3.54

u/ml

0.05

456

Erectile dysfunction

108

338

3.27

27.90

1.7

1.3

3.72

5.94

u/ml

0.77

162

Endocarditis

155

4.55

27.78

1.6

1.2

6.66

3.33

u/ml

1.02

Other disorders involving the immune mechanism, not elsewhere classified

194

4.16

27.74

1.4

1.2

4.17

6.02

u/ml

0.46

Other anxiety disorders

698

3794

1.58

27.55

1.3

3.66

4.10

u/ml

0.53

325

1803

Gastrointestinal diseases

779

2497

1.57

27.54

1.3

4.03

4.04

u/ml

0.01

378

1181

Speech disturbances, not elsewhere classified

126

437

2.94

27.25

1.4

1.2

3.77

5.61

u/ml

0.70

202

Chronic gastritis

281

1394

2.04

27.22

1.3

1.2

4.84

4.22

u/ml

0.28

146

641

Other retinal artery occlusion

6.52

27.19

1.3

2.86

7.31

u/ml

0.91

Nephrotic syndrome

167

4.39

27.09

1.2

2.19

5.03

u/ml

1.23

Intracranial trauma

658

2783

1.61

27.05

1.3

1.2

3.61

3.84

u/ml

0.20

314

1334

Gout, unspecified

218

990

2.23

26.65

1.3

1.2

3.53

4.42

u/ml

0.53

107

469

Visual field defects

125

441

2.90

26.26

1.4

1.2

8.81

3.73

u/ml

0.93

196

Other diseases of urinary system

1201

4781

1.42

26.18

1.3

1.2

4.29

3.87

u/ml

0.41

577

2231

Medical treatment for female infertility

372

2039

1.84

26.12

1.2

1.3

5.05

4.27

u/ml

0.23

174

889

Peripheral artery operations in Hilmo

131

474

2.80

26.08

1.3

1.2

6.72

3.93

u/ml

0.49

221

Disorders resulting from impaired renal tubular function

181

4.14

25.96

1.5

1.2

4.36

6.05

u/ml

0.32

Failure and rejection of transplanted organs and tissues

6.49

25.89

1.4

1.2

3.08

3.70

u/ml

0.19

Diseases of the digestive system

498

2970

1.68

25.82

1.3

1.2

4.02

3.93

u/ml

0.07

267

1384

Cerebral palsy and other paralytic syndromes

164

669

2.50

25.79

1.3

4.06

4.89

u/ml

0.35

314

Other disorders of fluid, electrolyte and acid-base balance

315

1555

1.92

25.75

1.3

1.2

4.40

3.97

u/ml

0.22

157

711

Candidiasis, including avohilmo

425

2454

1.75

25.71

1.3

1.2

4.49

3.91

u/ml

0.21

225

1116

Other diseases of arteries and capillaries

123

435

2.88

25.69

1.4

1.2

3.85

3.33

u/ml

0.26

195

Other diseases of pericardium

209

3.85

25.66

1.5

1.2

6.81

2.97

u/ml

1.13

Implicit fungal Sepsis

187

4.04

25.61

1.3

1.2

5.09

5.59

u/ml

0.09

Other specified/unspecified necrotizing vasculopathies

6.87

25.55

1.5

1.2

3.35

4.96

u/ml

0.45

Other arrhythmias

759

3740

1.52

25.28

1.3

1.2

4.65

3.54

u/ml

1.34

371

1723

Vascular diseases of the intestine

126

4.73

25.09

1.4

1.2

5.79

3.57

u/ml

0.31

Diverticular disease of intestine

758

3097

1.53

25.05

1.2

2.97

3.89

u/ml

2.77

371

1423

Allergic asthma (mode), excluding more controls

319

1662

1.89

24.89

1.3

1.2

3.31

4.38

u/ml

1.05

142

785

Undetermined asthma, excluding more controls

169

709

2.42

24.88

1.3

1.2

4.09

3.43

u/ml

0.29

321

Disorders of other endocrine glands

563

3467

1.61

24.87

1.4

1.3

4.61

4.10

u/ml

0.30

242

1663

Chronic apical periodontitis

1387

5703

1.37

24.80

1.3

3.59

4.06

u/ml

0.78

635

2717

Enlarged lymph nodes

203

927

2.22

24.55

1.4

1.2

3.63

4.30

u/ml

0.43

105

428

Genitourinary diseases

699

2252

1.57

24.33

1.4

1.3

4.31

3.92

u/ml

0.23

354

1133

Liquid cancers, including Hilmo

375

1862

1.79

24.15

1.2

3.88

3.99

u/ml

0.07

174

881

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

183

4.00

24.02

1.5

1.2

4.12

6.23

u/ml

0.51

Injuries to the knee and lower leg

1468

5895

1.35

24.00

1.2

1.3

4.04

4.01

u/ml

0.03

709

2795

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

1139

6391

1.39

23.97

1.3

4.29

3.95

u/ml

0.36

559

3028

Diplopia

181

799

2.30

23.85

1.4

1.3

4.00

4.10

u/ml

0.04

356

Pregnancy examination and test

249

744

2.11

23.81

1.3

3.13

4.16

u/ml

0.81

120

370

Concussion

560

2725

1.60

23.47

1.3

1.2

3.36

3.88

u/ml

0.57

271

1303

Undetermined asthma

169

728

2.35

23.47

1.3

1.2

4.09

3.51

u/ml

0.25

337

Lower back pain or/and sciatica

1331

6104

1.36

23.36

1.2

1.3

3.97

3.95

u/ml

0.01

588

2933

Diseases of liver

407

2389

1.72

23.22

1.4

1.2

3.87

3.84

u/ml

0.02

212

1119

Major coronary heart disease event excluding revascularizations

571

2368

1.60

23.13

1.3

1.2

5.42

3.54

u/ml

1.95

270

1076

Allergic asthma (mode)

319

1704

1.85

23.06

1.3

3.31

4.37

u/ml

1.05

142

807

Other diseases of intestine

191

875

2.21

22.97

1.3

1.2

4.10

4.12

u/ml

0.01

100

383

Cutaneous abscess, furuncle and carbuncle

359

2042

1.78

22.97

1.4

1.3

3.32

4.13

u/ml

0.91

179

930

COPD-related respiratory insufficiency

131

508

2.62

22.90

1.4

1.2

3.06

5.83

u/ml

1.70

228

Other dorsopathies, not elsewhere classified

1253

4749

1.38

22.82

1.3

4.64

3.82

u/ml

0.70

578

2326

Covid-19 suspected case

317

1742

1.84

22.80

1.2

3.67

4.05

u/ml

0.19

144

812

Other disorders of urethra and urinary system

819

3894

1.47

22.78

1.3

1.2

4.84

3.87

u/ml

0.78

379

1771

Migraine without aura

310

1693

1.85

22.73

1.3

4.19

4.35

u/ml

0.08

156

780

Pregnancy with abortive outcome

799

2802

1.50

22.72

1.2

1.3

4.64

3.86

u/ml

0.48

359

1286

Hypothyroidism, strict autoimmune

842

3791

1.47

22.72

1.3

1.2

4.17

3.69

u/ml

0.38

421

1713

Benign neoplasm of colon, rectum, anus and anal canal

636

3516

1.54

22.62

1.3

1.2

3.93

3.96

u/ml

0.02

307

1624

Other/unspecified cytomegaloviral diseases

106

4.98

22.51

1.5

1.3

4.72

4.29

u/ml

0.08

Mycoses

353

2012

1.77

22.42

1.3

1.2

5.72

3.88

u/ml

0.55

183

928

Outcome of delivery

256

783

2.04

22.42

1.3

3.55

4.24

u/ml

0.39

124

388

Ischaemic heart disease, wide definition

807

3381

1.48

22.41

1.3

1.2

5.10

3.49

u/ml

1.64

396

1558

Myocardial infarction

455

1913

1.67

22.21

1.3

1.2

4.99

3.65

u/ml

1.12

216

862

Abnormalities of heart beat

390

2219

1.72

22.14

1.3

1.2

3.77

3.76

u/ml

0.01

185

1015

Maternal care for known or suspected fetal abnormality and damage

298

1366

1.88

22.02

1.3

3.81

4.72

u/ml

0.46

125

635

Diseases of the respiratory system

753

2522

1.50

21.95

1.2

4.70

4.13

u/ml

0.30

329

1182

Pericarditis

167

3.96

21.93

1.6

1.2

5.10

3.17

u/ml

0.61

Benign neoplasm: Colon

530

3159

1.58

21.84

1.3

1.2

3.89

3.97

u/ml

0.05

254

1468

Vascular disorders of the intestines

248

3.33

21.72

1.4

1.2

5.09

5.79

u/ml

0.10

116

Disorders of the thyroid gland

1133

5365

1.38

21.49

1.3

1.2

4.25

3.87

u/ml

0.35

558

2496

Cytomegalovirus infection, IBD co-morbidity

131

4.41

21.44

1.5

1.3

4.55

3.98

u/ml

0.12

Gout, strict definition

181

837

2.19

21.28

1.3

1.2

3.72

4.73

u/ml

0.52

412

Cytomegaloviral disease

136

4.32

21.28

1.5

1.2

4.55

3.61

u/ml

0.22

Iron deficiency anaemia secondary to blood loss (chronic)

185

864

2.17

21.23

1.4

1.2

5.61

4.92

u/ml

0.24

102

388

Gastro-oesophageal reflux disease

782

4562

1.45

21.13

1.3

1.2

3.93

3.77

u/ml

0.15

366

2099

Cellulitis

285

1552

1.86

21.13

1.4

1.3

4.26

4.34

u/ml

0.03

146

718

Cytomegaloviral disease, including avohilmo

137

4.28

21.07

1.5

1.2

4.55

3.61

u/ml

0.22

Intracerebral haemorrhage

119

459

2.62

21.02

1.4

1.2

3.83

3.84

u/ml

0.00

209

Hemiplegia

265

3.22

20.90

1.3

1.2

3.20

4.06

u/ml

0.33

116

Cardiodefibrillation

325

1844

1.77

20.73

1.4

1.2

4.61

3.80

u/ml

0.64

170

865

Cardiomyopathy, Hypertrophic obstructive

5.51

20.35

1.5

1.1

2.44

2.67

u/ml

0.13

Symptoms and signs involving the nervous and musculoskeletal systems

659

4465

1.48

20.33

1.3

3.69

3.83

u/ml

0.14

298

2102

Other external causes of accidental injury

979

3500

1.41

20.31

1.3

1.2

4.20

3.66

u/ml

0.43

442

1679

Other encephalitis

169

3.83

20.09

1.5

1.2

3.21

6.61

u/ml

0.96

Abnormalities of gait and mobility

145

629

2.34

19.98

1.2

3.19

5.31

u/ml

1.33

275

Emphysema

314

2.95

19.98

1.3

1.2

3.84

5.48

u/ml

0.47

152

Asthma and allergy, excluding more controls

197

954

2.07

19.89

1.3

1.2

3.30

4.29

u/ml

0.68

457

Asthma and allergy

197

954

2.07

19.87

1.3

1.2

3.30

4.27

u/ml

0.66

460

Other/unspecified dorsalgia

448

2771

1.61

19.86

1.3

1.2

4.31

3.58

u/ml

0.49

191

1352

CR(E)ST syndrome

5.30

19.79

1.4

1.1

7.10

6.74

u/ml

0.03

Recurrent or chronic depression

533

2383

1.56

19.75

1.2

1.3

3.15

3.85

u/ml

1.25

235

1180

Other aneurysm

199

3.49

19.65

1.4

1.2

4.68

3.42

u/ml

0.41

100

Coronary atherosclerosis

606

2527

1.52

19.57

1.3

1.2

5.11

3.51

u/ml

1.29

312

1146

Polyneuropathies and other disorders of the peripheral nervous system

235

1236

1.92

19.45

1.4

1.2

3.96

4.41

u/ml

0.24

115

577

Acute tubulo-interstitial nephritis

682

3949

1.47

19.29

1.3

1.2

5.00

3.98

u/ml

0.78

325

1825

Other viral diseases

401

2458

1.64

19.25

1.3

4.56

4.02

u/ml

0.34

204

1177

Chronic sinusitis

526

3440

1.54

19.24

1.3

1.2

3.74

4.02

u/ml

0.23

241

1615

Encephalitis

179

3.66

19.21

1.5

1.3

3.21

6.43

u/ml

0.95

Other and unspecified polyneuropathies, also in other diseases

208

1055

1.99

19.17

1.4

1.2

3.98

4.39

u/ml

0.19

103

483

Accidents

970

3500

1.39

19.12

1.3

1.2

4.15

3.66

u/ml

0.39

439

1679

Fall on same level

1418

5783

1.31

19.03

1.3

3.86

4.06

u/ml

0.25

688

2760

Other congenital malformations of peripheral vascular system

5.02

19.01

1.3

1.2

2.52

3.13

u/ml

0.31

Dorsopathies

1255

4774

1.34

18.97

1.3

4.64

3.82

u/ml

0.68

570

2341

Other viral diseases, including avohilmo

540

3534

1.53

18.94

1.3

4.34

4.10

u/ml

0.16

270

1697

Chronic rhinitis, nasopharyngitis and pharyngitis

413

2573

1.62

18.81

1.3

1.2

3.93

3.80

u/ml

0.07

195

1205

Other abnormal immunological findings in serum

137

4.06

18.58

1.5

1.2

5.39

5.54

u/ml

0.02

Drug-induced cataract

137

4.05

18.55

1.2

2.35

5.80

u/ml

1.13

Vocal cord dysfunction

143

556

2.29

18.37

1.3

1.2

4.03

3.82

u/ml

0.06

249

Other functional intestinal disorders

489

2886

1.55

18.27

1.2

5.26

3.78

u/ml

0.92

240

1351

Drug-induced osteoporosis with pathological fracture

5.48

18.17

1.3

1.1

4.85

3.72

u/ml

0.24

Other antidepressants

1206

4629

1.34

18.17

1.2

1.3

3.42

4.12

u/ml

1.42

539

2259

Rash and other nonspecific skin eruption

126

537

2.39

18.15

1.3

5.33

5.11

u/ml

0.05

254

Viral pneumonia (unknown virus, not influenza)

108

432

2.56

17.92

1.5

1.2

3.56

4.71

u/ml

0.60

205

Amputation

105

413

2.58

17.92

1.3

1.2

7.64

3.74

u/ml

0.62

195

Nontraumatic intracranial haemmorrhage

171

828

2.08

17.88

1.4

1.2

3.77

3.60

u/ml

0.08

362

Noninfective enteritis and colitis

553

3713

1.50

17.87

1.3

3.95

3.86

u/ml

0.08

277

1777

Zoster [herpes zoster], including avohilmo

546

3530

1.50

17.83

1.3

1.2

4.64

3.81

u/ml

0.64

259

1635

Sleep apnoea

1069

5023

1.35

17.78

1.3

1.2

4.51

3.75

u/ml

1.01

479

2368

Other disorders of lacrimal gland

422

2688

1.58

17.55

1.3

1.2

3.73

4.15

u/ml

0.31

190

1214

Viral hepatitis, IBD co-morbidity

199

3.32

17.51

1.3

3.98

4.29

u/ml

0.08

Osteonecrosis

333

2.76

17.47

1.4

1.2

3.56

5.01

u/ml

0.66

148

Sleep disorders (combined)

1295

5172

1.31

17.45

1.3

1.2

4.68

3.78

u/ml

0.78

611

2487

Hereditary deficiency of other clotting factors

6.20

17.43

1.5

1.2

3.50

4.52

u/ml

0.22

Diseases of pulp and periapical tissues, including avohilmo

1227

4816

1.32

17.40

1.2

1.3

4.23

4.03

u/ml

0.12

573

2324

Hyperkalaemia

215

3.22

17.40

1.2

1.3

4.44

5.60

u/ml

0.20

112

Injuries to unspecified part of trunk, limb or body region

136

611

2.26

17.34

1.5

1.2

3.47

5.35

u/ml

1.08

279

Pyoderma gangrenosum

6.41

17.33

1.7

1.2

7.50

3.35

u/ml

0.50

COPD (mode)

258

1115

1.82

17.33

1.3

1.2

3.45

3.60

u/ml

0.12

131

505

Explicit bacterial Sepsis, including avohilmo

127

554

2.32

17.32

1.4

1.3

5.15

4.58

u/ml

0.19

250

Injuries to the ankle and foot

937

5921

1.36

17.21

1.3

3.84

4.02

u/ml

0.20

451

2835

Dysphagia

253

1417

1.80

17.17

1.3

1.2

3.64

u/ml

0.00

119

659

Respiratory disorders in diseases classified elsewhere

5.22

17.13

1.2

2.87

3.75

u/ml

0.43

Functional dyspepsia

315

1879

1.69

17.11

1.2

3.49

3.96

u/ml

0.39

151

866

Other diseases of liver

231

1263

1.85

17.05

1.4

1.3

3.87

4.13

u/ml

0.12

118

565

IgA nephropathy (IgA glomerulonephritis)

141

3.85

17.04

1.6

1.2

3.86

5.70

u/ml

0.42

Candidiasis

193

996

1.97

17.03

1.3

6.16

4.22

u/ml

0.36

102

435

Methotrexate

160

773

2.10

16.94

1.3

1.2

3.69

4.17

u/ml

0.23

350

Explicit bacterial Sepsis

123

536

2.33

16.83

1.4

1.2

4.71

4.54

u/ml

0.05

241

Irregular menses

668

3514

1.44

16.80

1.3

4.90

3.95

u/ml

0.51

293

1617

Disorders of parathyroid gland

203

1059

1.91

16.65

1.4

1.2

4.13

4.15

u/ml

0.01

478

Other disorders of white blood cells

303

2.81

16.58

1.3

1.2

4.21

5.32

u/ml

0.33

134

Conjunctivitis (acute, non atopic), including avohilmo

1194

5514

1.31

16.52

1.3

4.11

3.83

u/ml

0.32

567

2632

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

125

554

2.30

16.51

1.4

1.3

3.28

4.46

u/ml

0.91

253

Seropositive rheumatoid arthritis, wide

276

1605

1.74

16.49

1.3

1.2

3.93

4.19

u/ml

0.13

122

733

Other bacterial intestinal infections, including avohilmo

263

1510

1.76

16.44

1.4

1.2

5.03

4.04

u/ml

0.73

135

703

Primary_lymphoid and hematopoietic malignant neoplasms

236

1313

1.81

16.42

1.2

4.01

4.29

u/ml

0.14

102

612

Other or ill-defined heart diseases

271

2.90

16.41

1.3

1.2

4.80

3.01

u/ml

0.28

118

Misadventures to patients during surgical and medical care

174

878

2.01

16.39

1.3

1.2

3.84

4.71

u/ml

0.47

388

Any mental disorder

1252

4814

1.31

16.28

1.3

1.2

3.71

3.99

u/ml

0.32

568

2300

Trochanteric bursitis

160

785

2.06

16.27

1.3

1.2

2.93

3.39

u/ml

0.32

347

Superficial injury of lower leg

326

1990

1.65

16.24

1.3

3.39

4.08

u/ml

0.71

156

943

Urticaria and erythema

465

3081

1.52

16.22

1.3

4.59

3.86

u/ml

0.62

221

1441

Other complications of surgical and medical care, not elsewhere classified

131

598

2.23

16.11

1.5

1.2

4.81

4.29

u/ml

0.16

265

Neoplasms

1001

3918

1.35

16.09

1.3

4.19

3.95

u/ml

0.21

481

1893

External causes of morbidity and mortality

783

2812

1.40

16.02

1.3

1.2

4.76

3.63

u/ml

0.85

358

1368

Other/unspecified seropositive rheumatoid arthritis

271

1583

1.73

15.95

1.2

3.68

4.20

u/ml

0.33

119

722

Congenital varicose veins

7.05

15.95

1.2

1.1

2.89

2.75

u/ml

0.04

Other CVD

183

948

1.95

15.92

1.3

1.2

5.91

4.25

u/ml

0.37

425

Injuries to the thorax

489

3284

1.50

15.89

1.3

1.2

3.32

3.82

u/ml

0.78

249

1540

Sequelae with surgical and medical care as external cause

223

1234

1.83

15.85

1.3

1.2

4.13

4.57

u/ml

0.17

565

Vascular syndromes of brain in cerebrovascular disorders

157

3.51

15.84

1.3

1.2

5.95

8.53

u/ml

0.29

Agranulocytosis

142

674

2.14

15.84

1.3

1.2

3.72

4.48

u/ml

0.43

283

Complications of cardiac and vascular prosthetic devices, implants and grafts

4.90

15.78

1.9

1.1

5.21

3.00

u/ml

0.53

Inflammatory diseases of the central nervous system

119

528

2.30

15.72

1.4

1.2

4.69

4.60

u/ml

0.03

242

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

268

1569

1.72

15.66

1.3

1.2

3.69

4.22

u/ml

0.32

118

714

Streptococcal septicaemia, including avohilmo

106

448

2.40

15.61

1.4

1.2

4.74

4.48

u/ml

0.08

201

Streptococcal septicaemia

104

436

2.42

15.60

1.4

1.2

4.81

4.41

u/ml

0.13

197

Cerebral aneurysm, nonruptured

101

418

2.46

15.59

1.5

1.2

4.71

3.82

u/ml

0.32

169

Myeloproliferative diseases (CML excluded)

353

2.60

15.58

1.2

4.04

6.06

u/ml

0.50

154

Conjunctivitis

946

5724

1.34

15.57

1.3

4.83

3.88

u/ml

0.78

463

2713

Open wound of lower leg

184

965

1.93

15.51

1.3

4.14

4.71

u/ml

0.25

104

453

Asthma/COPD (KELA code 203)

1126

5777

1.31

15.45

1.2

1.3

3.67

4.03

u/ml

0.47

493

2772

Oesophageal varices

175

3.34

15.40

1.4

1.2

2.31

4.69

u/ml

1.31

Cervicalgia

236

1341

1.78

15.35

1.3

1.2

6.60

3.81

u/ml

0.58

102

632

Adverse effects, not elsewhere classified

266

1565

1.72

15.33

1.3

1.2

3.52

4.05

u/ml

0.36

127

700

Unspecified fall

559

3810

1.45

15.32

1.3

1.2

3.52

4.05

u/ml

0.73

253

1840

Injury, poisoning and certain other consequences of external causes

649

2274

1.44

15.31

1.3

4.98

3.71

u/ml

0.77

291

1114

Voice disturbances

297

1800

1.66

15.26

1.2

3.29

4.08

u/ml

0.93

142

820

Migraine, single triptan purchase ok & required. ICD-code if available is included

975

4985

1.33

15.22

1.3

4.04

4.00

u/ml

0.02

441

2392

Triptan medication for migraine, single purchase ok

975

4985

1.33

15.22

1.3

4.04

4.00

u/ml

0.02

441

2392

Nonorganic sleeping disorders, excluding more controls

281

1681

1.69

15.20

1.3

1.2

4.28

4.45

u/ml

0.07

134

812

Falls/tendency to fall

1298

5069

1.29

15.09

1.3

3.20

4.14

u/ml

2.25

606

2418

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

396

2547

1.55

15.08

1.2

1.3

4.11

4.56

u/ml

0.29

208

1180

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

127

589

2.19

15.06

1.4

1.2

4.16

5.03

u/ml

0.23

263

Other localized connective tissue disorders

107

4.09

15.04

1.4

1.2

4.32

3.31

u/ml

0.33

Other and unspecified disorders of white blood cells

209

3.10

15.01

1.3

1.2

3.88

5.68

u/ml

0.44

Myeloproliferative diseases

402

2.45

14.96

1.2

4.00

5.91

u/ml

0.54

184

Focal epilepsy, strict definition

229

1301

1.78

14.92

1.4

1.3

4.78

4.24

u/ml

0.23

112

610

Other noninfective gastroenteritis and colitis

285

1720

1.67

14.85

1.3

1.2

4.29

4.08

u/ml

0.11

139

804

Disorders of conjunctiva

1015

6008

1.31

14.82

1.3

4.76

3.87

u/ml

0.77

489

2850

Other viral diseases, not elsewhere classified, including avohilmo

360

2291

1.58

14.75

1.3

3.98

4.04

u/ml

0.03

177

1089

Disorders of skin appendages

625

4444

1.41

14.66

1.4

1.3

4.07

4.05

u/ml

0.01

289

2121

Focal epilepsy, mode (most common among epilepsy diagnosis)

218

1231

1.79

14.52

1.3

3.90

4.38

u/ml

0.22

109

572

Medical abortion

714

2784

1.40

14.50

1.2

1.3

3.85

3.86

u/ml

0.00

312

1278

Sequelae of other external causes

319

2.62

14.49

1.5

1.2

3.24

5.15

u/ml

0.94

144

Injury of unspecified body region

102

439

2.36

14.49

1.4

1.2

3.43

4.33

u/ml

0.42

209

Focal epilepsy

245

1432

1.73

14.44

1.4

1.3

4.63

4.37

u/ml

0.10

120

673

Hypothyroidism, other/unspecified

1005

5049

1.31

14.30

1.3

1.2

4.19

3.87

u/ml

0.27

492

2340

Disorders of lacrimal system

482

3249

1.47

14.24

1.3

1.2

3.62

4.04

u/ml

0.39

219

1490

Gingivitis and periodontal diseases

1102

4381

1.30

14.23

1.2

1.3

3.43

4.20

u/ml

1.49

520

2050

Other autoimmune haemolytic anaemias

5.04

14.22

1.5

1.1

5.46

3.48

u/ml

0.34

Need for immunization against other single viral diseases

117

3.84

14.09

1.7

1.3

5.35

3.94

u/ml

0.24

Gonarthrosis

640

2572

1.41

14.08

1.2

3.30

3.72

u/ml

0.52

264

1243

Osteoporosis with pathological fracture (FG)

267

2.74

13.95

1.2

4.27

3.54

u/ml

0.17

111

Other (seronegative) rheumatoid arthritis, wide

200

1116

1.81

13.90

1.3

1.2

3.98

4.46

u/ml

0.27

503

Central retinal artery occlusion

4.83

13.86

1.3

4.54

8.41

u/ml

0.47

Fibromyalgia

129

623

2.10

13.82

1.4

1.2

4.79

3.56

u/ml

0.43

267

Chronic nephritic syndrome

214

2.98

13.82

1.3

1.2

3.53

5.55

u/ml

0.60

Disorders of myoneural junction and muscle in diseases classified elsewhere

6.28

13.75

1.3

1.1

7.46

4.00

u/ml

0.36

Obesity due to excess calories

594

4260

1.40

13.74

1.3

4.56

4.16

u/ml

0.29

281

2026

All influenza (not pneumonia)

178

962

1.87

13.73

1.3

4.22

3.42

u/ml

0.38

434

Pleural effusion

143

718

2.01

13.72

1.3

1.2

3.39

4.87

u/ml

0.92

320

Persons encountering health services in circumstances related to reproduction

682

3322

1.38

13.70

1.3

3.35

3.87

u/ml

0.82

322

1654

Disorders of lens

672

3016

1.39

13.63

1.3

1.2

4.61

3.78

u/ml

0.61

324

1382

Other disorders of eye and adnexa

186

1023

1.84

13.61

1.3

1.2

4.28

4.71

u/ml

0.15

453

Aneurysms, operations, SAH

154

798

1.95

13.50

1.5

1.2

5.11

3.95

u/ml

0.54

353

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

336

2.51

13.49

1.6

1.2

7.89

5.76

u/ml

0.37

152

Gonarthrosis [arthrosis of knee](FG)

717

3016

1.37

13.47

1.2

3.29

3.69

u/ml

0.51

297

1436

Diabetic nephropathy, excluding more controls

157

660

1.96

13.45

1.3

3.89

3.91

u/ml

0.01

300

Atrial septal defect, secundum type

180

3.15

13.41

1.3

4.88

5.43

u/ml

0.10

Cluster headache, wide

223

2.89

13.41

1.3

1.2

3.28

3.37

u/ml

0.03

101

Irritable bowel syndrome

326

2088

1.57

13.40

1.2

4.06

3.90

u/ml

0.09

156

937

Other bacterial intestinal infections

191

1063

1.81

13.40

1.4

1.2

5.97

4.05

u/ml

1.17

491

Conduction disorders

257

1235

1.68

13.29

1.3

1.2

5.19

3.58

u/ml

1.22

115

561

Cluster headache, strict

208

2.96

13.27

1.3

1.2

3.33

3.45

u/ml

0.04

Left ventricular outflow tract obstruction, narrow definition

310

2.58

13.27

1.3

1.2

6.62

4.97

u/ml

0.36

146

Somatoform disorder

208

1192

1.76

13.26

1.3

1.2

3.21

4.03

u/ml

0.86

101

541

169

912

1.89

13.24

1.3

1.2

4.71

3.89

u/ml

0.28

396

Budesonide

167

896

1.88

13.21

1.3

1.2

3.37

4.24

u/ml

0.70

413

Other and unspecified drugs and medicaments

113

529

2.17

13.16

1.4

1.2

3.35

4.43

u/ml

0.68

239

Artificial opening status

276

2.66

13.15

1.2

3.80

4.52

u/ml

0.24

124

Fracture of rib(s), sternum and thoracic spine

304

1925

1.59

13.13

1.3

1.2

3.21

4.04

u/ml

1.06

153

906

Hyperparathyroidism

166

880

1.88

13.11

1.3

1.2

3.65

4.17

u/ml

0.22

395

Hypertensive heart and/or renal disease

213

885

1.77

13.10

1.3

1.2

3.43

3.72

u/ml

0.18

110

398

Myocardial infarction, strict

378

1757

1.53

13.10

1.3

1.2

5.22

3.69

u/ml

1.09

178

783

Sulfasalazine

295

1858

1.60

13.04

1.2

3.65

3.72

u/ml

0.05

137

895

Sciatica+with lumbago

589

3758

1.39

13.01

1.2

3.60

3.61

u/ml

0.01

235

1802

Hypothyreosis and Thyroxine purchase for inclusion criteria

1039

5294

1.29

12.98

1.3

1.2

4.15

3.92

u/ml

0.18

506

2455

Arthrosis

744

3013

1.36

12.96

1.2

4.21

3.69

u/ml

0.32

324

1452

Other and unspecified effects of external causes

355

2336

1.53

12.96

1.3

4.58

4.03

u/ml

0.16

171

1083

Essential (haemorrhagic) thrombocythaemia

174

3.12

12.89

1.2

4.48

7.51

u/ml

0.39

Congenital malformations of the urinary system

345

2.46

12.83

1.3

3.76

4.63

u/ml

0.23

160

Immunodeficiencies

298

2.58

12.79

1.2

3.97

4.92

u/ml

0.25

132

Symptoms and signs involving the urinary system

790

4490

1.33

12.76

1.3

1.2

4.81

3.57

u/ml

1.12

370

2118

Other diseases of anus and rectum

290

1822

1.60

12.73

1.4

1.2

4.93

3.89

u/ml

0.34

145

816

Complications of internal orthopaedic prosthetic devices, implants and grafts

196

1118

1.77

12.66

1.2

3.83

4.05

u/ml

0.09

499

Other specified disorders of kidney and ureter

171

3.13

12.64

1.4

1.2

6.09

6.25

u/ml

0.02

Disorders of choroid and retina

805

4257

1.33

12.64

1.3

1.2

4.67

3.79

u/ml

0.58

405

1964

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

248

2.74

12.62

1.5

1.3

3.63

4.86

u/ml

0.28

105

Gastroduodenal ulcer

216

1264

1.71

12.57

1.3

1.2

3.90

4.02

u/ml

0.08

115

576

Isolated proteinuria

167

3.15

12.52

1.3

1.2

2.46

5.06

u/ml

1.03

Diabetic nephropathy

157

830

1.89

12.50

1.3

3.89

4.73

u/ml

0.41

390

Persons encountering health services in other circumstances

450

3092

1.45

12.48

1.4

1.2

4.18

3.97

u/ml

0.13

219

1452

Symptoms and signs concerning food and fluid intake

111

526

2.13

12.43

1.2

3.50

4.58

u/ml

0.64

230

L01XX Other antineoplastic agents

238

2.74

12.41

1.2

3.93

4.51

u/ml

0.10

110

Disorders of gallbladder, biliary tract and pancreas

1077

5263

1.28

12.40

1.3

1.2

4.20

3.85

u/ml

0.32

522

2423

Thyroiditis, ILD-related definition

146

767

1.93

12.38

1.4

1.2

3.93

3.86

u/ml

0.03

329

Other specified and unspecified disorders of eye and adnexa

211

2.87

12.37

1.3

1.2

6.07

5.52

u/ml

0.06

COPD

370

2001

1.51

12.32

1.3

1.2

3.56

3.88

u/ml

0.32

184

930

Polyarteritis nodosa and related conditions

4.66

12.27

1.7

1.2

2.93

3.36

u/ml

0.16

Other gastritis (incl. Duodenitis)

212

1248

1.71

12.27

1.3

1.2

3.61

4.03

u/ml

0.24

112

576

Venous complications and haemorrhoids in pregnancy

144

3.34

12.24

1.2

1.3

2.45

5.98

u/ml

1.21

Other skin changes

198

1145

1.74

12.23

1.3

1.2

3.39

4.37

u/ml

0.86

534

Congenital malformations of aortic and mitral valves

252

2.68

12.22

1.3

1.2

7.05

5.04

u/ml

0.38

123

Female infertility, associated with anovulation

133

681

1.99

12.22

1.3

2.98

5.27

u/ml

1.51

317

Other specified and unspecified retinal disorders

159

3.16

12.17

1.2

4.03

6.06

u/ml

0.46

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

191

2.93

12.12

1.2

4.71

8.33

u/ml

0.68

Other immunodeficiencies

4.64

12.10

1.2

3.54

3.25

u/ml

0.08

Hypotension

147

780

1.90

12.04

1.3

1.2

6.54

4.56

u/ml

0.33

355

Other and unspecified diseases of blood and blood-forming organs

130

3.41

12.01

1.6

1.2

5.15

u/ml

0.00

Gastric ulcer

155

838

1.86

11.98

1.2

3.97

4.23

u/ml

0.12

369

Invasive ventilation

406

2.28

11.98

1.4

1.2

4.89

5.47

u/ml

0.12

189

Hereditary factor VIII deficiency

14.34

11.97

1.2

3.50

4.67

u/ml

—

Chronic periodontitis, complicated

574

4082

1.38

11.95

1.2

3.50

3.78

u/ml

0.23

270

1921

Congenital malformations of the urinary system, including avohilmo

369

2.35

11.94

1.3

3.76

4.73

u/ml

0.27

172

Enthesopathies of lower limb, excluding foot

263

1653

1.60

11.81

1.2

3.74

3.57

u/ml

0.07

110

807

Dermatopolymyositis (FG)

4.63

11.79

1.1

1.2

4.36

7.82

u/ml

0.42

Allergic purpura

173

3.03

11.79

1.4

1.2

5.74

3.70

u/ml

0.55

Other diseases of blood and blood-forming organs

391

2.29

11.71

1.5

1.2

5.12

4.69

u/ml

0.10

175

Behavioural syndromes associated with physiological disturbances and physical factors

1108

5961

1.26

11.70

1.3

4.62

3.89

u/ml

0.51

515

2840

Benign neoplasms

1161

5031

1.26

11.68

1.3

4.05

3.99

u/ml

0.05

545

2414

Hernia

1011

5283

1.28

11.67

1.3

1.2

3.93

3.77

u/ml

0.17

508

2454

Anosmia

9.00

11.64

1.1

1.0

5.33

1.50

u/ml

—

Systemic sclerosis,strict definition

4.94

11.62

1.3

1.1

5.12

3.95

u/ml

0.13

Abnormal involuntary movements

155

848

1.85

11.61

1.3

4.35

4.76

u/ml

0.17

384

Other viral diseases, not elsewhere classified

227

1378

1.66

11.60

1.3

4.49

4.36

u/ml

0.04

111

653

Other diseases of upper respiratory tract

1210

5044

1.25

11.57

1.3

3.94

4.05

u/ml

0.11

582

2407

Overexertion and strenuous or repetitive movements

132

687

1.95

11.57

1.3

5.44

3.97

u/ml

0.35

319

Sleep apnoea, including avohilmo

1097

5264

1.26

11.57

1.3

1.2

4.43

3.73

u/ml

0.97

493

2501

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

376

2566

1.48

11.54

1.3

1.2

6.22

3.82

u/ml

2.33

178

1193

Zoster [herpes zoster]

184

1061

1.75

11.52

1.3

4.17

4.28

u/ml

0.03

485

Periodontitis

1099

5569

1.26

11.51

1.2

1.3

3.25

4.03

u/ml

1.76

502

2623

Abnormal serum enzyme levels

269

1650

1.58

11.43

1.3

1.2

4.02

4.16

u/ml

0.05

133

778

Malignant neoplasm, including Hilmo

996

4556

1.28

11.40

1.3

3.83

3.78

u/ml

0.04

473

2106

Early onset COPD

223

1361

1.65

11.31

1.3

1.2

3.63

4.10

u/ml

0.32

617

Inflammatory diseases of female pelvic organs

756

3939

1.32

11.31

1.3

1.2

5.19

3.91

u/ml

1.24

317

1801

Other and unspecified local infections of skin and subcutaneous tissue

120

610

1.99

11.26

1.5

1.2

3.90

4.41

u/ml

0.21

280

Other local infections of skin and subcutaneous tissue

127

659

1.95

11.23

1.5

1.2

3.86

4.31

u/ml

0.19

294

5-aminosalicylic acid

239

1487

1.62

11.22

1.3

1.2

3.93

3.83

u/ml

0.06

122

710

Allergic urticaria

111

550

2.05

11.21

1.3

4.64

4.28

u/ml

0.12

248

Chronic periodontitis, including avohilmo

1094

5567

1.26

11.18

1.2

1.3

3.26

4.02

u/ml

1.69

501

2622

Enterocolitis due to Clostridium difficile

107

523

2.07

11.16

1.4

1.2

6.96

5.16

u/ml

0.54

241

Urticaria

373

2559

1.47

11.16

1.3

4.48

3.99

u/ml

0.30

169

1197

Pain and other conditions associated with female genital organs and menstrual cycle

272

1452

1.58

11.14

1.3

3.97

4.84

u/ml

0.45

132

694

Use of hypnotics and sedatives

1199

5514

1.25

11.12

1.3

3.36

4.05

u/ml

1.67

534

2618

Nonorganic sleeping disorders

281

1822

1.56

11.08

1.3

1.2

4.28

4.03

u/ml

0.14

134

862

Personal history of other diseases and conditions

155

857

1.82

11.07

1.3

3.41

4.03

u/ml

0.43

387

Unspecified haematuria

379

2113

1.47

11.07

1.3

1.2

4.86

3.69

u/ml

0.86

191

985

Other and unspecified haemorrhagic conditions

3.96

11.06

1.8

1.2

5.33

4.00

u/ml

0.22

Pneumocystosis

3.84

10.97

1.4

1.2

6.21

7.29

u/ml

0.12

Pneumocystosis, including avohilmo

3.84

10.97

1.4

1.2

6.21

7.29

u/ml

0.12

Other general symptoms and signs

275

2.49

10.94

1.3

1.2

5.26

5.71

u/ml

0.09

118

Malignant neoplasm, wide definition

992

4558

1.27

10.93

1.3

3.84

3.78

u/ml

0.06

469

2110

Migraine without aura and triptan purchases

245

1546

1.60

10.91

1.3

1.2

4.38

4.19

u/ml

0.08

125

698

Disorders of sclera, cornea, iris and ciliary body

605

4524

1.34

10.87

1.3

1.2

3.97

3.78

u/ml

0.14

282

2134

Crystal arthropathies, rheuma endpoint

5.24

10.84

1.3

4.55

5.74

u/ml

0.20

Viral infections characterized by skin and mucous membrane lesions

469

3368

1.40

10.83

1.3

3.70

3.93

u/ml

0.16

227

1622

Mucosal proctocolitis

166

948

1.77

10.83

1.3

3.84

3.91

u/ml

0.04

442

Pain in thoracic spine

182

1066

1.72

10.83

1.3

1.2

4.80

3.75

u/ml

0.59

504

Cystic kidney disease

182

2.88

10.79

1.3

1.2

4.43

5.12

u/ml

0.12

Systemic disorders of connective tissue in diseases classified elsewhere

10.03

10.71

1.3

1.2

2.14

6.00

u/ml

0.71

Memory loss

387

2.22

10.67

1.2

5.53

6.07

u/ml

0.08

181

Progressive vascular leukoencephalopathy

3.78

10.60

1.0

1.1

4.81

2.81

u/ml

0.35

Depression or dysthymia

709

2936

1.32

10.52

1.2

3.90

3.83

u/ml

0.05

328

1440

Personal history of malignant neoplasm

103

509

2.05

10.50

1.2

3.18

4.51

u/ml

0.91

209

Internal derangement of knee

396

2753

1.43

10.45

1.2

1.3

3.04

3.71

u/ml

0.82

163

1340

Other puerperal infections

133

720

1.88

10.43

1.3

2.61

4.10

u/ml

1.44

315

Benign neoplasm of other and ill-defined parts of digestive system

176

1033

1.72

10.41

1.3

1.2

5.31

4.50

u/ml

0.21

467

Diagnoses used for exclusion with ILD

239

1515

1.59

10.40

1.3

1.2

5.20

4.24

u/ml

0.39

112

701

Other and unspecified acquired haemolytic anaemias

4.95

10.39

1.5

1.2

4.20

3.67

u/ml

0.09

Dermatopolymyositis

4.16

10.34

1.1

1.2

4.36

4.27

u/ml

0.02

Viral warts, including avohilmo

272

1780

1.54

10.32

1.2

1.3

4.11

4.02

u/ml

0.04

143

835

Diseases of salivary glands

358

2476

1.46

10.31

1.3

1.2

3.70

3.84

u/ml

0.05

172

1150

Other disorders of bone

232

1465

1.60

10.31

1.2

1.3

4.28

u/ml

0.00

664

Meniscus derangement

542

2644

1.37

10.26

1.2

1.3

3.30

3.80

u/ml

0.69

228

1285

Unspecified acute lower respiratory infection

176

1038

1.71

10.24

1.5

1.2

4.33

4.47

u/ml

0.05

498

Abnormal findings on diagnostic imaging of other body structures

156

890

1.77

10.22

1.2

3.11

4.70

u/ml

1.14

399

Hypokalaemia

121

639

1.91

10.17

1.3

1.2

5.29

4.45

u/ml

0.19

283

Hypertensive Renal Disease

108

3.39

10.16

1.5

1.1

5.60

3.32

u/ml

0.41

Other metabolic disorders

152

863

1.78

10.13

1.3

1.2

4.82

3.76

u/ml

0.47

376

Post-traumatic stress disorder

132

719

1.86

10.13

1.4

1.2

3.28

4.16

u/ml

0.53

322

Psychiatric diseases

1070

4296

1.25

10.10

1.3

1.2

3.88

3.78

u/ml

0.10

483

2057

Other chronic obstructive pulmonary disease

342

1915

1.47

10.09

1.3

1.2

3.55

3.87

u/ml

0.29

170

895

Hallux valgus (acquired)

302

1435

1.51

10.08

1.2

3.33

3.99

u/ml

0.68

119

675

Childhood asthma (age<16), excluding more controls

191

894

1.68

10.08

1.3

3.25

5.07

u/ml

1.29

445

Other problems related to primary support group, including family circumstances

158

884

1.76

10.05

1.2

1.3

4.23

4.15

u/ml

0.04

393

Idiopathic urticaria

151

3.01

10.05

1.2

1.3

2.78

5.69

u/ml

1.00

Seronegative rheumatoid arthritis

113

586

1.95

10.04

1.3

1.2

3.57

3.80

u/ml

0.10

261

Localized swelling, mass and lump of skin and subcutaneous tissue

323

2202

1.48

10.03

1.3

1.2

3.47

3.96

u/ml

0.54

137

1034

Hypermobility syndrome

392

2.19

10.02

1.3

4.70

4.04

u/ml

0.13

159

Protozoal diseases, including avohilmo

173

2.85

10.00

1.4

1.2

6.21

6.44

u/ml

0.03

Protozoal diseases

162

2.92

10.00

1.4

1.2

6.44

6.37

u/ml

0.01

Rotator cuff syndrome

578

2972

1.34

9.95

1.3

1.2

3.21

3.82

u/ml

1.19

249

1409

Disorders of optic nerve and visual pathways

120

638

1.91

9.94

1.4

1.3

4.38

4.44

u/ml

0.01

294

Colectomy operation

159

920

1.74

9.92

1.3

1.2

3.01

4.54

u/ml

1.34

417

Noninfectious colitis NAS

153

876

1.76

9.92

1.3

4.41

4.49

u/ml

0.03

397

Bacterial intestinal infections, IBD co-morbidities

183

1100

1.68

9.91

1.4

1.2

6.11

4.57

u/ml

0.75

499

Disorders of vitreous body and globe

473

3265

1.38

9.89

1.3

1.2

3.21

4.00

u/ml

1.45

244

1480

Malignant neoplasm

947

4412

1.26

9.85

1.3

3.66

3.80

u/ml

0.16

444

2044

Diseases of oral cavity, salivary glands and jaws

543

2057

1.36

9.82

1.2

1.3

4.71

3.91

u/ml

0.42

252

955

Senile cataract

565

2555

1.35

9.79

1.2

5.06

3.74

u/ml

0.87

259

1168

Complex cardiac defects

5.16

9.75

1.2

4.50

2.73

u/ml

0.53

Other and unspecified erythematous conditions

181

2.77

9.75

1.3

1.2

5.88

6.17

u/ml

0.04

Disorders of vitreous body

462

3205

1.38

9.74

1.3

1.2

3.26

4.03

u/ml

1.33

237

1454

Sleep disorders

1054

5869

1.24

9.73

1.3

4.69

3.90

u/ml

0.53

491

2793

Polymyalgia rheumatica

107

551

1.96

9.70

1.2

3.02

5.43

u/ml

1.35

245

Malignant neoplasm

946

4418

1.26

9.66

1.3

3.66

3.79

u/ml

0.15

444

2049

L01XE Protein kinase inhibitors

246

2.48

9.65

1.1

1.2

2.69

5.65

u/ml

1.42

111

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

350

2411

1.44

9.65

1.3

5.44

4.20

u/ml

0.66

159

1155

Unspecified/other endometriosis

133

722

1.83

9.64

1.3

4.21

4.57

u/ml

0.11

332

Molar incisor enamel hypoplasia, with caries

5.22

9.59

1.4

1.7

2.33

6.08

u/ml

1.19

Atopic dermatitis

741

4600

1.29

9.59

1.3

1.2

4.30

4.11

u/ml

0.13

345

2189

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

655

4829

1.30

9.57

1.2

1.3

4.64

3.98

u/ml

0.33

308

2238

Other infectious diseases, including avohilmo

493

2.01

9.54

1.3

1.2

3.23

5.56

u/ml

1.22

227

Superficial injury of head

257

1689

1.53

9.52

1.3

3.74

4.40

u/ml

0.48

129

798

Other diseases of lip and oral mucosa

446

3253

1.38

9.51

1.3

1.2

3.85

3.77

u/ml

0.05

209

1507

Insomnia

1047

5903

1.24

9.50

1.3

4.55

3.92

u/ml

0.39

484

2812

Thyrotoxicosis, other and/or unspecified

223

1424

1.58

9.48

1.4

1.2

5.41

3.84

u/ml

1.27

111

635

Diseases of pulp and periapical tissues and dental caries

648

2523

1.32

9.47

1.2

1.3

4.00

4.13

u/ml

0.09

296

1200

Bicuspidal aortic valve syndrome

225

2.55

9.44

1.4

1.3

7.03

5.31

u/ml

0.28

112

Childhood asthma (age<16)

191

911

1.65

9.42

1.3

3.25

5.03

u/ml

1.27

452

COPD related to multimorbidity

300

1717

1.48

9.41

1.3

1.2

3.56

4.00

u/ml

0.38

149

788

Other disorders of optic [2nd] nerve and visual pathways

389

2.14

9.39

1.4

1.3

3.45

4.93

u/ml

0.50

187

Abnormal findings on diagnostic imaging of central nervous system

318

2.27

9.38

1.2

2.87

5.20

u/ml

1.10

142

Injuries to the head

1270

6220

1.21

9.36

1.3

3.47

4.06

u/ml

1.21

622

2943

Other enthesopathies

303

2069

1.47

9.36

1.2

3.33

3.73

u/ml

0.31

130

970

Nonalcoholic fatty liver disease

128

709

1.83

9.34

1.3

1.2

4.44

4.09

u/ml

0.10

313

Wegener granulomatosis

3.94

9.33

1.1

1.2

2.86

3.60

u/ml

—

Polycystic kidney disease

153

2.89

9.21

1.3

1.2

3.65

4.26

u/ml

0.12

Other diseases of hard tissues of teeth

535

2055

1.35

9.21

1.3

3.13

3.91

u/ml

1.67

240

954

Cerebral cysts

353

2.19

9.19

1.3

2.91

4.46

u/ml

1.07

168

Other arthrosis

499

2473

1.36

9.16

1.2

5.27

3.75

u/ml

0.82

211

1200

Ulcerative colitis

279

1885

1.49

9.15

1.3

3.91

4.04

u/ml

0.08

142

871

Other erythematous conditions

205

2.59

9.12

1.3

1.2

5.81

5.78

u/ml

0.00

Disorders of eyelid, lacrimal system and orbit

924

5442

1.25

9.12

1.3

1.2

3.50

4.13

u/ml

1.00

444

2530

Other pleural conditions

453

2.03

9.12

1.3

1.2

4.42

5.95

u/ml

0.34

203

Drug-induced osteoporosis

3.98

9.07

1.3

1.2

1.33

4.00

u/ml

—

Coxarthrosis [arthrosis of hip](FG)

452

2270

1.37

9.06

1.2

4.09

3.88

u/ml

0.12

196

1071

AV-block

137

661

1.78

9.06

1.4

1.2

4.43

3.10

u/ml

0.81

298

Allergic conjunctivitis

680

5100

1.29

9.05

1.2

1.3

4.57

4.07

u/ml

0.25

322

2378

Polyarthritis, unspecified

171

2.74

9.04

1.4

1.3

3.33

3.88

u/ml

0.23

Venous complications and haemorrhoids in the puerperium

3.89

9.04

1.2

2.75

5.96

u/ml

0.43

Problems related to lifestyle

133

753

1.79

9.03

1.3

1.2

4.02

3.99

u/ml

0.01

344

Other inflammation of eyelid, including avohilmo

544

4123

1.33

9.02

1.3

4.77

4.16

u/ml

0.47

282

1917

Secondary thrombocytopenia

4.07

8.98

2.0

1.2

8.06

3.54

u/ml

0.85

Ascites

369

2.14

8.98

1.4

1.2

4.20

3.49

u/ml

0.29

159

Acute peritonitis

324

2.22

8.96

1.4

1.2

3.49

6.09

u/ml

0.78

149

Injuries to the abdomen, lower back, lumbar spine and pelvis

407

2913

1.38

8.91

1.4

1.2

3.46

3.96

u/ml

0.56

188

1372

Elevated blood glucose level

485

1.98

8.91

1.4

1.2

5.26

4.89

u/ml

0.09

227

Ectopic pregnancy

192

1203

1.61

8.90

1.2

6.91

3.36

u/ml

0.64

542

Idiopathic gout

417

2.06

8.89

1.3

2.78

5.73

u/ml

1.29

199

Abnormal results of function studies

107

571

1.90

8.81

1.4

1.2

2.54

4.37

u/ml

1.91

258

Exclusions for E4_PCOS_BROAD

200

1268

1.59

8.79

1.3

7.68

4.06

u/ml

1.22

575

Shoulder lesions

722

3382

1.28

8.77

1.2

3.63

3.86

u/ml

0.27

316

1599

Dermatophytosis, including avohilmo

720

5564

1.27

8.75

1.3

4.52

3.83

u/ml

0.50

344

2658

Dental pulpitis, including avohilmo

1103

5802

1.22

8.74

1.2

1.3

4.46

3.83

u/ml

0.41

497

2796

Other juvenile arthritis

246

2.40

8.72

1.2

1.3

3.45

3.68

u/ml

0.10

114

Olecranon bursitis

315

2.22

8.71

1.3

1.2

2.50

3.89

u/ml

1.11

152

Intestinal stricture

270

1830

1.48

8.71

1.3

1.2

5.74

4.16

u/ml

0.40

137

843

Vitreous haemorrhage

106

566

1.89

8.71

1.3

1.2

3.98

4.73

u/ml

0.28

251

Other crystal arthropathies

4.33

8.70

1.3

1.4

4.55

4.85

u/ml

0.05

Polycythaemia vera

130

2.98

8.70

1.2

3.14

6.80

u/ml

0.64

Excessive, frequent and irregular menstruation

423

1631

1.39

8.70

1.2

1.3

4.80

4.85

u/ml

0.01

187

763

Viral pneumonia (known virus, not influenza)

147

2.86

8.66

1.2

3.52

4.97

u/ml

0.39

Other shoulder lesions

109

589

1.87

8.63

1.3

4.74

3.66

u/ml

0.35

271

Cystic kidney disease, including avohilmo

205

2.55

8.63

1.3

1.2

4.43

4.74

u/ml

0.05

Acute pancreatitis

187

1175

1.60

8.56

1.3

1.2

6.45

3.66

u/ml

0.67

543

Localized scleroderma [morphea]

3.58

8.47

1.5

1.1

3.94

3.60

u/ml

0.10

Persistent mood disorders

210

1360

1.56

8.45

1.3

3.49

4.23

u/ml

0.43

626

Other inflammation of eyelid

153

918

1.68

8.45

1.3

4.59

4.95

u/ml

0.11

413

Diseases of peritoneum

105

565

1.88

8.44

1.3

1.2

3.48

5.26

u/ml

0.76

253

Algoneurodystrophy

226

2.45

8.40

1.2

3.27

4.84

u/ml

0.60

Visual impairment including blindness (binocular or monocular)

307

2.21

8.38

1.3

1.2

4.27

3.77

u/ml

0.15

133

Total colectomy operation

245

2.37

8.34

1.3

1.2

3.71

5.36

u/ml

0.48

102

Total colectomy

245

2.37

8.34

1.3

1.2

3.71

5.36

u/ml

0.48

102

Fibrosis and cirrhosis of liver

421

2.02

8.33

1.5

1.2

3.53

5.47

u/ml

0.69

186

Inflammatory bowel disease

354

2545

1.40

8.33

1.3

3.84

3.80

u/ml

0.03

180

1183

Endometriosis

368

1526

1.41

8.31

1.3

4.41

4.95

u/ml

0.14

156

699

Disorder of lipoprotein metabolism, unspecified

109

597

1.84

8.26

1.2

5.86

4.32

u/ml

0.30

281

Other abnormal findings of blood chemistry

271

2.29

8.26

1.5

1.2

2.42

4.24

u/ml

1.28

128

Abnormal findings on examination of urine, without diagnosis

246

2.36

8.26

1.3

1.2

3.19

5.28

u/ml

0.79

111

Amputation of toe

309

2.19

8.26

1.3

1.2

9.33

5.11

u/ml

0.43

146

Hypoplasia of dental enamel

4.39

8.25

1.3

1.5

1.93

5.03

u/ml

1.46

Other diseases of pancreas

464

1.96

8.24

1.2

3.52

3.98

u/ml

0.17

200

Triptan medication for migraine, min. 3 purchases

726

4300

1.27

8.24

1.3

4.36

3.94

u/ml

0.21

338

1997

Carcinoma in situ of skin of other and unspecified parts of face

277

2.26

8.23

1.1

1.2

3.46

6.44

u/ml

0.87

134

Reactive arthropathies

478

1.95

8.23

1.2

1.3

2.21

4.00

u/ml

3.03

233

Antenatal screening

267

1004

1.50

8.22

1.3

3.94

4.44

u/ml

0.26

122

484

Pre-eclampsia or poor fetal growth

394

2878

1.37

8.20

1.3

1.2

4.56

4.11

u/ml

0.28

189

1279

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

489

3656

1.33

8.19

1.3

3.27

4.15

u/ml

1.39

234

1751

Hypertensive Heart Disease

175

821

1.62

8.17

1.3

1.2

2.91

3.75

u/ml

0.90

369

Any death

559

2997

1.31

8.15

1.3

1.2

3.97

3.95

u/ml

0.01

280

1408

Cholelithiasis

843

4635

1.24

8.14

1.3

1.2

3.85

3.82

u/ml

0.03

403

2113

Cholelithiasis, broad definition with cholecystitis

879

4733

1.24

8.13

1.3

1.2

4.03

3.91

u/ml

0.11

423

2162

Dental caries, including avohilmo

716

2882

1.28

8.12

1.2

1.3

4.06

4.03

u/ml

0.02

326

1364

Transport accidents

520

3299

1.32

8.11

1.2

5.54

3.71

u/ml

0.71

246

1580

Other hammer toe(s) (acquired)

137

731

1.72

8.09

1.2

4.86

3.61

u/ml

0.59

336

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

144

862

1.69

8.04

1.4

1.2

3.39

4.58

u/ml

0.79

399

Congenital malformations of cardiac chambers and connections

4.92

8.03

1.4

1.3

6.00

2.79

u/ml

0.80

Other maternal disorders predominantly related to pregnancy

662

3248

1.28

8.00

1.2

3.65

4.25

u/ml

0.63

297

1481

Other congenital malformations of circulatory system

137

2.84

7.98

1.4

1.2

3.84

4.64

u/ml

0.14

Myocardial infarction, without ST-elevation

292

1841

1.44

7.94

1.3

1.2

4.48

3.88

u/ml

0.33

131

863

Hypo-osmolality and hyponatraemia

143

850

1.68

7.93

1.3

1.2

3.43

3.91

u/ml

0.27

385

Conotruncal defects

3.36

7.92

1.4

1.2

6.13

3.95

u/ml

0.54

Ocular pain

106

585

1.83

7.91

1.2

1.3

3.52

4.61

u/ml

0.58

251

Juvenile arthritis (FINNGEN)

283

2.23

7.89

1.2

1.3

3.25

4.29

u/ml

0.45

126

Gingival hyperplasia

208

2.45

7.89

1.3

1.2

2.78

5.90

u/ml

1.19

Lumbar disc prolapse

680

3981

1.27

7.88

1.2

1.3

3.91

3.71

u/ml

0.17

304

1908

Traumatic subdural haemorrhage

419

1.95

7.87

1.6

1.2

5.49

3.47

u/ml

0.53

203

Special screening examination for neoplasms

309

2.16

7.85

1.2

3.79

3.68

u/ml

0.04

148

Amenorrhoea

522

1.88

7.85

1.3

9.42

4.33

u/ml

0.52

237

Defects in the complement system

4.58

7.82

1.2

1.3

3.00

3.52

u/ml

—

Noninflammatory disorders of female genital tract

441

1637

1.36

7.79

1.2

1.3

3.19

4.84

u/ml

2.54

188

768

Collagenous colitis

102

560

1.84

7.74

1.4

1.2

4.45

4.82

u/ml

0.10

248

Crushed, pushed or stepped on by crowd or human stampede

539

1.86

7.73

1.2

1.3

3.28

4.20

u/ml

0.37

258

Pneumonia due to other infectious organisms, not elsewhere classified

186

2.52

7.71

1.3

1.2

4.65

4.43

u/ml

0.03

Paralytic ileus and intestinal obstruction

211

1396

1.52

7.68

1.3

1.2

6.14

4.12

u/ml

0.40

106

636

Missing teeth due to accident, extraction or parodontitis

573

3987

1.29

7.67

1.2

4.25

3.87

u/ml

0.29

267

1865

Inflammatory disease of uterus

183

1179

1.57

7.63

1.3

1.2

3.78

3.65

u/ml

0.04

498

Other intervertebral disc disorders

870

4216

1.23

7.62

1.2

1.3

3.50

3.87

u/ml

0.44

386

2032

Disorders of vestibular function (Vertigo)

431

3156

1.34

7.60

1.3

1.2

4.44

3.83

u/ml

0.42

192

1452

Personality disorders, excluding more controls

315

2253

1.40

7.59

1.3

4.64

4.07

u/ml

0.27

156

1098

Giant cell arteritis

152

2.67

7.58

1.3

1.2

4.06

6.25

u/ml

0.50

Amyloidosis

3.29

7.57

1.2

1.80

3.58

u/ml

—

Myelodysplastic syndrome, including Hilmo

3.20

7.57

1.2

3.55

8.93

u/ml

0.66

Sarcoidosis

139

839

1.67

7.57

1.3

1.2

4.73

4.00

u/ml

0.21

378

Temporal arteritis

124

2.87

7.56

1.3

1.2

3.94

5.44

u/ml

0.35

Haemorrhoids and perianal venous thrombosis

301

2125

1.41

7.56

1.3

1.2

3.39

3.92

u/ml

0.55

149

974

Injuries to the wrist and hand

1138

6311

1.20

7.55

1.2

1.3

4.22

3.99

u/ml

0.19

528

3019

COPD, hospital admission 2, with asthma infections

241

1411

1.48

7.54

1.3

1.2

3.95

4.09

u/ml

0.08

116

642

Renal tubulo-interstitial disorders in diseases classified elsewhere

4.57

7.51

1.7

1.2

3.75

8.25

u/ml

0.33

Chronic diseases of tonsils and adenoids

906

4677

1.23

7.50

1.3

4.06

4.04

u/ml

0.01

431

2244

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

445

1.93

7.49

1.3

1.2

3.84

5.85

u/ml

0.71

195

Sequelae of injuries of lower limb

111

632

1.78

7.49

1.3

1.2

3.15

4.25

u/ml

0.48

287

Other cataract

389

2134

1.36

7.48

1.3

1.2

4.89

3.72

u/ml

0.60

204

984

Poor fetal growth

184

1194

1.56

7.46

1.4

1.2

5.03

4.06

u/ml

0.41

522

Diseases of the ear and mastoid process

1318

5584

1.19

7.42

1.3

4.19

3.88

u/ml

0.25

590

2697

Generalized anxiety disorder

221

1491

1.49

7.37

1.3

1.2

3.37

4.62

u/ml

1.11

110

693

Separation of retinal layers (serosa)

240

2.29

7.36

1.4

1.2

3.45

5.60

u/ml

0.65

106

Other disorders of patella

187

1220

1.54

7.36

1.3

1.2

3.44

3.94

u/ml

0.34

603

Certolizumab pegol

138

2.77

7.35

1.4

1.3

2.86

6.25

u/ml

0.99

Panic disorder

195

1285

1.53

7.34

1.3

3.68

4.65

u/ml

0.59

588

Iridocyclitis

232

1584

1.47

7.33

1.2

1.3

2.83

4.18

u/ml

2.16

108

727

Other medical care

417

2626

1.34

7.31

1.2

3.87

4.09

u/ml

0.20

202

1228

Calcific aortic valvular stenosis, diagnosis (helper)

199

1266

1.52

7.28

1.3

1.2

4.53

4.35

u/ml

0.06

110

576

Operations 2 for CAVS

199

1266

1.52

7.28

1.3

1.2

4.53

4.35

u/ml

0.06

110

576

Acute myeloid leukaemia and myelodysplastic syndromes

3.44

7.28

1.2

1.1

4.00

9.09

u/ml

0.46

Anogenital herpesviral [herpes simplex] infection, including avohilmo

158

996

1.60

7.27

1.3

1.2

5.24

3.46

u/ml

0.79

451

Unspecified nephritic syndrome

111

2.96

7.23

1.2

4.55

6.00

u/ml

0.23

Calcific aortic valvular stenosis, operated

199

1269

1.52

7.21

1.3

1.2

4.53

4.34

u/ml

0.06

110

579

Calcific aortic valvular stenosis

199

1269

1.52

7.21

1.3

1.2

4.53

4.34

u/ml

0.06

110

579

Tobacco use

375

2.01

7.21

1.3

4.68

5.02

u/ml

0.06

176

Asthma and opportunity respiratory infection

192

2.43

7.21

1.5

1.2

2.71

7.78

u/ml

1.30

Caries of dentine, including avohilmo

788

3251

1.24

7.21

1.2

1.3

4.11

4.07

u/ml

0.03

363

1551

Acute pancreatitis (for exclusion)

187

1227

1.53

7.17

1.3

1.2

6.45

4.03

u/ml

0.55

558

Atrophic disorders of skin

155

975

1.60

7.16

1.3

1.2

3.00

3.80

u/ml

0.47

434

Polyuria

196

1300

1.52

7.14

1.4

1.2

5.37

3.87

u/ml

0.31

593

Haemolytic-uraemic syndrome

9.52

7.14

2.6

1.2

5.56

3.40

u/ml

—

Cervicocranial syndrome

113

656

1.74

7.12

1.2

4.32

3.67

u/ml

0.30

294

Calcific aortic valvular stenosis, including rheumatic fever

199

1271

1.51

7.12

1.3

1.2

4.53

4.34

u/ml

0.06

110

578

ILD and respiratory illness in diseases classified elsewhere

6.28

7.11

1.2

2.38

4.80

u/ml

—

Reactive arthropathies, FINNGEN

391

1.97

7.07

1.2

1.97

4.03

u/ml

2.55

186

Other and unspecified rosacea

105

599

1.77

7.06

1.4

1.3

5.06

4.39

u/ml

0.14

266

Polycystic ovarian syndrome, consortium definition

824

3855

1.23

7.01

1.2

1.3

4.38

4.03

u/ml

0.18

347

1781

Nerve, nerve root and plexus disorders

1151

5824

1.19

6.98

1.3

4.20

3.94

u/ml

0.30

536

2736

Cholecystectomy

684

4674

1.25

6.98

1.3

1.2

3.94

3.88

u/ml

0.05

320

2129

Gout due to impairment of renal function

4.10

6.97

1.5

1.3

2.00

7.42

u/ml

—

Other infectious diseases

393

1.96

6.97

1.3

1.2

2.95

5.93

u/ml

1.28

179

Disorders of calcium metabolism

325

2.06

6.94

1.3

1.2

2.04

3.43

u/ml

1.92

142

Deforming dorsopathies

273

1940

1.41

6.94

1.2

3.73

3.64

u/ml

0.05

119

931

Other retinal disorders

557

3321

1.28

6.93

1.3

1.2

4.45

3.77

u/ml

0.45

283

1541

COPD, hospital admissions 1, only main diagnosis

248

1483

1.44

6.93

1.3

1.2

3.77

4.03

u/ml

0.17

126

682

Other and unspecified immunodeficiencies with predominantly antibody defects

3.46

6.92

1.2

1.71

3.22

u/ml

—

Sequelae of injuries, of poisoning and of other consequences of external causes

253

1777

1.43

6.91

1.3

3.63

4.05

u/ml

0.22

115

833

COPD, early/later onset

342

2110

1.36

6.91

1.3

1.2

3.55

3.92

u/ml

0.35

170

972

Other and unspecified urticaria

220

1506

1.47

6.90

1.3

1.2

4.40

3.85

u/ml

0.27

680

Rosacea

145

907

1.61

6.89

1.4

1.2

4.49

3.97

u/ml

0.15

396

Disorders of plasma-protein metabolism, not elsewhere classified

5.95

6.89

1.3

2.50

4.24

u/ml

—

Autoimmune hepatitis, wide definition

234

2.26

6.89

1.3

1.2

5.48

5.60

u/ml

0.02

Diffuse large B-cell lymphoma

215

2.31

6.88

1.2

3.37

8.15

u/ml

1.45

102

Diffuse large B-cell lymphoma, including Hilmo

215

2.31

6.88

1.2

3.38

8.15

u/ml

1.45

102

Diffuse large B-cell lymphoma, helper endpoint

215

2.31

6.88

1.2

3.38

8.15

u/ml

1.45

102

COPD, hospital admissions

339

2098

1.37

6.88

1.3

1.2

3.57

3.92

u/ml

0.33

167

966

Selective serotonin reuptake inhibitors

1069

4649

1.20

6.87

1.2

1.3

3.61

4.11

u/ml

0.71

484

2267

Dislocation, sprain and strain of joints and ligaments of knee

708

5185

1.24

6.87

1.2

1.3

4.48

4.02

u/ml

0.24

335

2468

Fracture of lower leg, including ankle

553

4284

1.27

6.83

1.2

1.3

4.11

3.87

u/ml

0.10

275

2019

Acute and subacute iridocyclitis

196

1314

1.50

6.82

1.2

1.3

2.92

4.26

u/ml

1.70

604

Benign neoplasm: Sigmoid colon

165

1066

1.56

6.81

1.2

3.19

4.31

u/ml

0.89

489

Other symptoms and signs involving the circulatory and respiratory systems

355

1.99

6.79

1.4

1.2

4.66

3.40

u/ml

0.46

156

Microscopic polyangiitis

6.27

6.76

1.4

1.2

3.38

5.09

u/ml

—

Suppurative and necrotic conditions of lower respiratory tract

275

2.14

6.76

1.2

3.07

6.33

u/ml

1.11

123

Radiculopathy

139

865

1.62

6.73

1.3

1.2

3.75

3.95

u/ml

0.11

400

Dissection of aorta

2.97

6.72

1.3

1.2

2.76

3.82

u/ml

0.54

Plantar fascial fibromatosis

103

593

1.75

6.72

1.3

1.2

4.35

3.52

u/ml

0.37

261

Dissection of cerebral arteries, nonruptured

6.15

6.71

1.1

2.78

2.09

u/ml

—

Diseases of inner ear

497

3710

1.29

6.71

1.3

1.2

4.17

3.80

u/ml

0.26

221

1736

Conjunctivitis (acute, non atopic)

317

2316

1.37

6.69

1.3

5.12

3.95

u/ml

0.74

168

1106

Giant cell arteritis with polymyalgia rheumatica

133

2.67

6.67

1.3

1.2

3.94

4.86

u/ml

0.22

Brachial plexus disorders

117

700

1.69

6.66

1.5

1.2

3.83

4.04

u/ml

0.10

313

Suggestive for eosinophilic asthma

529

1.80

6.64

1.3

1.2

3.47

5.40

u/ml

0.94

241

Amputation of thigh

3.08

6.64

1.4

1.2

5.40

6.23

u/ml

—

Anaemia in chronic diseases classified elsewhere

111

2.85

6.63

1.4

1.2

2.21

5.07

u/ml

0.89

Symptoms and signs involving emotional state

188

2.39

6.61

1.3

1.2

5.11

6.22

u/ml

0.20

Polyarteritis nodosa

6.48

6.58

1.4

1.1

2.86

2.18

u/ml

—

Other/unspecified rheumatoid arthritis

109

642

1.71

6.56

1.3

1.2

5.12

4.84

u/ml

0.07

277

Lymphoid leukaemia

239

2.20

6.55

1.3

1.2

5.04

4.58

u/ml

0.08

116

Multiple myeloma, including Hilmo

164

2.47

6.54

1.2

3.00

8.62

u/ml

1.26

Disease of hard tissues of teeth, NOS

503

2041

1.29

6.53

1.2

1.3

3.70

3.92

u/ml

0.20

219

948

Hypothyroidism, strict autoimmune, 3 medication purchases required

890

4963

1.21

6.53

1.3

1.2

4.38

4.00

u/ml

0.29

440

2278

Aspergillosis

4.08

6.53

1.4

1.2

1.91

3.79

u/ml

0.77

Oesophagitis

293

2.08

6.49

1.3

1.2

6.90

5.61

u/ml

0.20

129

Arthropathies in other diseases classified elsewhere

177

2.41

6.49

1.7

1.3

3.57

4.05

u/ml

0.17

Small fibre neuropathy

153

2.53

6.48

1.7

1.2

4.80

6.41

u/ml

0.27

Bacterial, viral and other infectious agents, including avohilmo

111

660

1.70

6.48

1.2

1.3

2.57

4.14

u/ml

1.96

309

Prophylactic surgery

3.90

6.46

1.2

6.67

3.06

u/ml

—

Embolic stroke with flimmer

3.33

6.43

1.2

3.50

6.19

u/ml

0.46

Fibroblastic disorders

186

1249

1.50

6.43

1.3

1.2

5.56

3.72

u/ml

0.43

591

Papilloedema, unspecified

148

2.56

6.42

1.5

1.3

4.70

5.79

u/ml

0.16

Dislocation, sprain and strain of joints and ligaments at neck level

187

1259

1.50

6.42

1.3

1.2

7.05

3.83

u/ml

0.53

586

Maternal care for known or suspected abnormality of pelvic organs

342

1712

1.36

6.42

1.3

3.86

4.39

u/ml

0.30

152

800

Complications predominantly related to the puerperium

322

2387

1.36

6.42

1.2

2.90

4.26

u/ml

2.23

132

1062

Benzodiazepine use

1098

6278

1.18

6.41

1.3

3.46

4.08

u/ml

1.16

500

2983

Coxarthrosis

418

2056

1.32

6.39

1.2

4.06

3.87

u/ml

0.10

180

988

Other diseases of oesophagus

484

1.81

6.39

1.3

1.2

4.62

5.13

u/ml

0.10

207

Injury of muscle and tendon at lower leg level

153

988

1.56

6.38

1.2

1.3

3.59

4.83

u/ml

0.87

475

Hernia of abdominal wall

431

3331

1.30

6.37

1.3

1.2

3.89

3.84

u/ml

0.04

215

1588

Hydronephrosis

106

625

1.71

6.37

1.3

1.2

3.61

4.25

u/ml

0.36

267

Chondrocostal junction syndrome [Tietze]

223

2.24

6.36

1.3

1.2

3.50

5.41

u/ml

0.65

101

Biological medication for rheuma

212

1466

1.46

6.36

1.3

4.48

3.85

u/ml

0.30

686

Hallux rigidus

113

678

1.68

6.35

1.2

3.28

3.67

u/ml

0.21

327

Exposure to other and unspecified inanimate mechanical forces

537

1.77

6.35

1.2

1.3

4.36

4.41

u/ml

0.01

253

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

541

4144

1.26

6.34

1.3

3.87

3.93

u/ml

0.04

260

1961

Other/unspecified soft tissue disorders related to use, overuse and pressure

167

2.44

6.33

1.2

3.48

3.56

u/ml

0.02

Diabetic retinopathy, excluding more controls

232

897

1.46

6.32

1.3

4.88

3.83

u/ml

0.29

120

408

6.16

6.31

1.1

1.2

2.83

5.23

u/ml

—

Other disorders of adrenal gland

263

2.12

6.31

1.1

1.2

4.00

3.80

u/ml

0.04

120

Disorders of mineral metabolism

472

1.82

6.30

1.3

2.86

3.31

u/ml

0.29

210

Endometriosis diagnosis and infertility diagnosis occurring together

140

890

1.59

6.29

1.3

1.2

7.13

3.91

u/ml

0.41

380

Disorders of synovium and tendon

535

3598

1.26

6.28

1.3

1.2

5.28

4.00

u/ml

0.62

237

1691

Oligomenorrhoea

244

2.17

6.27

1.2

1.3

1.82

5.22

u/ml

1.82

102

Thyrotoxicosis

254

1819

1.40

6.26

1.4

1.2

4.97

3.99

u/ml

0.72

129

818

Ovarian cyst

365

1564

1.34

6.21

1.3

6.01

4.90

u/ml

0.29

161

719

Cluster headache, wide,, including avohilmo

368

1.93

6.19

1.3

1.2

3.34

4.35

u/ml

0.42

159

Hypoglycaemia, other or unspecified

403

1.88

6.18

1.3

6.18

4.84

u/ml

0.39

184

Aspergillosis, including avohilmo

3.91

6.17

1.4

1.2

1.91

3.70

u/ml

0.77

KRA_PSY_EATING, excluding more controls

121

739

1.64

6.16

1.4

1.2

6.31

5.19

u/ml

0.29

342

Monoarthritis, not elsewhere classified

207

2.25

6.13

1.2

3.54

3.68

u/ml

0.05

104

Other chronic obstructive pulmonary disease, including avohilmo

422

2674

1.30

6.13

1.3

1.2

4.26

3.90

u/ml

0.23

203

1238

Anterior Iridocyclitis

203

1402

1.46

6.13

1.2

1.3

2.90

4.35

u/ml

1.95

641

Metatarsalgia

580

1.72

6.11

1.1

1.2

2.76

3.52

u/ml

0.51

259

Other symptoms and signs involving the nervous and musculoskeletal systems

416

3219

1.30

6.10

1.3

3.63

3.94

u/ml

0.25

172

1529

Other hereditary haemolytic anaemias

4.09

6.10

1.4

1.2

6.00

4.32

u/ml

0.19

Superficial injury of ankle and foot

155

1016

1.54

6.08

1.4

1.3

5.06

4.30

u/ml

0.33

473

Immunodeficiency with predominantly antibody defects

165

2.42

6.03

1.2

5.25

4.70

u/ml

0.06

Viral and other specified intestinal infections, including avohilmo

335

2425

1.34

6.02

1.3

3.78

4.35

u/ml

0.48

157

1189

Other intracranial haemorrhages

2.96

6.02

1.7

1.1

9.11

2.61

u/ml

0.88

Other/unspecified enthesopathies of lower limb, excluding foot

458

1.81

5.99

1.2

3.86

3.76

u/ml

0.04

214

Pruritus

120

744

1.63

5.98

1.3

1.2

4.57

4.93

u/ml

0.10

325

Scar conditions and fibrosis of skin

249

2.12

5.97

1.2

1.90

3.94

u/ml

2.85

109

Complications of other internal prosthetic devices, implants and grafts

184

2.31

5.97

1.3

1.2

2.43

4.49

u/ml

0.85

Constipation

886

5026

1.20

5.96

1.3

1.2

4.42

3.82

u/ml

0.53

431

2348

Intracranial and intraspinal abscess and granuloma

3.63

5.94

1.4

1.3

8.45

5.17

u/ml

0.30

Viral agents as the cause of diseases classified to other chapters

142

2.53

5.93

1.3

1.2

1.94

5.32

u/ml

1.23

Solid cancers, including Hilmo

910

4445

1.20

5.92

1.3

3.83

3.79

u/ml

0.03

431

2054

Other and unspecified paralytic syndromes

3.03

5.91

1.4

1.3

4.07

4.21

u/ml

0.03

Disorders of tooth development and eruption

187

1036

1.48

5.91

1.3

2.80

4.11

u/ml

1.17

480

COPD, hospital admissions 3, with asthma pneumonia sepsis

190

1113

1.47

5.91

1.3

1.2

3.87

4.45

u/ml

0.33

499

Other, unspecified and serous retinal detachments

148

2.47

5.90

1.3

1.2

2.95

6.61

u/ml

0.93

Disorders of speech understanding and production

245

2.11

5.89

1.5

1.3

3.73

5.08

u/ml

0.57

121

Injuries to the neck

258

1874

1.38

5.88

1.4

1.3

7.07

3.98

u/ml

0.79

120

877

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

184

1260

1.47

5.85

1.3

4.64

3.97

u/ml

0.39

596

Benign neoplasm: Colon, unspecified

199

1382

1.45

5.84

1.3

1.2

4.33

4.27

u/ml

0.02

634

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

193

2.26

5.80

1.4

1.2

13.41

4.57

u/ml

0.73

Striking against or struck by other objects

372

2854

1.31

5.80

1.3

4.49

3.89

u/ml

0.37

168

1389

Stomatitis and related lesions

208

1460

1.43

5.79

1.3

1.2

6.42

3.72

u/ml

0.75

106

666

Contusion of other and unspecified parts of foot

384

1.87

5.78

1.4

1.3

5.32

5.00

u/ml

0.07

167

Cluster headache, strict, including avohilmo

356

1.91

5.77

1.3

1.2

3.39

4.35

u/ml

0.37

150

Bacterial, viral and other infectious agents

103

621

1.68

5.76

1.2

1.3

2.57

4.31

u/ml

2.11

289

Unspecified abortion

321

1.96

5.76

1.3

1.2

2.21

3.65

u/ml

1.47

125

Intracranial injury

584

4413

1.24

5.72

1.3

1.2

3.55

4.20

u/ml

0.80

291

2123

Other or unspecified ileus, impaction or obstruction

145

949

1.54

5.71

1.3

1.2

4.50

4.40

u/ml

0.04

425

Benign paroxysmal vertigo

262

1918

1.37

5.69

1.3

1.2

4.59

4.09

u/ml

0.20

115

873

Postprocedural endocrine and metabolic disorders, not elsewhere classified

125

793

1.59

5.68

1.3

1.2

5.29

3.62

u/ml

0.69

343

Injuries to the shoulder and upper arm

872

5661

1.19

5.68

1.3

4.41

3.93

u/ml

0.49

396

2719

Cirrhosis of liver, NAS

295

1.99

5.67

1.6

1.2

3.54

5.01

u/ml

0.50

142

Any event in cancer register

1025

5091

1.18

5.66

1.3

3.82

4.04

u/ml

0.15

485

2373

Haemorrhagic disorder due to circulating anticoagulants

4.84

5.65

1.6

1.1

7.17

4.46

u/ml

—

Infections with a predominantly sexual mode of transmission, including avohilmo

508

3719

1.25

5.64

1.3

4.81

3.94

u/ml

0.68

263

1772

Maternal care for other conditions predominantly related to pregnancy

281

2031

1.36

5.64

1.3

3.70

4.67

u/ml

0.58

132

918

Other enthesopathy of foot (+metatarsalgia)

105

640

1.65

5.62

1.1

1.2

2.74

3.55

u/ml

0.57

288

Dependence on enabling machines and devices, not elsewhere classified

3.48

5.60

1.3

1.2

3.33

2.89

u/ml

—

Injury of muscle and tendon at hip and thigh level

112

695

1.63

5.60

1.4

1.2

2.68

5.07

u/ml

2.04

317

Abnormal spermatozoa

607

0.38

5.60

1.2

1.3

12.36

4.40

u/ml

0.42

308

Hyperhidrosis

177

2.29

5.58

1.3

1.2

7.31

6.17

u/ml

0.09

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

302

2267

1.34

5.58

1.3

3.74

3.91

u/ml

0.10

126

1086

Pollen allergy

239

1707

1.39

5.56

1.3

4.29

4.18

u/ml

0.04

115

811

Pneumothorax

339

1.91

5.55

1.2

4.83

6.05

u/ml

0.25

154

Disorders of continuity of bone

109

674

1.63

5.53

1.2

1.3

4.98

4.42

u/ml

0.11

297

Viral agents as the cause of diseases classified to other chapters, including avohilmo

172

2.32

5.52

1.2

1.3

1.89

5.09

u/ml

1.60

Superficial injury of wrist and hand

243

1768

1.38

5.52

1.3

3.29

3.87

u/ml

0.58

117

831

Later onset COPD, excluding more controls

115

543

1.62

5.51

1.2

3.52

3.87

u/ml

0.20

236

Rheumatism, unspecified

114

713

1.61

5.51

1.3

1.2

2.87

3.46

u/ml

0.39

313

Artrosis, including avohilmo

875

4028

1.19

5.49

1.3

4.31

3.73

u/ml

0.42

373

1921

Other/unspecified synovitis and tenosynovitis

111

691

1.62

5.47

1.3

4.92

3.92

u/ml

0.43

310

Ulcerative colitis, NAS

149

992

1.51

5.47

1.3

3.53

4.27

u/ml

0.45

461

IBD patients in KELA-register

252

1847

1.37

5.47

1.3

4.30

4.02

u/ml

0.18

126

861

Other spirochaetal diseases, including avohilmo

330

2517

1.32

5.46

1.2

3.30

3.92

u/ml

0.59

161

1168

Ulcerative colitis (strict definition, require KELA)

186

1296

1.45

5.43

1.3

4.60

4.03

u/ml

0.32

608

Fall on same level involving ice and snow

583

4759

1.23

5.43

1.2

1.3

3.07

3.88

u/ml

1.86

286

2233

Amyloidosis, other/unspecified

3.08

5.41

1.1

1.2

2.00

3.71

u/ml

—

Status epilepticus

148

2.40

5.41

1.1

1.2

2.24

3.46

u/ml

1.36

Bronchiectasis

335

1.90

5.40

1.4

1.2

3.40

5.57

u/ml

0.81

150

Acute posthaemorrhagic anaemia

142

2.43

5.40

1.3

1.2

3.12

6.68

u/ml

0.84

Contact with and exposure to communicable diseases

230

3130

0.73

5.40

1.3

6.46

3.98

u/ml

0.49

1491

Drug-induced adrenocortical insufficiency

101

2.74

5.39

1.1

1.2

2.50

5.92

u/ml

—

Pain associated with micturition

118

749

1.59

5.38

1.2

1.3

5.66

4.15

u/ml

0.17

312

Acne

143

944

1.52

5.35

1.5

1.3

5.55

3.89

u/ml

0.53

459

Keratitis

364

2822

1.30

5.35

1.3

1.2

4.58

3.90

u/ml

0.37

170

1325

Other surgical follow-up care

220

2.13

5.34

1.3

1.2

13.79

5.17

u/ml

0.47

Paracetamol or NSAID medication

170

575

1.50

5.34

1.3

6.47

3.94

u/ml

0.69

314

Hypoparathyroidism

181

2.24

5.32

1.7

1.2

6.33

3.47

u/ml

0.52

Substance abuse, excluding more controls

555

3768

1.23

5.31

1.3

4.11

4.08

u/ml

0.02

249

1825

Other/unspecified enthesopathies, not elsewhere classified

431

1.78

5.31

1.2

4.00

3.49

u/ml

0.14

188

Other demyelinating diseases of the central nervous system

275

2.00

5.31

1.4

1.3

7.05

5.37

u/ml

0.19

119

Chondropathies

163

1113

1.48

5.30

1.2

1.3

4.85

3.91

u/ml

0.30

516

Carcinoma in situ of skin

359

1.85

5.29

1.2

3.70

6.24

u/ml

0.80

160

Nail disorders

575

1.67

5.27

1.4

1.2

3.11

4.05

u/ml

0.73

264

Appendectomy

714

5675

1.20

5.26

1.2

1.3

5.14

3.91

u/ml

0.74

322

2699

Eosinophilic disease (BM)

2.95

5.24

1.3

1.1

5.00

3.89

u/ml

0.29

Acute generalized exanthematous pustulosis

256

2.02

5.21

1.3

1.2

5.66

5.22

u/ml

0.08

109

Volume depletion

412

1.78

5.18

1.3

1.2

4.19

4.50

u/ml

0.06

195

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

195

1383

1.42

5.18

1.3

4.55

4.01

u/ml

0.31

651

Pre-eclampsia or eclampsia

248

1831

1.36

5.18

1.4

1.2

4.53

3.56

u/ml

0.55

117

801

Menorrhagia

334

1417

1.32

5.17

1.2

1.3

3.94

5.00

u/ml

0.61

147

645

Other disorders starting during childhood or adolecense, excluding more controls

338

1.86

5.16

1.3

5.38

3.66

u/ml

0.63

164

Contraceptive management

446

2475

1.26

5.16

1.3

3.00

3.93

u/ml

1.62

200

1211

Polyarthrosis

151

916

1.49

5.15

1.3

1.2

4.94

3.67

u/ml

0.62

437

Diseases of middle ear and mastoid

664

4500

1.21

5.15

1.3

5.21

3.97

u/ml

0.75

301

2177

Substance use, excluding alcohol

221

1603

1.39

5.15

1.3

4.08

4.06

u/ml

0.01

755

Heartburn

109

687

1.60

5.14

1.3

1.2

3.08

3.77

u/ml

0.53

307

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

516

3626

1.24

5.13

1.3

1.2

4.40

4.05

u/ml

0.22

233

1625

Adrenocortical insufficiency

211

2.12

5.09

1.2

4.44

3.49

u/ml

0.18

L04AC Interleukin inhibitors

475

1.73

5.08

1.4

1.2

2.52

4.37

u/ml

1.61

207

Abscess of anal and rectal regions

558

1.66

5.08

1.2

2.93

4.18

u/ml

1.02

259

Non-Hodgkin lymphoma, all, including Hilmo

104

650

1.61

5.07

1.2

4.20

4.76

u/ml

0.20

307

Ventral hernia

207

1489

1.40

5.06

1.4

1.2

4.70

4.11

u/ml

0.33

105

682

Other congenital malformations

101

628

1.62

5.05

1.3

7.54

4.33

u/ml

0.35

282

Other spirochaetal diseases

323

2486

1.31

5.04

1.2

3.26

3.84

u/ml

0.54

158

1151

Fracture of skull and facial bones

215

1558

1.39

5.04

1.3

4.24

4.40

u/ml

0.06

110

747

Inflammatory bowel disease, strict (require KELA)

252

1874

1.35

5.02

1.3

4.30

4.00

u/ml

0.19

126

864

Spondylopathies

734

3628

1.20

5.02

1.2

4.83

3.71

u/ml

0.78

303

1738

Other congenital malformations, including avohilmo

146

988

1.49

4.99

1.3

6.54

4.27

u/ml

0.32

452

Right ventricular outflow tract obstruction

3.35

4.98

1.2

3.70

3.57

u/ml

—

Other extrapyramidal and movement disorders in other diseases

218

1587

1.38

4.97

1.2

3.57

4.18

u/ml

0.45

730

Endometriosis of ovary

173

1138

1.44

4.97

1.3

7.39

4.80

u/ml

0.38

518

Nonspecific lymphadenitis

331

1.86

4.96

1.2

4.28

4.46

u/ml

0.03

142

Obsessive-compulsive disorder

562

1.65

4.95

1.2

1.3

4.27

4.58

u/ml

0.11

250

Disorders of oesophagus in diseases classified elsewhere

2.71

4.95

1.3

1.2

5.00

6.41

u/ml

—

Other nonthrombocytopenic purpura

3.45

4.95

1.2

3.29

4.33

u/ml

—

Speech and linguistic disorders, excluding more controls

562

1.63

4.94

1.4

1.3

4.64

3.90

u/ml

0.20

272

Other degenerative diseases of the nervous system

195

1009

1.41

4.92

1.2

4.70

3.75

u/ml

0.39

459

Diseases of the myoneural junction and muscle

110

703

1.58

4.91

1.2

3.94

4.87

u/ml

0.30

317

Spirochaetal infections, other/unspecified, including avohilmo

321

2479

1.30

4.90

1.2

3.15

3.84

u/ml

0.68

157

1150

Other bursopathies

114

735

1.56

4.89

1.2

3.12

4.03

u/ml

0.63

336

Multiple myeloma and malignant plasma cell neoplasms

181

2.18

4.89

1.2

3.00

7.51

u/ml

1.08

Infections with a predominantly sexual mode of transmission

377

2968

1.27

4.87

1.4

1.3

4.35

4.13

u/ml

0.11

197

1377

Osteomyelitis

326

1.86

4.87

1.4

1.2

4.49

4.84

u/ml

0.09

152

Demyelinating diseases of the central nervous system

103

651

1.60

4.85

1.3

4.90

3.96

u/ml

0.19

292

Benign neoplasm: Stomach

504

1.68

4.84

1.3

1.2

5.91

5.34

u/ml

0.12

223

Premature separation of placenta [abruptio placentae]

163

2.26

4.84

1.2

1.3

2.90

3.65

u/ml

0.39

Primary hyperparathyroidism

581

1.63

4.83

1.4

1.2

3.37

4.00

u/ml

0.27

245

Bipolar affective disorders

217

1588

1.37

4.82

1.3

3.96

3.86

u/ml

0.05

102

744

Other congenital malformations of the digestive system

255

1.97

4.80

1.6

1.3

9.00

5.51

u/ml

0.64

117

Monoplegia

2.74

4.80

1.3

1.2

3.11

3.52

u/ml

—

Pregnancy hypertension

475

3439

1.24

4.79

1.3

1.2

4.56

4.01

u/ml

0.36

211

1555

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

350

2745

1.28

4.77

1.3

5.44

4.26

u/ml

0.63

159

1292

Fracture of foot, except ankle

267

2020

1.33

4.76

1.2

1.3

4.05

4.04

u/ml

0.00

126

951

Lactose intolerance

177

2.18

4.75

1.2

1.3

3.45

3.65

u/ml

0.08

Vasomotor and allergic rhinitis

423

3314

1.25

4.74

1.3

4.27

4.14

u/ml

0.07

211

1589

Faecal incontinence

439

1.72

4.74

1.3

1.2

3.10

4.52

u/ml

0.86

192

Nonhereditary hypogammaglobulinemia

3.11

4.73

1.2

2.33

3.54

u/ml

—

Delirium, not induced by alcohol and other psychoactive substances

544

1.64

4.72

1.4

1.2

3.50

5.26

u/ml

0.76

253

Recurrent aphthous stomatitis , including avohilmo

144

984

1.47

4.71

1.3

7.43

3.92

u/ml

0.69

432

Abnormal findings in nipple discharge synovial fluid wound secretions

2.71

4.71

1.3

1.2

6.60

3.85

u/ml

0.54

Other complications of labour and delivery, not elsewhere classified

177

1112

1.42

4.70

1.2

1.3

2.91

4.64

u/ml

1.37

515

Non-selective monoamine reuptake inhibitors

316

2348

1.30

4.70

1.3

1.2

4.52

4.17

u/ml

0.22

141

1105

Other and unspecified vaccines and biological substances

3.49

4.69

1.8

1.1

2.22

3.17

u/ml

—

Congenital malformations of pulmonary and tricuspid valves

3.47

4.68

1.3

1.2

3.67

2.83

u/ml

—

Thyroiditis

464

1.70

4.67

1.4

1.3

5.20

4.40

u/ml

0.19

195

Seropositive rheumatoid arthritis, strict definition

137

929

1.48

4.67

1.3

1.2

4.06

4.62

u/ml

0.20

410

Neovascular glaucoma

185

2.13

4.65

1.2

1.3

2.12

6.16

u/ml

1.84

Urolithiasis

266

2018

1.32

4.65

1.3

1.2

5.70

3.73

u/ml

0.64

124

952

Other disorders of glucose regulation and pancreatic internal secretion

495

1.67

4.64

1.3

6.22

5.20

u/ml

0.27

231

Gestational diabetes (for exclusion)

492

2754

1.23

4.63

1.3

3.46

4.40

u/ml

0.99

207

1263

Molar incisor enamel hypoplasia

262

1.92

4.62

1.3

1.4

2.43

4.04

u/ml

1.72

137

Acute pharyngitis

183

1299

1.40

4.61

1.3

4.78

4.44

u/ml

0.12

636

Solid cancers

855

4280

1.17

4.61

1.3

3.71

3.76

u/ml

0.05

400

1982

Amputation of ankle bones

2.65

4.59

1.5

1.2

2.60

6.64

u/ml

0.96

Type 2 diabetes, wide definition

738

3930

1.19

4.59

1.3

1.2

4.69

3.63

u/ml

1.33

355

1843

Postprocedural disorders of nervous system

536

1.64

4.57

1.3

4.89

3.59

u/ml

0.26

229

Benign neoplasm: Small intestine

180

2.14

4.56

1.2

9.54

4.46

u/ml

0.29

Lyme disease, including avohilmo

316

2462

1.29

4.55

1.2

3.17

3.84

u/ml

0.65

156

1141

Lyme disease

316

2462

1.29

4.55

1.2

3.17

3.84

u/ml

0.65

156

1141

Angina pectoris

415

2200

1.25

4.54

1.2

5.79

3.54

u/ml

1.21

204

985

Glaucoma secondary to other eye disorders

187

2.11

4.53

1.2

1.3

2.12

6.06

u/ml

1.83

Intestinal adhesions without obstruction

415

1.72

4.53

1.3

1.2

11.91

4.51

u/ml

0.52

173

Other noninflammatory disorders of vagina

514

1.65

4.53

1.3

1.2

3.44

4.32

u/ml

0.51

232

Spondylosis

472

2999

1.23

4.52

1.2

5.26

3.69

u/ml

0.78

201

1442

Appendicitis, broad definition

789

6044

1.17

4.52

1.2

1.3

4.87

3.90

u/ml

0.60

353

2872

Fentanyl

444

1.70

4.52

1.3

1.2

6.46

3.35

u/ml

0.58

199

Diseases of appendix

794

6064

1.17

4.52

1.2

1.3

4.92

3.90

u/ml

0.65

355

2883

Haemorrhage in early pregnancy

316

2394

1.29

4.50

1.3

1.2

3.96

4.56

u/ml

0.39

141

1081

Umbilical hernia

259

1968

1.32

4.50

1.3

3.26

3.92

u/ml

0.61

125

931

Open wound of forearm

616

1.59

4.49

1.4

1.3

2.79

4.95

u/ml

1.48

296

Retinal haemorrhage

2.56

4.49

1.2

2.86

7.82

u/ml

0.93

Fenamates

155

731

1.45

4.48

1.3

3.90

3.59

u/ml

0.16

354

Postpartum haemorrhage

322

2075

1.29

4.46

1.3

2.91

4.34

u/ml

2.24

129

947

Maternal care related to the fetus and amniotic cavity and possible delivery problems

511

2451

1.23

4.45

1.2

3.97

4.27

u/ml

0.18

227

1119

Personal history of medical treatment

3.09

4.45

1.3

1.1

1.71

3.48

u/ml

—

Phobic anxiety disorders

165

1168

1.42

4.44

1.3

1.2

4.29

4.07

u/ml

0.10

539

Tuberculosis, IBD comorbidity

257

1.92

4.44

1.4

1.2

2.24

6.88

u/ml

1.77

125

Acne, including avohilmo

298

1865

1.30

4.44

1.3

6.80

4.14

u/ml

0.84

150

898

Eating disorders

137

939

1.47

4.42

1.4

1.3

5.79

4.02

u/ml

0.78

440

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

2.65

4.41

1.1

1.2

2.63

10.32

u/ml

—

Multiple myeloma

2.65

4.41

1.1

1.2

2.63

10.32

u/ml

—

Otalgia

572

1.60

4.41

1.3

2.55

4.08

u/ml

2.10

255

Retinal detachment with retinal break

109

714

1.54

4.40

1.3

1.2

3.86

4.33

u/ml

0.16

303

Myelodysplastic syndrome

4.33

4.35

1.2

4.56

4.35

u/ml

—

Hypercalcemia

204

2.03

4.34

1.3

1.2

2.19

5.61

u/ml

1.53

Recurrent dislocation of patella

376

1.75

4.34

1.2

1.3

2.13

4.44

u/ml

2.12

172

Seborrhoeic keratosis

192

1403

1.37

4.34

1.2

4.54

4.01

u/ml

0.18

632

Retention of urine

255

1566

1.32

4.32

1.3

1.2

5.80

3.62

u/ml

0.71

120

720

Benign neoplasm: Transverse colon

575

1.59

4.32

1.3

4.60

5.45

u/ml

0.22

256

Other/unspecified reactive arthropathies

414

1.71

4.32

1.2

1.97

4.77

u/ml

2.84

187

Ingrowing nail

347

1.78

4.32

1.3

1.2

2.34

4.01

u/ml

1.44

161

Supervision of normal pregnancy

231

980

1.35

4.30

1.3

3.90

4.36

u/ml

0.18

102

476

Superficial injury of abdomen, lower back and pelvis

161

1145

1.41

4.29

1.2

1.3

3.03

4.58

u/ml

1.60

524

Crohn disease

138

955

1.46

4.28

1.4

1.3

4.39

4.19

u/ml

0.09

445

Contracture of joint

3.11

4.28

1.1

1.2

2.75

3.33

u/ml

—

Bell's palsy

112

744

1.52

4.26

1.3

3.38

4.47

u/ml

0.60

333

Other chondrocalcinosis

3.21

4.24

1.3

1.2

4.89

8.38

u/ml

—

Pre-eclampsia

230

1736

1.33

4.24

1.4

1.2

4.61

3.61

u/ml

0.56

114

754

Personality disorders

315

2479

1.28

4.23

1.3

4.64

4.19

u/ml

0.21

156

1150

Traumatic subarachnoid haemorrhage

108

2.43

4.23

1.1

2.00

4.06

u/ml

1.07

Other symptoms and signs involving the digestive system and abdomen

143

998

1.44

4.23

1.2

3.86

3.67

u/ml

0.11

445

Other sleep disorders

102

665

1.54

4.23

1.3

5.04

3.99

u/ml

0.38

312

Spondylopathies (FG)

132

908

1.46

4.22

1.2

1.3

3.30

4.47

u/ml

0.90

429

Non-follicular lymphoma

462

1.66

4.22

1.2

4.26

5.89

u/ml

0.56

214

Congenital aortic valve stenosis

4.59

4.22

1.0

1.3

9.57

4.50

u/ml

—

Dentofacial anomalies [including malocclusion]

804

5406

1.17

4.21

1.2

1.3

4.72

3.93

u/ml

0.38

363

2578

Nonsuppurative otitis media, including avohilmo

368

2545

1.25

4.21

1.3

4.53

4.06

u/ml

0.30

184

1240

Hyperaldosteronism

140

2.25

4.21

1.4

1.2

2.36

4.43

u/ml

1.44

Scleritis

2.73

4.21

1.3

1.2

6.00

6.29

u/ml

—

Dermatophytosis

126

860

1.47

4.20

1.2

1.3

5.69

4.28

u/ml

0.21

388

Injuries to the hip and thigh

405

2937

1.24

4.19

1.3

1.2

3.08

4.05

u/ml

1.76

200

1382

Spinal stenosis

384

2269

1.25

4.19

1.2

5.54

3.73

u/ml

0.68

159

1082

Other disorders starting during childhood or adolescence

384

1.72

4.17

1.3

1.4

6.21

4.07

u/ml

0.69

195

Cushing syndrome

3.06

4.17

1.4

1.2

40.20

4.52

u/ml

—

Insulin, combination of fast acting with intermediate-acting or long-acting

553

4188

1.20

4.16

1.3

1.2

4.80

3.70

u/ml

0.73

266

1985

Other keratitis

122

830

1.48

4.15

1.3

4.16

3.90

u/ml

0.09

382

Tuberculosis of other organs

2.84

4.14

1.2

1.38

7.18

u/ml

—

Somnolence

2.77

4.13

1.2

5.82

3.97

u/ml

0.23

Other postsurgical states

374

1.73

4.13

1.3

1.2

3.15

4.60

u/ml

0.92

169

Benign neoplasm: Other and unspecified parts of small intestine

2.76

4.12

1.2

2.25

4.24

u/ml

—

Tuberculosis, wide

264

1.87

4.12

1.4

1.2

2.24

6.99

u/ml

1.89

129

Disorders of ocular muscles, binocular movement, accommodation and refraction

515

4245

1.21

4.12

1.3

3.34

4.15

u/ml

1.59

255

2021

Dementia in Alzheimer disease

524

0.48

4.12

1.1

1.2

2.85

4.96

u/ml

1.19

242

Other and unspecified injuries of lower leg

520

1.61

4.11

1.3

4.98

4.56

u/ml

0.09

239

Acute bronchiolitis

357

1.71

4.11

1.3

1.4

4.32

3.95

u/ml

0.12

189

Diabetes mellitus in pregnancy

429

2215

1.24

4.10

1.3

3.69

4.59

u/ml

0.83

192

1020

Eating disorder

121

823

1.48

4.10

1.4

1.3

6.31

4.16

u/ml

0.87

386

Diffuse brain injury

135

2.24

4.10

1.2

1.1

1.58

3.56

u/ml

1.86

Brain meningioma, including Hilmo

258

1.88

4.09

1.2

4.06

4.53

u/ml

0.10

105

Other noninflammatory disorders of vulva and perineum

647

1.54

4.08

1.3

1.2

2.44

4.26

u/ml

2.11

287

Other secondary gonarthrosis

287

1.83

4.08

1.3

1.2

3.24

5.29

u/ml

0.79

138

Calculus of kidney and ureter

246

1884

1.31

4.08

1.3

1.2

5.98

3.78

u/ml

0.66

114

883

Atlantoaxial subluxation

4.36

4.07

1.3

1.1

6.57

4.27

u/ml

—

Ulcer of vagina/vulva

189

2.04

4.07

1.4

1.3

6.06

4.58

u/ml

0.13

Insulin, fast-acting

332

2640

1.26

4.07

1.4

1.2

5.29

3.69

u/ml

0.72

171

1258

Benign neoplasm: Ascending colon

113

760

1.50

4.06

1.2

3.43

4.94

u/ml

0.83

329

Decubitus ulcer and pressure area

230

1.93

4.06

1.5

1.2

3.87

5.03

u/ml

0.41

108

Malignant neoplasm of thymus

5.92

4.06

1.3

1.2

2.00

5.91

u/ml

—

Diabetes mellitus

1111

5640

1.14

4.06

1.3

4.40

3.95

u/ml

0.40

534

2668

Hyperfunction of pituitary gland

332

1.77

4.05

1.5

1.3

4.04

3.81

u/ml

0.09

150

Cholecystitis

110

737

1.50

4.03

1.3

1.2

5.42

4.31

u/ml

0.35

321

Other noninfective disorders of lymphatic vessels and lymph nodes

176

2.07

4.02

1.3

1.2

4.27

4.71

u/ml

0.07

Third [oculomotor] nerve palsy

2.72

4.02

1.3

1.1

5.50

6.68

u/ml

—

Diabetes, varying definitions

1104

5629

1.14

4.02

1.3

4.43

3.94

u/ml

0.45

531

2662

Tuberculosis of other organs, strict

2.70

4.01

1.3

1.2

1.33

6.61

u/ml

—

Sleep disorders, other/unspecified

253

1.88

4.01

1.3

5.88

4.87

u/ml

0.16

116

Crohn's disease NAS

408

1.68

4.00

1.4

1.2

3.89

4.52

u/ml

0.24

188

Amputation of foot

105

2.42

4.00

1.2

3.29

5.87

u/ml

0.59

150

2.17

4.00

1.2

1.3

4.92

4.02

u/ml

0.17

Atopic dermatitis, strict definition with reimbursement

364

2817

1.25

3.99

1.3

3.94

4.10

u/ml

0.09

176

1350

Open wound of ankle and foot

106

707

1.51

3.99

1.4

1.3

4.44

4.89

u/ml

0.14

332

Fall on and from stairs and steps

246

1891

1.31

3.99

1.3

1.2

3.54

4.05

u/ml

0.33

107

884

Carbimazole or st.post thyroidectomy, condition for graves disease

209

1571

1.34

3.98

1.3

1.2

5.24

3.76

u/ml

0.96

108

708

Unspecified threat to breathing

2.80

3.98

1.4

1.1

1.71

3.42

u/ml

1.29

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

222

1684

1.33

3.98

1.3

1.2

4.63

4.18

u/ml

0.19

755

Adenomyosis (Endometriosis of uterus)

123

844

1.46

3.98

1.3

1.2

3.39

4.18

u/ml

0.42

375

Abnormal findings in secretions and smears from cervix uteri vagina vulva

569

3515

1.19

3.97

1.3

5.93

3.82

u/ml

0.82

245

1590

Primary Sclerosing Cholangitis, IBD and UDCA required

131

2.25

3.96

1.5

1.2

4.14

3.46

u/ml

0.27

Fracture of lumbar spine and pelvis

170

1235

1.38

3.96

1.4

1.2

3.67

4.43

u/ml

0.38

567

Congenital malformations of gallbladder, bile ducts and liver

2.97

3.95

1.4

1.1

5.20

3.56

u/ml

—

Tuberculosis, wide, including avohilmo

268

1.84

3.95

1.4

1.2

2.24

6.94

u/ml

1.92

132

Artificial joint operation, meniscal resection

832

4600

1.16

3.94

1.2

4.73

3.77

u/ml

0.68

370

2167

Follow-up care involving plastic surgery

226

1.93

3.94

1.1

1.2

5.75

4.97

u/ml

0.12

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

424

1.66

3.93

1.3

5.05

4.49

u/ml

0.15

208

Type 2 diabetes

1046

5315

1.14

3.93

1.3

4.43

3.94

u/ml

0.42

492

2482

Neuralgia and neuritis, unspecified

269

1.84

3.92

1.2

2.47

3.45

u/ml

0.70

124

Speech and linguistic disorders

101

641

1.52

3.92

1.6

1.3

5.03

4.43

u/ml

0.16

317

Tuberculosis of other organs, strict, including avohilmo

2.67

3.91

1.3

1.2

1.33

6.56

u/ml

—

Specific development disorders of speech and language

366

1.70

3.91

1.5

1.3

5.21

4.77

u/ml

0.07

179

Papulosquamous disorders

358

2888

1.24

3.91

1.3

1.2

4.29

3.87

u/ml

0.30

170

1366

Dental operations

554

2377

1.20

3.91

1.2

1.3

4.74

3.97

u/ml

0.37

253

1104

Other and unspecified aplastic anaemias

2.85

3.90

1.5

1.2

14.50

7.13

u/ml

—

Hepatic failure, not elsewhere classified

199

1.99

3.89

1.3

1.2

3.96

5.76

u/ml

0.49

Acute suppurative otitis media

324

2408

1.26

3.89

1.3

5.64

4.07

u/ml

0.48

160

1188

Ehlers-Danlos syndrome, including avohilmo

101

2.44

3.87

1.4

1.2

3.50

3.33

u/ml

—

Use of donepezil

708

0.54

3.87

1.1

1.2

5.38

5.07

u/ml

0.04

321

Anogenital herpesviral [herpes simplex] infection

521

1.59

3.87

1.4

1.3

5.12

4.17

u/ml

0.21

231

Other other unspecified disorders of the circulatory system

179

2.04

3.86

1.4

1.2

4.00

6.03

u/ml

0.44

Brain meningioma

249

1.87

3.85

1.2

4.06

4.65

u/ml

0.13

101

Congenital malformations of uterus and cervix

173

2.07

3.84

1.1

1.4

3.87

5.37

u/ml

0.35

Other and unspecified disorders of vitreous body

341

2679

1.25

3.84

1.3

1.2

3.14

4.12

u/ml

1.59

181

1198

Other eating disorders

452

1.63

3.83

1.3

5.13

3.93

u/ml

0.31

207

Maternal care for other known or suspected fetal problems

322

1603

1.27

3.83

1.3

3.87

4.56

u/ml

0.40

145

765

Lung cancer and mesothelioma

111

636

1.49

3.82

1.2

3.58

u/ml

0.00

284

Squamous cell neoplasms and carcinomas of the skin

337

1.73

3.82

1.2

6.56

5.82

u/ml

0.11

160

Spirochaetal infections, other/unspecified

546

1.57

3.82

1.2

1.3

2.39

4.61

u/ml

2.60

244

Hepatomegaly and splenomegaly, not elsewhere classified

3.27

3.81

2.0

1.2

4.78

4.40

u/ml

—

Congenital malformations of great arteries

118

2.29

3.81

1.1

1.2

5.89

3.19

u/ml

0.54

Other Crohn's disease

476

1.61

3.80

1.4

1.3

4.12

4.41

u/ml

0.12

223

Juvenile rheumatoid arthirtis

140

2.18

3.80

1.2

1.3

3.21

4.26

u/ml

0.29

Excessive attrition of teeth

671

5693

1.17

3.79

1.2

1.3

3.87

4.01

u/ml

0.06

328

2674

Tubulo-interstitial nephritis, not specified as acute or chronic

331

1.74

3.79

1.5

1.2

3.56

4.90

u/ml

0.50

134

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

167

1223

1.37

3.78

1.2

1.3

2.90

4.28

u/ml

1.66

563

Cyst of kidney

354

1.71

3.77

1.4

1.2

3.68

6.21

u/ml

0.74

158

Acute appendicitis

738

5913

1.16

3.77

1.2

1.3

4.97

3.89

u/ml

0.65

334

2805

Scoliosis

556

1.56

3.76

1.2

5.58

3.54

u/ml

0.55

250

Benign neoplasm: Adrenal gland

431

1.64

3.75

1.4

1.2

4.32

4.08

u/ml

0.03

194

Degenerative macular diseases

532

1.57

3.75

1.3

1.2

5.00

4.93

u/ml

0.02

234

Other mycoses, not elsewhere classified/unspecified, including avohilmo

115

2.31

3.75

1.2

5.36

5.26

u/ml

0.01

Viral and other specified intestinal infections

229

1717

1.31

3.74

1.3

4.21

4.49

u/ml

0.14

108

853

Other follicular disorders

549

1.56

3.74

1.5

1.3

4.49

4.09

u/ml

0.11

245

Exclusion endpoint for clefts

128

2.23

3.72

1.4

1.3

5.28

3.80

u/ml

0.29

Hypoplasia of dental enamel , including avohilmo

249

1.84

3.72

1.4

2.42

3.95

u/ml

1.53

132

Endovascular or surgical operations to intracerebral aneurysms

252

1.84

3.72

1.4

1.2

3.22

3.78

u/ml

0.19

102

Dermatographic urticaria

487

1.60

3.71

1.3

4.14

4.28

u/ml

0.02

209

Fissure and fistula of anal and rectal regions

213

1623

1.32

3.71

1.4

1.2

3.50

4.01

u/ml

0.39

101

748

Spondyloarthritis

159

1160

1.38

3.70

1.2

5.74

4.16

u/ml

0.42

526

Alzheimer disease, including avohilmo

108

1088

0.69

3.69

1.2

3.91

4.78

u/ml

0.37

491

Leukaemia of unspecified cell type

3.20

3.69

1.5

1.2

8.40

5.24

u/ml

—

Insulin, fast-acting or short human

332

2674

1.24

3.68

1.4

1.2

5.29

3.70

u/ml

0.71

171

1275

Agoraphobia

239

1.87

3.68

1.2

1.3

2.81

5.54

u/ml

1.17

106

Achilles tendinitis

100

672

1.50

3.66

1.2

2.98

4.08

u/ml

1.04

307

Viral infections of the central nervous system

450

1.61

3.65

1.3

1.2

6.10

4.63

u/ml

0.40

203

Other and unspecified bullous disorders

2.82

3.63

1.0

1.1

2.17

3.75

u/ml

—

Early complications of trauma

269

1.80

3.63

1.4

1.2

4.57

5.16

u/ml

0.11

122

!Aliquae complicationes praecoces traumatis

269

1.80

3.63

1.4

1.2

4.57

5.16

u/ml

0.11

122

Other meningitis

104

2.36

3.63

1.4

1.2

10.27

3.76

u/ml

0.69

Other specified congenital malformation syndromes affecting multiple systems

104

2.36

3.63

1.5

1.3

5.63

3.92

u/ml

0.30

Deviated nasal septum

301

2401

1.26

3.62

1.2

1.3

3.82

3.75

u/ml

0.03

137

1154

Golimumab

255

1.83

3.62

1.3

1.2

3.19

4.54

u/ml

0.49

111

Myocardial infarction, with ST-elevation

111

763

1.46

3.61

1.2

7.67

4.41

u/ml

0.68

371

Eosinophilia

2.40

3.61

1.3

5.00

6.30

u/ml

0.20

Disturbances of smell and taste

226

1.88

3.61

1.1

1.2

3.92

5.51

u/ml

0.33

Acute lymphadenitis

382

1.67

3.61

1.3

1.2

2.69

4.74

u/ml

1.38

171

Exclusions for E4_PCOS_CONSORTIUM

794

4302

1.15

3.60

1.3

4.82

4.10

u/ml

0.63

360

2009

Emotional disorders starting during childhood or adolecense, excluding more controls

333

1.71

3.60

1.3

5.21

3.53

u/ml

0.59

167

Primary biliary cholangitis (PBC)

2.43

3.58

1.5

1.2

3.38

5.57

u/ml

—

Dermatitis due to substances taken internally

322

1.72

3.58

1.3

4.00

4.86

u/ml

0.25

145

Non-allergic asthma

491

1.58

3.58

1.4

1.3

6.72

5.04

u/ml

0.28

238

Benign neoplasm of meninges

555

1.54

3.57

1.3

1.2

2.89

4.27

u/ml

1.02

233

Family history of malignant neoplasm

115

799

1.45

3.57

1.2

4.18

3.99

u/ml

0.06

337

Unspecified misadventure during surgical and medical care

330

1.71

3.57

1.3

1.2

4.68

5.13

u/ml

0.10

145

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

122

852

1.43

3.56

1.4

1.3

4.04

4.29

u/ml

0.11

404

Biomechanical lesions, not elsewhere classified

278

1.78

3.56

1.4

1.2

6.54

4.76

u/ml

0.22

119

Benign neoplasm: Rectum, anus and anal canal

152

1109

1.38

3.55

1.3

1.2

3.99

4.24

u/ml

0.08

500

Extrapyramidal and movement disorders

309

2482

1.25

3.55

1.2

3.42

3.99

u/ml

0.62

138

1161

Mixed disorders of conduct and emotions, excluding more controls

151

2.09

3.54

1.2

1.3

3.60

4.51

u/ml

0.41

Other and unspecified follicular disorders

264

1.80

3.54

1.6

1.2

5.71

4.55

u/ml

0.21

115

Tumor necrosis factor alpha inhibitors

176

1316

1.35

3.53

1.3

4.73

4.01

u/ml

0.30

621

Other injuries of upper limb, level unspecified

2.76

3.52

1.5

1.2

3.80

3.28

u/ml

—

Disorders of adult personality and behaviour

329

2665

1.24

3.52

1.3

4.61

4.10

u/ml

0.26

169

1245

Benign neoplasm: Caecum

557

1.54

3.52

1.2

3.95

5.15

u/ml

0.34

241

Benign neoplasm: Tongue

138

2.13

3.52

1.4

1.2

4.00

6.66

u/ml

0.54

Assault

153

1121

1.37

3.51

1.3

4.30

3.98

u/ml

0.11

534

Emotional disorders and disorders of social functioning with onset specific to childhood

407

1.63

3.50

1.3

1.4

4.97

4.27

u/ml

0.21

210

Autoimmune hyperthyroidism

362

1.67

3.50

1.3

1.2

2.50

4.35

u/ml

1.16

144

Somnolence, stupor and coma

207

1.90

3.50

1.1

1.3

4.47

6.03

u/ml

0.28

Other abnormalities of plasma proteins

2.58

3.49

1.7

1.2

3.13

4.78

u/ml

—

Malignant neoplasm of thymus, including Hilmo

4.77

3.49

1.3

1.1

2.00

5.58

u/ml

—

Ulcerative colitis (strict definition, all Crohn cases excluded)

149

1088

1.38

3.49

1.2

1.3

3.85

3.90

u/ml

0.03

505

Other bullous disorders

152

2.07

3.49

1.1

1.2

3.00

6.13

u/ml

0.76

Benign neoplasm: Liver/bile ducts

173

2.00

3.47

1.6

1.2

2.13

4.88

u/ml

1.10

Severe visual impairment, monocular

3.05

3.44

1.4

1.3

1.67

3.90

u/ml

—

Charcot foot

2.80

3.44

1.9

1.1

2.22

2.40

u/ml

—

Other sexually transmitted chlamydial diseases

585

1.52

3.44

1.3

3.15

4.33

u/ml

0.66

280

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

148

1082

1.37

3.43

1.3

2.99

4.35

u/ml

1.41

495

Abdominal aortic aneurysm (AAA)

271

1.76

3.43

1.3

1.2

3.57

4.07

u/ml

0.20

131

Benign neoplasm: Cerebral meninges

505

1.56

3.42

1.3

1.2

2.64

4.29

u/ml

1.21

210

Varicose veins of other sites

319

1.71

3.41

1.2

3.80

4.30

u/ml

0.15

152

Shigellosis, including avohilmo

3.20

3.41

1.3

5.14

5.65

u/ml

—

Erosion of teeth , including avohilmo

299

2406

1.25

3.41

1.3

3.27

3.80

u/ml

0.45

155

1107

Complications of the puerperium, not elsewhere classified

358

1.67

3.41

1.4

1.3

3.73

4.19

u/ml

0.15

146

Benign neoplasm: Rectum

137

991

1.39

3.40

1.2

4.17

4.36

u/ml

0.05

446

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

445

1.59

3.40

1.2

5.84

5.49

u/ml

0.06

220

Other inflammation of vagina/vulva

298

1.73

3.38

1.3

10.63

4.88

u/ml

0.66

122

6-mercaptopurine

217

1.86

3.37

1.3

1.2

3.56

3.72

u/ml

0.06

103

therapeutic use

127

2.15

3.37

1.3

1.2

4.18

5.19

u/ml

0.18

Chronic lymphocytic leukaemia

101

2.30

3.37

1.2

1.78

5.49

u/ml

—

Chronic lymphocytic leukaemia, helper endpoint

101

2.30

3.37

1.2

1.78

5.49

u/ml

—

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

101

2.30

3.37

1.2

1.78

5.49

u/ml

—

Bitten or struck by other mammals

128

918

1.40

3.36

1.3

1.2

2.98

4.34

u/ml

0.97

409

Melanocytic naevi

314

2545

1.24

3.36

1.3

1.2

3.50

3.98

u/ml

0.46

161

1174

Hypoplasia of dental enamel, prenatal , including avohilmo

4.12

3.35

1.3

3.33

3.94

u/ml

—

Patellar tendinitis

108

2.26

3.35

1.4

1.1

2.15

3.89

u/ml

1.08

Cervicobrachial syndrome

202

1553

1.31

3.34

1.2

4.47

3.72

u/ml

0.27

738

Cardiac murmurs and other cardiac sounds

565

1.51

3.34

1.6

1.3

4.58

3.78

u/ml

0.32

259

Striae atrophicae

2.60

3.33

1.2

3.33

4.22

u/ml

—

Uterine polyps

254

1164

1.28

3.33

1.2

3.83

4.86

u/ml

0.71

124

512

Gonarthrosis, primary, with knee surgery

431

2797

1.20

3.33

1.2

4.10

3.91

u/ml

0.12

177

1307

Benign neoplasm: Liver

155

2.03

3.33

1.6

1.2

2.20

5.22

u/ml

1.01

Scleritis and episcleritis

422

1.60

3.33

1.4

1.3

2.89

4.43

u/ml

0.90

184

Pulmonary eosinophilia, not elsewhere classified

2.98

3.33

1.2

1.1

2.14

4.11

u/ml

—

Disorders of puberty, all

115

2.22

3.32

1.5

1.3

3.00

4.35

u/ml

0.65

Erythema intertrigo

128

2.14

3.32

1.2

2.43

6.82

u/ml

1.10

Other predominantly sexually transmitted diseases, not elsewhere classified

201

1548

1.31

3.31

1.4

1.2

4.55

3.80

u/ml

0.27

700

Acne vulgaris

106

737

1.45

3.29

1.5

1.3

6.46

3.68

u/ml

0.73

350

Other and unspecified iridocyclitis

293

1.72

3.28

1.2

3.11

4.39

u/ml

0.64

132

Pyothorax

212

1.86

3.28

1.2

2.57

5.31

u/ml

1.65

101

Other specified/unspecified soft tissue disorders

212

1.86

3.27

1.2

4.80

3.50

u/ml

0.18

Acute appendicitis, no complications

598

5118

1.16

3.27

1.2

1.3

4.93

3.90

u/ml

0.50

275

2456

264

1890

1.26

3.26

1.2

3.40

4.09

u/ml

0.56

123

868

Specific personality disorders

267

2135

1.26

3.25

1.4

1.3

4.60

3.76

u/ml

0.42

128

987

Postmenopausal osteoporosis with pathological fracture

249

1.78

3.24

1.2

3.72

4.26

u/ml

0.09

110

Insulin, intermediate and long-acting

472

3849

1.19

3.23

1.3

1.2

4.99

3.67

u/ml

0.81

236

1828

Follow-up examination after treatment for malignant neoplasms

401

1.60

3.23

1.2

4.81

3.95

u/ml

0.29

177

Ulcerative enterocolitis

199

1.89

3.23

1.3

1.2

2.75

5.89

u/ml

1.16

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

272

1.74

3.22

1.2

4.45

3.62

u/ml

0.17

120

Poisoning by drugs, medicaments and biological substances

256

2040

1.26

3.21

1.3

5.93

3.90

u/ml

0.96

115

967

Viral warts

103

717

1.45

3.21

1.2

1.3

3.67

3.73

u/ml

0.02

322

Disorders of refraction and accommodation

302

2443

1.24

3.19

1.3

3.02

4.12

u/ml

1.96

152

1154

Trigeminal neuralgia

334

1.66

3.17

1.4

1.2

1.91

4.07

u/ml

1.89

141

Other bursitis of elbow

3.03

3.17

1.2

1.83

3.76

u/ml

—

Polycystic ovarian syndrome, broad definition

152

1134

1.35

3.16

1.3

2.83

4.63

u/ml

1.57

512

Excessive vomiting in pregnancy

621

1.48

3.16

1.2

2.68

4.20

u/ml

1.23

267

Poisoning by medicine

234

1850

1.27

3.15

1.3

5.86

3.66

u/ml

0.99

107

872

Bicipital tendinitis

237

1.79

3.14

1.1

1.2

3.05

3.41

u/ml

0.21

101

Lack of expected normal physiological development

2.29

3.13

1.4

1.3

4.46

3.89

u/ml

0.11

Event of undetermined intent

437

1.57

3.12

1.3

2.64

4.53

u/ml

1.21

204

Atypical facial pain

305

1.69

3.12

1.3

1.2

2.24

4.53

u/ml

1.44

125

Postpartum hemorraghe, parous women as controls

322

2204

1.23

3.11

1.3

1.2

2.91

3.90

u/ml

1.82

129

970

Ptosis of eyelid

606

1.48

3.11

1.2

3.27

5.27

u/ml

0.81

259

Benign neoplasm of mouth and pharynx

639

1.46

3.11

1.3

1.2

4.70

5.20

u/ml

0.13

281

Chromosomal abnormalities, not elsewhere classified

159

1.98

3.11

1.5

1.3

4.50

4.72

u/ml

0.05

Temporomandibular joint disorders, including avohilmo

512

4238

1.17

3.10

1.3

4.84

4.02

u/ml

0.33

230

2007

Oter anti-inflammatory and antirheumatic agents, non-steroids

173

714

1.34

3.10

1.3

5.39

3.42

u/ml

0.66

358

Other and unspecified disorders of skin and subcutaneous tissue

321

1.66

3.09

1.2

6.08

4.53

u/ml

0.28

141

Complications associated with artificial fertilization

139

2.05

3.09

1.3

1.4

6.23

5.78

u/ml

0.05

Other inflammatory liver diseases

383

1.61

3.09

1.2

4.89

5.10

u/ml

0.05

172

Degenerative diseases of the nervous system

116

1157

0.72

3.09

1.1

1.2

4.11

4.61

u/ml

0.21

520

Convergent concomitant strabismus

407

1.59

3.08

1.3

3.38

4.46

u/ml

0.49

185

Iron deficiency

262

1.74

3.06

1.7

1.3

4.70

4.82

u/ml

0.02

119

Other bursitis of hip

2.29

3.05

1.0

1.2

14.63

3.05

u/ml

—

Autonomic disorders

126

2.09

3.04

1.3

3.87

5.89

u/ml

0.40

Radial styloid tenosynovitis [de Quervain]

338

1.64

3.04

1.2

1.3

4.00

3.78

u/ml

0.07

151

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

621

4181

1.16

3.04

1.3

6.25

3.89

u/ml

1.05

270

1923

Crohn's disease of small intestine

464

1.54

3.04

1.4

1.3

4.15

4.23

u/ml

0.02

214

Other misadventures during surgical and medical care

133

2.06

3.04

1.1

1.2

1.93

5.04

u/ml

0.96

Ganglion

192

1488

1.30

3.03

1.2

6.46

3.78

u/ml

0.44

686

Rare circulating lymphoid malignancy, including Hilmo

133

2.05

3.03

1.4

1.2

6.80

3.97

u/ml

0.41

Other specified/unspecified bacterial intestinal infections

354

1.62

3.02

1.5

1.2

4.87

4.67

u/ml

0.04

155

Atopic dermatitis, strict definition

352

2856

1.21

3.02

1.3

4.03

4.22

u/ml

0.10

170

1380

Macular pucker

107

759

1.42

3.02

1.2

6.81

4.37

u/ml

0.30

332

Actinic keratosis

231

1664

1.27

3.02

1.2

3.49

4.16

u/ml

0.47

108

768

Bullous disorders

278

1.70

3.00

1.2

5.29

6.44

u/ml

0.17

128

Disorders of psychological development

134

915

1.37

3.00

1.4

1.3

4.60

4.02

u/ml

0.19

447

Suppurative and unspecified otitis media

417

3110

1.19

3.00

1.3

5.61

4.09

u/ml

0.57

193

1516

Isolated patent ductus arteriosus

2.53

3.00

1.1

1.3

2.70

3.90

u/ml

—

Allergic rhinitis

348

2851

1.21

2.99

1.3

4.69

4.05

u/ml

0.33

171

1379

Lesion of lateral popliteal nerve

294

1.68

2.98

1.5

1.2

4.81

4.35

u/ml

0.11

128

Morphin

2.43

2.98

1.4

1.1

3.14

u/ml

—

Benign neoplasm: Orbit, unspecified

3.36

2.98

1.2

2.00

4.29

u/ml

—

Erythema nodosum

176

1.90

2.98

1.4

1.2

2.63

4.72

u/ml

0.75

Congenital stenosis of pulmonary valve

2.92

2.96

1.2

1.3

4.43

3.17

u/ml

—

Other congenital malformations of the digestive system, including avohilmo

315

1.65

2.96

1.6

1.3

8.76

4.82

u/ml

0.83

149

Other infective otitis externa

380

1.59

2.95

1.3

4.71

5.02

u/ml

0.08

174

severe traumatic brain injury, does not include concussion

156

1180

1.33

2.95

1.4

1.3

4.09

4.56

u/ml

0.16

556

Unspecific neurodegenerative disorder

146

1328

0.75

2.94

1.2

4.52

4.40

u/ml

0.04

610

Procedures for purposes other than remedying health state

142

2.00

2.92

1.2

3.27

5.14

u/ml

0.31

Hordeolum and other deep inflammation of eyelid

389

1.58

2.92

1.2

1.3

2.88

5.07

u/ml

1.31

175

Corneal ulcer

177

1366

1.30

2.91

1.3

3.51

4.24

u/ml

0.42

634

Respiratory and cardiovascular disorders specific to the perinatal period

120

2.04

2.91

1.1

1.5

7.67

3.92

u/ml

0.57

Hypopituitarism

493

1.51

2.91

1.4

1.3

6.89

3.58

u/ml

0.98

238

Adult respiratory distress syndrome

2.64

2.90

1.3

1.1

2.50

8.45

u/ml

—

Infection due to other mycobacteria, including avohilmo

2.47

2.90

1.6

1.2

3.18

3.23

u/ml

0.01

Skin changes due to chronic exposure to nonionizing radiation

238

1722

1.25

2.89

1.2

3.55

4.13

u/ml

0.39

110

790

Malignant neoplasm of retroperitoneum and peritoneum, including Hilmo

2.54

2.89

1.0

1.1

2.60

4.26

u/ml

—

L02BG Aromatase inhibitors

234

1847

1.26

2.89

1.2

3.88

3.83

u/ml

0.03

100

819

Alzheimer disease

953

0.70

2.89

1.1

1.2

4.20

4.87

u/ml

0.23

424

Congenital malformations of the musculoskeletal system, not elsewhere classified, including avohilmo

136

2.02

2.89

1.3

1.2

3.50

5.98

u/ml

—

Primary biliary cholangitis, wide definition

102

2.19

2.88

1.5

1.1

3.50

4.88

u/ml

0.25

Mental and behavioural disorders due to opioids

282

1.69

2.88

1.3

3.04

4.57

u/ml

0.88

134

Postpartum hemorraghe, all women as controls

322

2600

1.21

2.86

1.3

2.91

4.31

u/ml

2.48

129

1184

Panhypopituitarism

2.23

2.86

1.5

1.3

9.56

6.02

u/ml

—

Use of other anti-dementia drugs

840

0.67

2.85

1.1

1.2

4.91

4.67

u/ml

0.05

371

Use of memantine

840

0.67

2.85

1.1

1.2

4.91

4.67

u/ml

0.05

371

Personal history of allergy to drugs, medicaments and biological substances

2.39

2.85

1.1

1.2

2.75

7.86

u/ml

—

Routine general health check-up of defined subpopulation

2.21

2.85

1.3

1.2

1.60

3.83

u/ml

—

Other congenital malformations of skin, including avohilmo

561

1.47

2.84

1.3

3.55

4.56

u/ml

0.54

259

Diabetic retinopathy

261

1304

1.25

2.83

1.3

5.14

4.22

u/ml

0.26

133

595

Pneumonia derived septicemia

179

1.86

2.83

1.4

1.2

6.16

4.96

u/ml

0.22

Unspecified event, undetermined intent

165

1.91

2.83

1.3

1.2

2.58

5.03

u/ml

1.00

Lung diseases due to external agents

652

1.43

2.82

1.2

6.32

4.95

u/ml

0.28

301

Use of pramipexole

167

1285

1.30

2.82

1.2

3.68

4.36

u/ml

0.32

590

Viral encephalitis, not elsewhere classified/unspecified

110

2.12

2.81

1.2

7.69

5.67

u/ml

0.22

Other and unspecified tonsillitis

404

2837

1.19

2.81

1.2

1.3

3.07

4.05

u/ml

1.81

214

1374

Family history of certain disabilities and chronic diseases leading to disablement

362

1.59

2.79

1.2

1.3

6.84

4.69

u/ml

0.23

155

Dysplasia of cervi uteri

241

1359

1.25

2.78

1.3

4.79

5.01

u/ml

0.04

113

626

Haemangioma, any site

539

1.48

2.78

1.3

1.2

7.90

4.13

u/ml

0.82

248

Schizophrenia

1234

0.70

2.78

1.2

1.3

2.58

4.08

u/ml

1.98

588

Presence of other functional implants

436

2534

1.18

2.78

1.2

4.30

3.86

u/ml

0.19

201

1153

conjunctival haemorrhage

402

1.55

2.77

1.4

1.2

4.89

4.87

u/ml

0.00

184

Viral infections of the central nervous system, including avohilmo

507

1.49

2.77

1.3

1.2

5.97

4.35

u/ml

0.47

227

Cervical disc disorders

296

2439

1.22

2.77

1.2

4.39

3.68

u/ml

0.37

129

1187

Focal brain injury

247

1.71

2.75

1.2

3.10

3.76

u/ml

0.25

118

Postviral fatigue syndrome

2.49

2.75

1.3

4.55

3.80

u/ml

0.13

Other diseases of stomach and duodenum

332

1.61

2.75

1.2

4.84

4.29

u/ml

0.14

139

Other and specified injuries of hip and thigh

111

2.10

2.74

1.3

1.2

2.92

6.19

u/ml

0.80

Hyperprolactinaemia

248

1.71

2.74

1.5

1.3

4.22

4.18

u/ml

0.01

112

Whooping cough, including avohilmo

118

2.07

2.74

1.4

1.2

5.85

3.40

u/ml

0.31

Disorders of puberty

2.18

2.73

1.4

3.08

4.55

u/ml

0.61

Recurrent dislocation and subluxation of joint

444

1.52

2.72

1.1

1.3

2.65

4.27

u/ml

1.53

208

Lactose intolerance, other/unspecified

153

1.92

2.72

1.2

1.3

3.87

3.70

u/ml

0.05

Other and unspecified injuries of head

436

1.52

2.72

1.4

1.2

3.52

5.13

u/ml

0.45

213

Fracture of shoulder and upper arm

302

2495

1.21

2.71

1.3

1.2

4.27

3.88

u/ml

0.25

153

1181

Diabetic retinopathy, strict definition

138

922

1.33

2.70

1.4

1.3

6.26

4.38

u/ml

0.33

439

Haemangioma and lymphangioma, any site

592

1.45

2.70

1.3

7.41

4.36

u/ml

0.69

272

Pyogenic arthritis

310

1.62

2.70

1.2

1.3

2.54

3.63

u/ml

1.31

155

Pneumonitis due to solids and liquids

373

1.56

2.69

1.2

5.84

5.69

u/ml

0.02

183

Unspecified jaundice

219

1.75

2.69

1.2

3.24

3.35

u/ml

0.06

Background retinopathy and retinal vascular changes

2.20

2.69

1.2

1.3

2.13

6.85

u/ml

1.19

Episcleritis

366

1.57

2.68

1.4

1.2

2.96

4.56

u/ml

0.79

147

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

219

1.75

2.68

1.4

1.2

4.75

4.30

u/ml

0.09

104

Diabetic maculopathy, excluding more controls

660

1.42

2.67

1.3

3.43

4.26

u/ml

0.52

312

Postmenopausal bleeding

205

844

1.28

2.66

1.2

3.26

4.77

u/ml

1.35

366

Coxarthrosis, primary

439

3115

1.17

2.66

1.2

4.42

3.86

u/ml

0.38

190

1466

Etanercept

455

1.51

2.66

1.3

1.2

8.10

3.79

u/ml

1.03

199

Ventricular septal defect, a heart condition

140

1.95

2.65

1.2

1.3

5.68

4.34

u/ml

0.25

Right hemicolectomy

235

1.71

2.65

1.3

1.2

3.46

6.92

u/ml

0.86

112

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

313

2607

1.20

2.64

1.2

1.3

4.84

3.77

u/ml

0.36

157

1246

Benign neoplasm: Connective and other soft tissue, unspecified

2.51

2.64

1.3

1.1

4.67

3.78

u/ml

—

Otitis media, unspecified

114

772

1.37

2.62

1.3

4.58

4.43

u/ml

0.05

376

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

602

1.43

2.62

1.5

1.3

3.81

4.44

u/ml

0.28

280

Herpesviral [herpes simplex] infections, including avohilmo

274

2256

1.22

2.62

1.3

1.2

4.81

3.63

u/ml

0.63

134

1058

Insulin medication

552

3988

1.15

2.62

1.3

1.2

4.81

3.59

u/ml

0.85

265

1903

Superficial injury of hip and thigh

116

857

1.36

2.61

1.3

2.74

4.73

u/ml

2.03

389

Cholangitis (primary sclerosing, PSC)

321

1.60

2.61

1.4

1.2

4.06

4.58

u/ml

0.16

147

Emotional disorders starting during childhood or adolescence

381

1.55

2.60

1.3

1.4

5.09

4.29

u/ml

0.22

187

Other and unspecified disorders of binocular movement

2.96

2.59

1.2

1.1

3.43

4.06

u/ml

—

Hepatocellular carcinoma

2.32

2.59

1.3

1.2

2.25

8.89

u/ml

0.74

Seborrhoeic dermatitis

589

1.43

2.59

1.4

1.2

2.72

5.30

u/ml

2.05

271

Impetigo

322

1.60

2.59

1.4

1.3

1.88

4.72

u/ml

2.15

145

Carcinoma in situ of other and unspecified digestive organs

222

1.73

2.59

1.7

1.2

3.21

4.88

u/ml

0.44

102

Malignant neoplasm of colon, including Hilmo

118

872

1.35

2.58

1.2

2.61

4.43

u/ml

1.86

404

Benign neoplasm of other and unspecified endocrine glands

114

843

1.36

2.57

1.4

1.2

6.51

4.10

u/ml

0.50

371

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

2.92

2.57

1.1

2.83

4.06

u/ml

—

Von Willebrand disease

2.27

2.57

1.3

1.2

6.50

3.34

u/ml

—

Synovial cyst of popliteal space [Baker]

346

1.57

2.56

1.3

1.2

4.29

3.52

u/ml

0.24

146

Other dermatomyositis

3.35

2.56

1.1

2.20

5.00

u/ml

—

Polyp of the female genital tract

265

1224

1.23

2.56

1.2

3.44

4.78

u/ml

1.27

126

546

Postprocedural disorders of digestive system, not elsewhere classified

171

1.83

2.55

1.0

1.2

4.85

6.03

u/ml

0.14

Type 1 diabetes

237

1925

1.23

2.55

1.4

1.3

4.77

3.65

u/ml

0.73

123

908

Unspecified dementia

285

0.44

2.55

1.1

1.2

2.80

5.03

u/ml

—

143

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

243

1983

1.23

2.55

1.4

1.2

4.95

4.33

u/ml

0.23

117

913

Other symptoms and signs involving general sensations and perceptions

193

1.78

2.55

1.2

1.3

3.42

5.29

u/ml

0.44

Sulfonylureas

126

1324

0.75

2.55

1.4

1.2

7.13

3.66

u/ml

0.61

617

Otitis externa

213

1714

1.25

2.54

1.2

1.3

4.28

4.18

u/ml

0.03

103

775

Herpesviral [herpes simplex] infections

107

786

1.37

2.52

1.3

3.60

4.10

u/ml

0.24

352

Other and unspecified mood [affective] disorders

576

1.43

2.52

1.4

1.3

3.47

3.72

u/ml

0.08

257

Complications of genitourinary prosthetic devices, implants and grafts

122

1.99

2.52

1.1

1.2

4.08

4.84

u/ml

0.13

Marginal zone B-cell lymphoma, including Hilmo

2.35

2.50

1.3

1.2

4.86

4.69

u/ml

—

Other disorders of eyelid

324

2566

1.19

2.50

1.2

2.86

4.14

u/ml

2.45

148

1173

Other disorders of optic disc

2.24

2.50

1.4

1.2

1.73

3.49

u/ml

1.47

Congenital malformations and deformations of the musculoskeletal system

657

1.40

2.49

1.4

1.3

4.45

4.10

u/ml

0.13

317

Abnormal weight loss

519

1.45

2.49

1.2

1.3

3.89

5.32

u/ml

0.64

238

Injury of muscle and tendon at shoulder and upper arm level

293

2441

1.20

2.49

1.3

1.2

5.14

3.86

u/ml

0.60

127

1160

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

269

1936

1.22

2.48

1.3

3.60

4.29

u/ml

0.66

138

964

Acute myringitis

2.62

2.48

1.0

1.2

3.40

2.63

u/ml

—

Viral encephalitis, not elsewhere classified/unspecified, including avohilmo

116

2.01

2.47

1.2

7.69

5.46

u/ml

0.26

Periapical abscess

449

3879

1.16

2.47

1.3

3.48

3.72

u/ml

0.16

210

1833

Other/unspecified disorders of vestibular function

210

1.73

2.47

1.2

5.57

4.21

u/ml

0.18

In situ neoplasms

325

2735

1.19

2.47

1.3

1.2

5.08

4.01

u/ml

0.30

155

1237

Acquired absence of organs, not elsewhere classified

2.50

2.47

1.3

1.2

1.14

3.36

u/ml

—

Sacrococcygeal disorders, not elsewhere classified

203

1.74

2.46

1.4

1.2

3.20

3.00

u/ml

0.07

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

241

1.68

2.46

1.5

1.2

2.15

5.15

u/ml

1.84

101

Valgus deformity, not elsewhere classified

3.20

2.46

1.7

1.3

4.60

3.47

u/ml

—

Disorders of muscles

604

1.41

2.45

1.3

2.47

3.69

u/ml

2.04

282

Fracture at wrist and hand level

339

2857

1.19

2.45

1.3

3.08

3.69

u/ml

0.70

153

1402

Psoriasis

254

2092

1.22

2.44

1.3

1.2

4.79

3.93

u/ml

0.50

116

974

Type 2 diabetes, definitions combined

953

5001

1.11

2.44

1.3

1.2

4.31

3.85

u/ml

0.35

446

2342

Psoriatic and enteropathic arthropathies

706

1.38

2.43

1.3

1.2

6.98

4.82

u/ml

0.57

329

Contusion of toe(s) without damage to nail

189

1.77

2.43

1.4

1.3

6.21

5.86

u/ml

0.03

Exposure to other and unspecified animate mechanical forces

227

1.69

2.42

1.3

2.63

5.09

u/ml

1.17

101

Laparoscopic right hemicolectomy

242

1.66

2.41

1.2

2.11

7.13

u/ml

1.77

113

Malignant neoplasm of mesothelium and soft tissue

167

1.81

2.41

1.0

1.2

4.15

8.29

u/ml

0.71

Dementia

173

1493

0.79

2.41

1.1

1.2

4.06

4.19

u/ml

0.05

684

Vestibular neuronitis

523

1.44

2.41

1.3

1.2

8.17

4.10

u/ml

0.57

231

Abscess of lung

2.24

2.39

1.2

1.3

4.38

4.56

u/ml

—

Lymphangioma, anys site

2.57

2.39

1.5

1.3

6.20

3.64

u/ml

—

Female infertility, tubal origin

361

1.54

2.39

1.3

1.2

3.33

4.27

u/ml

0.35

154

Adalimumab

105

778

1.36

2.37

1.3

3.69

3.92

u/ml

0.08

354

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

2.18

2.37

1.1

1.4

6.50

4.20

u/ml

—

Type 2 diabetes, definitions combined, including avohilmo

968

5061

1.11

2.37

1.3

1.2

4.21

3.92

u/ml

0.20

455

2375

Labour and delivery complicated by umbilical cord complications

370

1.53

2.36

1.3

5.23

3.38

u/ml

0.59

152

Mixed disorders of conduct and emotions

176

1.78

2.36

1.2

1.4

3.60

4.12

u/ml

0.24

Sequelae of injuries of head

338

1.55

2.36

1.2

2.33

4.95

u/ml

1.47

151

Chronic tubulo-interstitial nephritis

176

1.78

2.35

1.2

1.1

4.20

6.22

u/ml

0.35

Cramp and spasm

299

1.59

2.34

1.3

1.2

3.70

5.12

u/ml

0.44

137

Optic atrophy

2.07

2.33

1.4

1.2

2.57

3.95

u/ml

—

Other specified/unspecified inflammatory spondylopathies

323

1.56

2.33

1.2

4.37

4.02

u/ml

0.10

140

Cysts of oral region, not elsewhere classified

371

1.52

2.33

1.2

3.21

4.87

u/ml

0.82

171

Other peripheral vertigo

535

1.43

2.33

1.2

4.11

4.71

u/ml

0.16

235

Disorders of synovium and tendon in diseases classified elsewhere

2.07

2.33

1.2

2.09

4.13

u/ml

1.49

Emotionally unstable personality disorder

143

1111

1.29

2.33

1.4

1.2

6.07

3.76

u/ml

0.75

515

Type 2 diabetes, strict (exclude DM1)

955

5027

1.11

2.32

1.3

1.2

4.30

3.84

u/ml

0.36

447

2358

Other and/or unspecified nontoxic goitre

461

1.46

2.32

1.1

1.2

2.29

3.73

u/ml

1.26

187

Unspecified lump in breast

136

1050

1.30

2.31

1.3

1.2

4.48

3.88

u/ml

0.25

452

Sequelae of intentional self-harm, assault and events of undetermined intent

2.53

2.31

1.2

1.3

2.86

4.78

u/ml

—

Hepatocellular carcinoma, including Hilmo

112

1.98

2.31

1.3

1.2

2.25

8.17

u/ml

0.97

Other diseases of spinal cord

155

1.83

2.31

1.2

1.3

2.27

5.13

u/ml

0.97

Ovarian dysfunction

697

1.37

2.30

1.2

2.78

3.59

u/ml

0.64

314

Benign neoplasm of brain and other parts of central nervous system

364

1.52

2.30

1.3

1.2

2.93

5.05

u/ml

1.04

160

Lateral epicondylitis

115

868

1.33

2.30

1.2

3.90

3.85

u/ml

0.02

390

Exposure to other and unspecified forces of nature

2.83

2.30

1.4

1.2

3.67

3.95

u/ml

—

Infectious mononucleosis

714

1.37

2.30

1.2

1.3

3.51

3.62

u/ml

0.05

340

Infectious mononucleosis, including avohilmo

714

1.37

2.30

1.2

1.3

3.51

3.62

u/ml

0.05

340

Disorders of breast

491

3775

1.15

2.30

1.3

1.2

4.02

4.14

u/ml

0.08

234

1659

Mental and behavioural disorders due to psychoactive substance use

573

4633

1.13

2.29

1.3

4.07

3.95

u/ml

0.08

257

2247

Other diseases of gallbladder

215

1.69

2.29

1.3

1.2

2.88

5.35

u/ml

0.95

Other neurotic disorders

254

1.63

2.28

1.2

5.50

5.07

u/ml

0.05

116

Cerebral palsy

106

2.01

2.28

1.1

1.3

7.13

3.79

u/ml

0.45

Postpartum care and examination

138

666

1.31

2.27

1.3

2.75

4.27

u/ml

1.76

331

Chronic viral hepatitis

390

1.50

2.27

1.4

1.3

4.16

4.33

u/ml

0.04

187

Malignant neoplasm of testis, including Hilmo

2.18

2.26

2.2

1.3

5.80

4.36

u/ml

—

Pneumococcal septicemia

171

1.77

2.26

1.2

6.12

5.00

u/ml

0.18

Hypertrophic scar

350

1.53

2.25

1.4

1.3

2.36

3.70

u/ml

1.06

151

Hydrocele

581

1.40

2.24

1.2

2.67

4.03

u/ml

1.83

303

Gonarthrosis,primary

739

3987

1.12

2.24

1.2

3.59

3.89

u/ml

0.31

316

1889

2.11

2.24

1.2

2.90

6.89

u/ml

—

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

2.07

2.23

1.3

1.2

4.78

2.74

u/ml

—

Infective bursitis

135

1.87

2.23

1.3

1.2

2.17

3.82

u/ml

1.11

Restless leg syndrome

121

925

1.31

2.23

1.3

1.2

4.55

4.63

u/ml

0.03

413

Other specified and unspecified disorders of eyelid

2.23

1.2

1.88

10.15

u/ml

—

Phlebitis and thrombophlebitis of lower extremities, unspecified, drug-induced

2.92

2.23

1.4

1.1

18.80

4.35

u/ml

—

Lichen simplex chronicus and prurigo

359

1.51

2.22

1.5

1.2

2.83

4.81

u/ml

1.27

164

Spondylolisthesis/Spondylolysis

142

1109

1.28

2.22

1.2

2.85

3.67

u/ml

0.81

511

Myocardial infarction, unclassifiable

112

755

1.33

2.21

1.3

1.2

4.25

4.95

u/ml

0.25

358

Certain conditions originating in the perinatal period

576

1.38

2.21

1.3

1.4

3.51

4.36

u/ml

0.51

301

Unstable angina pectoris

219

1408

1.22

2.20

1.3

1.2

5.38

3.35

u/ml

1.12

104

630

Substance abuse

555

4558

1.13

2.20

1.3

4.11

3.86

u/ml

0.19

249

2213

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

119

910

1.31

2.19

1.2

4.65

4.48

u/ml

0.03

408

Diseases of external ear

304

2576

1.18

2.19

1.3

4.08

3.98

u/ml

0.04

152

1197

Use of anticholinesterases

112

1133

0.76

2.18

1.2

3.66

4.71

u/ml

0.50

516

N06DA Anticholinesterases

112

1133

0.76

2.18

1.2

3.66

4.71

u/ml

0.50

516

Combinations of oral blood glucose lowering drugs

144

1824

0.79

2.18

1.1

1.2

2.40

3.71

u/ml

3.21

869

Superficial injury of thorax

130

1007

1.30

2.18

1.3

4.18

4.39

u/ml

0.09

455

Ulcerative proctitis

410

1.47

2.18

1.4

1.3

3.50

4.55

u/ml

0.39

193

Other specified and unspecified personality disorders

713

1.35

2.17

1.4

1.3

3.31

3.82

u/ml

0.37

314

Superficial injury of shoulder and upper arm

105

790

1.34

2.17

1.3

4.16

4.48

u/ml

0.12

357

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

1005

0.71

2.17

1.2

1.3

3.31

4.18

u/ml

0.51

468

Weight loss

577

1.39

2.16

1.2

1.3

3.83

5.22

u/ml

0.67

261

Benign thyroid growths and nodules

258

2003

1.20

2.16

1.2

4.90

3.65

u/ml

0.59

114

879

LSIL lesion of the cervix uteri, vagina or vulva

155

1230

1.27

2.16

1.3

1.2

2.53

3.69

u/ml

2.08

531

Generalized skin eruption due to drugs and medicaments

227

1.64

2.15

1.4

1.2

4.50

5.02

u/ml

0.10

Open wound of head

476

3921

1.14

2.14

1.3

1.2

4.05

3.85

u/ml

0.15

228

1892

Other disorders of binocular movement

167

1.76

2.13

1.1

1.3

4.23

5.60

u/ml

0.29

Type 1 diabetes, wide definition, subgroup 1

197

1606

1.23

2.13

1.4

1.3

4.73

3.65

u/ml

0.71

107

755

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

537

1.40

2.12

1.2

2.95

4.41

u/ml

1.03

238

Myopia

139

1091

1.28

2.12

1.2

1.3

3.11

4.22

u/ml

1.07

503

Optic atrophy, wide definition

102

1.99

2.12

1.4

1.2

2.57

3.83

u/ml

—

Myeloid leukaemia

116

1.92

2.12

1.3

1.2

3.00

5.39

u/ml

—

Tinnitus

207

1699

1.22

2.12

1.2

1.3

5.88

3.95

u/ml

0.32

784

Malignant neoplasm of liver and intrahepatic bile ducts

116

1.91

2.11

1.3

1.2

2.47

8.00

u/ml

0.97

Chorioretinal inflammation

160

1.77

2.11

1.3

1.2

4.31

6.70

u/ml

0.41

Other congenital malformations of skin

260

1.59

2.10

1.3

2.96

4.77

u/ml

0.76

113

Conductive and sensorineural hearing loss

546

4089

0.88

2.10

1.2

5.36

3.85

u/ml

0.68

244

1935

Malignant neoplasm of testis

2.16

2.10

2.3

1.3

6.33

4.24

u/ml

—

Salpingitis and oophoritis

145

1146

1.27

2.09

1.2

5.75

3.74

u/ml

0.71

501

Bursitis of shoulder

124

1.87

2.08

1.1

1.2

2.00

3.37

u/ml

1.13

Femoral hernia, unilateral

124

1.87

2.08

1.3

1.2

6.18

5.68

u/ml

0.05

Inguinal hernia, unilateral

124

1.87

2.08

1.3

1.2

6.18

5.68

u/ml

0.05

Inguinal of femoral hernia, unilateral

124

1.87

2.08

1.3

1.2

6.18

5.68

u/ml

0.05

Any dementia

143

1250

0.79

2.08

1.1

1.2

3.49

4.57

u/ml

0.63

573

Malignant neoplasm of skin, including Hilmo

408

2370

1.15

2.08

1.3

1.2

4.42

3.92

u/ml

0.34

204

1103

Carrier of infectious disease

176

1.73

2.08

1.3

1.2

3.47

6.83

u/ml

0.85

Chronic pancreatitis

100

753

1.33

2.07

1.2

3.63

3.95

u/ml

0.16

339

Other orthopaedic follow-up care

325

1.52

2.06

1.3

1.2

3.67

4.03

u/ml

0.10

143

Nonsuppurative otitis media

245

1775

1.20

2.06

1.3

4.60

4.46

u/ml

0.07

130

873

Degeneration of macula and posterior pole

303

1986

1.18

2.06

1.3

1.2

5.45

3.88

u/ml

0.61

149

885

Malignant melanoma, including Hilmo

119

919

1.30

2.06

1.3

4.87

4.59

u/ml

0.08

424

Entropion and trichiasis of eyelid

317

1.52

2.05

1.4

1.2

2.79

6.61

u/ml

1.49

145

Mental and behavioural disorders due to sedatives or hypnotics

482

1.42

2.05

1.4

1.2

6.03

4.37

u/ml

0.37

224

Congenital obstruction of the pelviureteric junction

2.46

2.05

1.2

2.20

3.43

u/ml

—

Oral lichen planus, including avohilmo , including avohilmo

424

1.45

2.05

1.4

1.2

4.78

4.87

u/ml

0.02

167

Acetic acid derivatives and related substances

251

1079

1.20

2.04

1.3

4.61

3.86

u/ml

0.18

113

549

Nontoxic goitre/thyroid nodule

218

1806

1.21

2.04

1.2

5.26

4.18

u/ml

0.38

809

Benign lipomatous neoplasm

237

1980

1.20

2.03

1.3

1.2

4.15

3.95

u/ml

0.07

119

907

Isolated proteinuria with specified morphological lesion

2.26

2.03

1.7

1.3

2.13

3.42

u/ml

—

Other hearing loss

189

1495

1.23

2.03

1.2

2.72

4.06

u/ml

1.90

694

Short stature, not elsewhere classified

143

1.77

2.02

1.3

1.5

2.73

4.52

u/ml

1.13

Meralgia paraesthetica

208

1.65

2.02

1.1

1.2

4.43

4.56

u/ml

0.02

Neuromuscular dysfunction of bladder

475

1.42

2.02

1.4

1.2

4.20

3.96

u/ml

0.09

191

Toxic effect of ethanol

255

1.58

2.02

1.4

1.3

5.05

4.82

u/ml

0.03

114

Congenital malformations of genital organs

101

761

1.33

2.01

1.3

5.54

4.33

u/ml

0.34

343

Undefined dementia

265

0.49

2.01

1.1

1.2

2.80

5.13

u/ml

—

136

Open wound of wrist and hand

459

3902

1.14

2.01

1.3

4.20

3.94

u/ml

0.19

215

1925

Moderate visual impairment, binocular

104

1.94

2.01

1.3

1.1

4.63

5.45

u/ml

—

Subarachnoid haemorrhage

442

1.43

2.01

1.5

1.2

5.18

3.08

u/ml

0.70

189

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

501

1.40

2.00

1.1

1.3

2.64

4.08

u/ml

1.50

237

Benign neoplasm: Skin of lip

2.18

2.00

1.5

1.2

2.33

7.67

u/ml

—

Osteonecrosis due to drugs

2.18

2.00

1.1

1.3

4.71

4.62

u/ml

—

Other disorders of pigmentation

232

1.61

1.99

1.2

2.38

4.97

u/ml

1.32

Calcaneal spur

2.31

1.99

1.3

1.2

2.57

3.14

u/ml

—

Malignant melanoma

107

819

1.31

1.99

1.3

1.2

5.11

4.70

u/ml

0.11

376

Papillary adenocarcinoma of thyroid gland

312

1.52

1.99

1.3

1.2

5.18

4.69

u/ml

0.08

129

Pedal cyclist injured in collision with other pedal cycle or other nonmotor vehicle

2.12

1.99

1.1

1.3

2.33

4.24

u/ml

—

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

141

1.80

1.98

1.4

1.2

6.82

5.22

u/ml

0.12

Diseases of tongue

320

1.51

1.98

1.3

3.35

4.81

u/ml

0.59

131

Hypertrophic disorders of skin

386

1.46

1.97

1.4

1.3

2.46

4.66

u/ml

1.56

164

Anorexia (incl.atypical)

486

1.41

1.97

1.4

1.3

4.48

3.88

u/ml

0.20

227

Other disorders originating in the perinatal period

2.23

1.97

1.3

3.20

3.78

u/ml

—

Smoking dependency

605

1.36

1.97

1.2

4.41

u/ml

0.00

269

Prolonged pregnancy

128

1383

0.79

1.96

1.2

1.3

2.33

4.62

u/ml

2.85

645

Artificial joint re-operation

321

1.50

1.96

1.3

1.2

2.95

4.96

u/ml

1.06

149

Blindness, monocular

2.61

1.95

1.7

1.2

2.80

4.13

u/ml

—

Mental and behavioural disorders due to tobacco

606

1.36

1.95

1.2

4.41

4.32

u/ml

0.03

269

Right bundle-branch block

149

1.76

1.95

1.2

4.38

3.06

u/ml

0.38

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

632

1.35

1.95

1.3

1.2

3.50

3.95

u/ml

0.20

260

Neonatal jaundice from other and unspecified causes

2.10

1.94

1.1

1.3

12.40

3.23

u/ml

—

Injuries involving multiple body regions

234

1.59

1.94

1.4

1.2

2.54

5.25

u/ml

1.17

105

Other disorders of bone density and structure

157

1.74

1.94

1.3

2.40

5.16

u/ml

—

Other sexually transmitted chlamydial diseases, including avohilmo

121

946

1.29

1.94

1.4

1.3

4.06

3.84

u/ml

0.08

452

Carcinoma in situ of skin of lower limb, including hip

2.13

1.93

1.1

2.00

6.88

u/ml

—

Other disorders of the musculoskeletal system and connective tissue

116

903

1.29

1.92

1.3

1.2

6.24

4.59

u/ml

0.45

393

Benign neoplasm: Brain, supratentorial

1.99

1.92

1.3

1.2

4.27

3.90

u/ml

0.06

Suicide or other Intentional self-harm

242

2039

1.19

1.91

1.3

5.83

3.91

u/ml

0.93

121

955

Bruxism

143

1.77

1.91

1.2

2.00

5.04

u/ml

—

Social phobias

703

1.33

1.90

1.3

4.61

4.26

u/ml

0.10

322

Secondary polycythaemia

121

1.84

1.89

1.8

1.2

4.00

5.61

u/ml

0.29

Colorectal cancer, including Hilmo

170

1291

1.23

1.88

1.2

2.82

4.09

u/ml

1.65

608

Vitiligo

2.12

1.88

1.7

1.2

4.63

3.55

u/ml

—

Adhesive capsulitis of shoulder

120

941

1.28

1.88

1.2

4.27

3.73

u/ml

0.19

430

Malignant melanoma of skin

627

1.35

1.88

1.3

1.2

4.90

4.80

u/ml

0.02

289

Allergic contact dermatitis

124

977

1.27

1.87

1.3

1.2

3.67

4.14

u/ml

0.20

423

Post-traumatic wound infection, not elsewhere classified

174

1.68

1.87

1.2

3.00

3.90

u/ml

0.36

Contusion of toe(s) with damage to nail

2.06

1.87

1.2

1.3

4.33

4.03

u/ml

—

Hypocalcemia

129

1.80

1.87

1.4

1.2

1.67

3.98

u/ml

—

Left bundle-branch block

341

1.47

1.87

1.3

1.2

4.54

3.14

u/ml

0.41

140

Assault by bodily force

611

1.35

1.86

1.4

1.3

4.91

4.14

u/ml

0.14

295

Other lack of coordination

2.05

1.86

1.4

1.2

3.40

3.43

u/ml

—

Acute myeloid leukaemia, helper endpoint

2.42

1.86

1.2

3.17

4.74

u/ml

—

Acute myeloid leukaemia

2.42

1.86

1.2

3.17

4.74

u/ml

—

Acute myeloid leukaemia, including Hilmo

2.42

1.86

1.2

3.17

4.74

u/ml

—

Malignant melanoma of skin, including Hilmo

100

767

1.31

1.85

1.3

4.80

4.55

u/ml

0.06

354

Abnormal blood-pressure reading, without diagnosis

245

1.56

1.84

1.3

1.2

4.92

3.22

u/ml

0.50

104

Kela reimbursement Agammaglobulinemia (D80-84)

2.17

1.84

1.1

1.2

2.50

3.24

u/ml

—

Carcinoma in situ of cervix uteri

939

0.73

1.84

1.2

8.33

4.05

u/ml

0.33

406

Male infertility

326

1.48

1.84

1.3

3.56

3.65

u/ml

0.05

170

Oral lichen planus

137

1.77

1.84

1.3

1.2

2.64

4.89

u/ml

0.57

Single delivery by caesarean section

237

1135

1.20

1.83

1.3

4.80

5.08

u/ml

0.09

110

555

Streptococcus and staphylococcus as the cause of diseases classified to other chapters, including avohilmo

2.32

1.83

1.1

1.2

2.67

4.73

u/ml

—

MS-disease / Multiple Sclerosis

562

1.36

1.82

1.2

1.3

5.11

4.11

u/ml

0.15

244

Sensorineural hearing loss

502

3755

0.89

1.82

1.2

5.70

3.83

u/ml

0.79

220

1779

Melanocytic naevi of trunk

112

875

1.29

1.82

1.3

4.54

4.60

u/ml

0.02

400

Orchitis and epididymitis

519

1.37

1.82

1.2

3.45

4.07

u/ml

0.44

263

Malignant neoplasm of endocrine gland, including Hilmo

528

1.37

1.82

1.3

1.2

4.52

5.03

u/ml

0.12

230

119

1.81

1.1

1.3

10.82

2.80

u/ml

1.01

Myasthenia gravis

1.98

1.81

1.1

1.67

5.92

u/ml

—

Autoimmune thyroiditis

138

1.76

1.81

1.2

8.78

3.02

u/ml

—

Benign neoplasm of eye and adnexa

614

1.34

1.81

1.1

1.2

3.06

5.06

u/ml

1.08

267

Perineal laceration during delivery

215

1453

1.20

1.81

1.3

3.64

4.57

u/ml

0.44

101

666

Maternal care for known or suspected malpresentation of fetus

235

1412

1.19

1.81

1.3

2.95

4.69

u/ml

1.72

107

658

Other disorders of breast

128

1018

1.26

1.80

1.3

1.2

3.29

3.79

u/ml

0.21

437

Vitamin B12 deficiency anaemia

444

1.40

1.79

1.2

4.08

5.50

u/ml

0.41

198

Use of antiglaucoma preparations and miotics

295

1.50

1.79

1.3

1.2

1.86

5.93

u/ml

2.09

146

Acquired absence of limb

2.38

1.79

1.3

1.1

1.40

3.28

u/ml

—

Psoriatic arthropathies

598

1.34

1.79

1.3

7.29

4.35

u/ml

0.73

294

Macular hole

239

1.56

1.79

1.3

1.2

3.89

5.53

u/ml

0.44

105

Malignant neoplasm of vulva, including Hilmo

2.37

1.79

1.0

1.1

4.50

3.33

u/ml

—

LSIL lesion of the vagina

1.92

1.77

1.2

1.1

2.50

5.46

u/ml

—

Astigmatism

412

1.41

1.76

1.3

2.12

4.30

u/ml

2.02

192

Dislocations, sprains and strains involving multiple body regions

4.13

1.75

1.4

1.2

—

6.40

—

Other and unspecified acne

110

1.85

1.75

1.6

1.3

3.40

4.02

u/ml

—

Maternal care for cervical incompetence

257

1.53

1.74

1.4

1.3

3.14

4.38

u/ml

0.52

114

Monoamine oxidase A inhibitors

714

1.31

1.74

1.2

3.46

4.44

u/ml

0.54

337

Other benign neoplasms of skin

289

2494

1.16

1.73

1.2

3.05

3.99

u/ml

1.07

138

1153

Coxarthrosis, primary, with hip surgery

310

2491

1.16

1.73

1.2

3.82

3.73

u/ml

0.06

135

1168

Impotence

339

1.45

1.73

1.4

1.3

3.11

3.90

u/ml

0.37

177

Single spontaneous delivery

272

1676

0.85

1.73

1.2

1.3

5.83

4.66

u/ml

0.36

106

808

Endometriosis of rectovaginal septum and vagina

482

1.38

1.72

1.2

4.06

4.41

u/ml

0.07

210

Pulmonary oedema

2.15

1.72

1.4

1.1

2.43

6.96

u/ml

—

Dissociative [conversion] disorders

258

1.52

1.71

1.3

2.44

5.27

u/ml

1.45

115

Open wound of thorax

1.94

1.71

1.3

2.27

3.02

u/ml

0.56

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

2.03

1.71

1.6

1.2

2.17

4.07

u/ml

—

Anomalies of pupillary function

133

1.75

1.71

1.3

1.2

2.73

5.06

u/ml

0.66

Benign neoplasm: Duodenum

118

1.80

1.71

1.3

1.2

16.57

5.38

u/ml

—

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

169

1395

1.22

1.71

1.3

5.44

3.84

u/ml

0.64

658

Other viral hepatitis

466

1.38

1.71

1.3

4.05

4.66

u/ml

0.18

224

Melanocytic naevi of lower limb, including hip

291

1.49

1.70

1.3

2.19

5.09

u/ml

1.74

128

Injury of muscle and tendon at wrist and hand level

119

946

1.26

1.70

1.2

1.3

2.57

4.03

u/ml

2.07

451

Human immunodeficiency virus [HIV] disease resulting in other conditions

111

1.83

1.70

1.4

1.3

2.93

3.95

u/ml

0.48

Chalazion

770

1.29

1.69

1.4

1.3

4.32

4.80

u/ml

0.14

350

Other disorders of male genital organs

227

1.55

1.68

1.3

1.2

2.20

3.64

u/ml

1.78

117

Viral hepatitis, including avohilmo

562

1.34

1.68

1.3

3.83

4.68

u/ml

0.30

263

Car occupant injured in other and unspecified transport accidents

182

1517

1.20

1.67

1.3

6.12

4.16

u/ml

0.32

705

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

537

1.35

1.66

1.4

1.3

3.36

4.21

u/ml

0.47

253

Human immunodeficiency virus [HIV] disease resulting in other conditions, including avohilmo

112

1.81

1.66

1.4

1.3

2.93

3.95

u/ml

0.48

Respiratory tuberculosis

188

1.60

1.66

1.4

1.2

2.24

6.92

u/ml

1.16

Respiratory tuberculosis, confirmed and not-confirmed

188

1.60

1.66

1.4

1.2

2.24

6.92

u/ml

1.16

Other diseases of peritoneum

236

1.54

1.65

1.2

3.25

5.29

u/ml

0.44

Achalasia of cardia

1.95

1.65

1.5

1.2

2.86

5.87

u/ml

—

Spinal instabilities

173

1.63

1.65

1.1

2.29

3.63

u/ml

—

Benign neoplasm: Conjunctiva

173

1.63

1.65

1.1

1.2

5.08

6.57

u/ml

0.24

Foreign body or object entering through skin

410

1.40

1.64

1.3

4.10

4.84

u/ml

0.23

195

Melanocytic naevi of scalp and neck

150

1.68

1.64

1.6

1.3

2.06

7.86

u/ml

1.67

Other disorders of Eustachian tube

181

1.62

1.64

1.2

3.27

5.82

u/ml

0.54

Malignant neoplasm of skin

373

2220

1.14

1.64

1.3

1.2

4.70

3.85

u/ml

0.59

179

1025

Ulcerative ileocolitis

261

1.51

1.64

1.4

1.2

3.31

4.92

u/ml

0.60

113

Lichen simplex chronicus

189

1.60

1.64

1.5

1.2

2.88

5.74

u/ml

0.92

Viral hepatitis

530

1.35

1.63

1.3

3.93

4.73

u/ml

0.26

249

Other and unspecified nail disorders

135

1.72

1.63

1.5

1.2

3.69

4.68

u/ml

0.21

Hypothyroidism due to medicaments and other exogenous substances

2.17

1.62

1.4

1.1

4.57

2.32

u/ml

—

Generalized epilepsy, strict definition

143

1.70

1.62

1.1

1.2

2.25

5.33

u/ml

—

Injuries to the elbow and forearm

696

5443

1.10

1.62

1.2

1.3

3.13

4.13

u/ml

2.75

325

2591

Benign neoplasm: Descending colon

361

1.42

1.61

1.1

1.2

2.37

5.82

u/ml

1.64

165

Residual foreign body in soft tissue

303

1.46

1.61

1.2

2.46

3.44

u/ml

0.75

143

Benign neoplasm: Rectosigmoid junction

182

1.60

1.61

1.3

1.2

2.06

7.88

u/ml

1.54

LSIL lesion of the cervix uteri

126

1017

1.24

1.60

1.3

1.2

2.60

3.82

u/ml

1.66

438

Type 1 diabetes, wide definition

199

1678

1.19

1.60

1.4

1.3

4.68

3.70

u/ml

0.63

109

792

Pyoderma

106

1.81

1.60

1.6

1.2

6.80

8.08

u/ml

—

Liposarcoma, including Hilmo

2.36

1.60

1.0

1.3

3.20

5.30

u/ml

—

Optic neuritis

304

1.46

1.59

1.3

1.2

5.77

4.91

u/ml

0.10

135

Oxicams

190

901

1.20

1.59

1.2

1.3

4.39

3.53

u/ml

0.27

452

Endometriosis of pelvic peritoneum

151

1129

1.22

1.59

1.3

3.27

5.05

u/ml

0.99

523

Embedded and impacted teeth

317

2249

1.15

1.59

1.3

4.82

4.00

u/ml

0.24

169

1094

Causalgia

1.84

1.58

1.2

4.11

7.03

u/ml

—

460

0.65

1.58

1.3

3.39

5.15

u/ml

0.89

227

Precocious central puberty

2.33

1.57

1.3

3.60

3.64

u/ml

—

Other disorders of penis

585

1.32

1.57

1.3

1.2

4.12

3.91

u/ml

0.08

295

Corneal scars and opacities

160

1.64

1.56

1.8

1.2

4.33

3.91

u/ml

0.13

Tarsal tunnel syndrome

2.14

1.56

1.4

1.1

1.60

10.06

u/ml

—

Other viral hepatitis, including avohilmo

500

1.35

1.56

1.3

4.00

4.48

u/ml

0.14

239

Acute nephritic syndrome

122

1.74

1.56

1.1

1.2

5.78

5.44

u/ml

—

Endometriosis ASRM stages 3,4

212

1805

1.18

1.55

1.2

6.52

3.68

u/ml

0.54

803

Major anomalies of jaw size

184

1.59

1.55

1.1

1.3

7.36

4.92

u/ml

0.23

Persons with potential health hazards related to communicable diseases

421

3725

1.12

1.55

1.4

1.3

5.40

4.05

u/ml

0.53

203

1776

Labour and delivery complicated by fetal stress [distress]

294

1663

1.15

1.55

1.3

3.12

4.48

u/ml

1.46

138

772

Other superficial mycoses, including avohilmo

108

861

1.26

1.54

1.3

5.02

4.40

u/ml

0.14

393

Graves ophthalmopathy, strict

130

1.71

1.54

1.3

1.1

2.62

4.89

u/ml

0.50

Disorders of optic nerve, not elsewhere classified

100

1.82

1.54

1.3

1.1

1.67

8.05

u/ml

—

Medicines for HER+ breast cancer

283

2294

1.15

1.54

1.2

3.73

3.85

u/ml

0.08

121

1009

Tuberculosis

208

1.54

1.4

1.2

2.22

6.50

u/ml

1.19

Myositis

115

1.75

1.53

1.2

2.45

4.00

u/ml

0.92

Injury of eye and orbit

130

1059

1.23

1.53

1.4

1.3

2.32

4.75

u/ml

4.09

513

Fall involving bed

115

1.75

1.53

1.9

1.2

4.44

5.63

u/ml

—

Colorectal adenocarcinoma

120

956

1.24

1.53

1.2

2.74

4.32

u/ml

1.50

451

Other maltreatment syndromes

209

1.54

1.52

1.2

2.14

4.49

u/ml

1.35

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

258

1.48

1.51

1.4

1.3

5.00

5.24

u/ml

0.04

119

Other and unspecified injuries of wrist and hand

258

1.48

1.51

1.4

1.3

8.33

5.37

u/ml

0.29

116

Carcinoma in situ of skin of trunk

108

1.77

1.51

1.5

1.2

3.00

5.98

u/ml

—

Caught, crushed, jammed or pinched in or between objects

375

1.40

1.50

1.2

1.3

5.00

4.54

u/ml

0.07

185

All dysplastic lesions of the vulva

275

1.47

1.50

1.3

1.2

2.05

4.10

u/ml

1.10

105

Antepartum haemorrhage, not elsewhere classified

767

1.27

1.50

1.2

1.3

3.53

4.47

u/ml

0.44

343

Other endocrine disorders

319

1.42

1.49

1.4

2.32

4.01

u/ml

2.22

157

Other female pelvic inflammatory diseases

134

1099

1.22

1.49

1.3

1.2

5.06

3.63

u/ml

0.40

479

Desensitization to allergens

410

1.37

1.48

1.1

1.3

2.74

4.43

u/ml

1.21

182

Personal history of risk-factors, not elsewhere classified

1.83

1.48

1.5

1.2

3.57

4.88

u/ml

—

Mandibular hypoplasia

2.27

1.48

1.2

1.3

3.40

5.80

u/ml

—

Acute gastritis

376

1.39

1.48

1.2

3.41

5.30

u/ml

0.64

164

140

1.65

1.48

1.1

1.4

10.82

3.26

u/ml

0.93

Nasal polyp

147

1218

1.21

1.47

1.2

1.3

3.17

4.00

u/ml

0.71

582

Congenital ovarian cysts

343

1.41

1.47

1.1

1.3

2.13

4.42

u/ml

1.70

144

Extreme obesity with alveolar hypoventilation

227

1.51

1.47

1.1

1.2

3.33

6.18

u/ml

1.06

102

Disorders of orbit

268

1.47

1.2

2.75

5.07

u/ml

1.02

110

Carcinoma in situ of colon

132

1.68

1.46

1.9

1.2

4.60

6.02

u/ml

—

Human immunodeficiency virus [HIV] disease

117

1.73

1.46

1.4

1.2

2.93

3.91

u/ml

0.47

Impacted teeth

234

1731

1.16

1.46

1.3

3.45

4.43

u/ml

0.64

121

863

Other and unspecified types of non-Hodgkin lymphoma, hilmo

179

1.57

1.46

1.2

5.27

6.20

u/ml

0.15

Early lumbar disc prolapse, operated

107

859

1.25

1.46

1.2

1.3

3.16

3.76

u/ml

0.39

413

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

340

2025

1.13

1.45

1.3

1.2

4.30

3.85

u/ml

0.28

166

937

Preterm labour and delivery

235

2030

1.16

1.45

1.3

1.2

4.72

3.81

u/ml

0.38

103

894

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

302

1.43

1.44

1.1

1.2

4.26

6.70

u/ml

0.58

137

Behavioural disorders, excluding more controls

140

1.65

1.44

1.2

1.3

3.17

4.56

u/ml

0.51

Chronic laryngitis and laryngotracheitis

110

887

1.24

1.44

1.3

1.2

5.38

4.11

u/ml

0.27

414

Respiratory tuberculosis, confirmed

1.99

1.44

1.2

2.63

7.29

u/ml

—

Retained placenta and membranes, without haemorrhage

111

897

1.24

1.43

1.3

1.2

3.02

3.32

u/ml

0.16

382

Obstructed labour due to malposition and malpresentation of fetus

247

1985

1.16

1.43

1.4

1.3

5.52

4.42

u/ml

0.38

122

884

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

118

1.71

1.42

1.2

1.3

5.80

3.87

u/ml

—

Injury of urinary and pelvic organs

118

1.71

1.42

1.1

1.2

2.29

5.41

u/ml

1.00

Glaucoma, exfoliation

400

0.65

1.41

1.5

1.2

3.63

5.37

u/ml

—

195

Varicella [chickenpox]

346

1.40

1.41

1.2

4.50

4.52

u/ml

0.00

165

Chronic hepatitis, not elsewhere classified

205

1.52

1.41

1.4

1.2

4.71

4.63

u/ml

0.01

Supernumerary teeth EXCLUDE clefts and syndromes, including avohilmo

1.92

1.40

1.9

1.3

5.57

4.97

u/ml

—

Diseases caused by chlamydiae

1.92

1.40

1.1

3.56

6.91

u/ml

—

Alzheimer’s disease, strict definition

789

0.78

1.40

1.1

1.2

4.55

5.20

u/ml

0.18

355

Carcinoma in situ of skin of scalp and neck

1.86

1.40

1.3

1.2

3.33

10.51

u/ml

—

Autism spe, excluding more controls

157

1.60

1.40

1.3

5.17

4.30

u/ml

0.12

Helminthiases

1.79

1.40

1.6

1.2

1.33

5.80

u/ml

—

Pedestrian injured in transport accident

432

1.35

1.39

1.2

1.3

3.54

4.76

u/ml

0.39

203

Malignant neoplasm of colon

712

1.27

1.39

1.2

2.70

4.76

u/ml

1.57

327

Alzheimer’s disease (Atypical or mixed)

309

0.61

1.39

1.1

1.2

2.60

5.66

u/ml

—

156

Tongue abnormality

330

1.40

1.39

1.3

1.2

3.32

4.83

u/ml

0.57

143

Colorectal cancer

145

1158

1.20

1.39

1.2

1.3

2.82

4.09

u/ml

1.41

550

Other condition

126

1036

1.22

1.39

1.3

7.93

4.60

u/ml

0.36

480

Respiratory tuberculosis, bacteriologically and histologically confirmed

1.96

1.39

1.2

2.63

7.29

u/ml

—

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

108

1288

0.81

1.38

1.1

1.2

2.69

4.06

u/ml

1.93

614

Coxibs

242

1096

1.16

1.38

1.3

4.85

3.86

u/ml

0.45

111

562

Femoral hernia

198

1.52

1.38

1.2

5.29

4.46

u/ml

0.11

Colonic or urogenital fistula

224

1938

1.16

1.37

1.4

1.2

3.42

3.98

u/ml

0.45

105

900

Crowding of teeth, including avohilmo

634

1.26

1.37

1.2

1.3

7.65

4.65

u/ml

0.30

317

Hypersensitivity pneumonitis due to organic dust

1.85

1.36

1.3

1.2

6.63

4.03

u/ml

—

Drug-induced neutropenia

408

1.35

1.36

1.2

3.04

4.57

u/ml

0.92

175

Varicella [chickenpox], including avohilmo

391

1.36

1.3

1.2

4.54

4.43

u/ml

0.02

189

Other superficial mycoses

151

1.60

1.36

1.3

1.2

3.22

3.82

u/ml

—

Lesion of radial nerve

207

1.51

1.35

1.1

1.2

2.55

5.02

u/ml

1.13

Meningitis

315

1.41

1.35

1.3

1.2

7.70

4.59

u/ml

0.54

135

Human immunodeficiency virus [HIV] disease, including avohilmo

120

1.69

1.35

1.4

1.2

2.93

3.89

u/ml

0.46

1.94

1.35

1.3

1.1

2.14

2.77

u/ml

—

Other lesions of median nerve

120

1.68

1.34

1.2

1.1

1.67

5.49

u/ml

—

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

282

1.43

1.34

1.5

1.2

6.57

4.29

u/ml

0.45

121

Injury of nerves at forearm level

1.80

1.34

1.3

1.2

2.75

6.25

u/ml

—

Injury of nerves at wrist and hand level

257

1.45

1.34

1.1

1.2

3.11

5.21

u/ml

0.72

123

Bulimia nervosa (incl. atypical)

299

1.42

1.34

1.4

1.3

8.61

4.83

u/ml

0.52

131

Dislocation, sprain and strain of joints and ligaments of thorax

224

1.48

1.34

1.8

1.2

4.46

5.45

u/ml

0.12

Torticollis

105

1.73

1.34

1.3

1.2

4.00

3.89

u/ml

—

Mixed and other personality disorders

628

1.28

1.34

1.3

5.05

3.68

u/ml

0.43

282

Other and unspecified injuries of thorax

105

1.73

1.34

1.1

1.2

3.70

5.21

u/ml

—

Toxic effects of substances chiefly nonmedicinal as to source

101

815

1.24

1.34

1.3

3.62

4.13

u/ml

0.19

378

Respiratory tuberculosis, confirmed, including avohilmo

1.93

1.34

1.2

2.63

7.10

u/ml

—

Other specific arthropathies, wide

105

1.73

1.34

1.1

1.2

3.00

6.36

u/ml

—

Other specified/unspecified spondylopathies

105

1.73

1.33

1.0

1.2

3.20

3.94

u/ml

—

Left hemicolectomy

1.79

1.33

1.1

1.2

2.14

6.59

u/ml

—

Prepatellar bursitis

249

1.45

1.33

1.3

1.2

2.00

3.35

u/ml

1.57

120

Hyperkinetic disorders, excluding more controls

145

1132

1.20

1.33

1.3

3.76

4.59

u/ml

0.45

549

Secondary parkinsonism, excluding more controls

1.98

1.33

1.1

6.86

3.10

u/ml

—

Peroneal tendinitis

113

1.70

1.33

1.2

2.22

3.86

u/ml

—

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

192

1.52

1.33

1.6

1.3

5.06

5.02

u/ml

0.01

Generalized epilepsy

283

1.42

1.32

1.1

1.3

2.38

5.34

u/ml

1.87

134

Ankylosing spondylitis

559

1.29

1.31

1.3

3.16

3.93

u/ml

0.43

263

Malignant neoplasm of respiratory system and intrathoracic organs

122

833

1.22

1.30

1.2

3.49

4.53

u/ml

0.64

393

Dystonia

343

1.38

1.30

1.2

2.56

4.80

u/ml

1.11

147

Inflammatory disorders of breast

525

1.30

1.3

3.42

4.41

u/ml

0.43

224

Diabetic maculopathy

687

1.25

1.30

1.3

3.45

4.31

u/ml

0.52

325

Primary gonarthrosis, bilateral

358

2681

1.12

1.30

1.2

3.36

3.97

u/ml

0.67

170

1260

Bicornuate uterus

1.98

1.30

1.2

7.20

3.08

u/ml

—

Malignant immunoproliferative diseases

2.11

1.29

1.0

1.1

2.40

3.74

u/ml

—

Intestinal malabsorption

293

1.41

1.29

1.4

1.2

4.56

5.00

u/ml

0.11

132

Examination and encounter for administrative purposes

361

1.36

1.28

1.2

3.26

4.30

u/ml

0.59

176

Vitamin deficiency, wide

268

1.43

1.28

1.3

1.2

3.75

5.28

u/ml

0.48

123

Vitamin deficiency

268

1.43

1.28

1.3

1.2

3.75

5.28

u/ml

0.48

123

Hypotension due to drugs

2.02

1.28

1.4

1.2

10.33

7.86

u/ml

—

Motor neuron disease ALS

2.10

1.28

1.0

1.1

2.00

3.26

u/ml

—

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

138

948

1.20

1.28

1.2

1.3

3.35

4.27

u/ml

0.66

453

Diseases of male genital organs

427

1937

1.11

1.28

1.3

4.61

3.79

u/ml

0.38

223

1013

Colon adenocarcinoma

535

1.29

1.27

1.1

1.2

2.68

5.29

u/ml

1.49

249

Urethritis and urethral syndrome

130

1.63

1.27

1.3

1.2

2.45

3.52

u/ml

0.64

Ovarian hyperstimulation (induction)

162

1.56

1.27

1.3

1.4

6.25

5.19

u/ml

0.13

Lesion of ulnar nerve

114

938

1.22

1.27

1.3

1.2

4.25

4.46

u/ml

0.07

439

Melanoma in situ

194

1.50

1.27

1.2

4.00

5.46

u/ml

0.32

Complications of labour and delivery

596

3035

1.09

1.27

1.2

4.47

4.13

u/ml

0.21

273

1380

Pregnancy, childbirth and the puerperium

228

1032

1.16

1.26

1.2

1.3

4.35

4.21

u/ml

0.04

509

Tooth eruption problems

162

1330

1.18

1.26

1.3

6.36

4.10

u/ml

0.38

665

Polypectomy (DHB20)

388

1.35

1.26

1.3

1.2

3.29

4.53

u/ml

0.44

180

Viral meningitis

244

1.44

1.26

1.3

1.2

4.33

4.89

u/ml

0.13

104

Other deformities of toe(s)

162

1.55

1.26

1.2

1.3

6.33

3.01

u/ml

0.66

Toxic effect of contact with venomous animals

261

1.43

1.25

1.2

2.05

5.54

u/ml

1.79

108

Renal agenesis and other reduction defects of kidney

2.45

1.25

1.3

1.2

—

2.73

—

Ulcer of oesophagus

320

1.38

1.25

1.2

5.20

5.77

u/ml

0.08

141

Aggressive periodontitis

123

1.64

1.25

1.4

1.2

2.56

5.91

u/ml

—

Complications following infusion, transfusion and therapeutic injection

1.88

1.24

1.7

1.1

1.50

3.30

u/ml

—

Burns and corrosions of external body surface, specified by site

760

1.24

1.4

1.3

5.90

3.92

u/ml

0.65

360

Mental disorders, not otherwise specified

644

1.26

1.24

1.3

5.35

4.17

u/ml

0.32

288

Other disorders of breast and lactation associated with childbirth

155

1.57

1.24

1.1

1.4

2.29

4.17

u/ml

—

Disorders of lacrimal system and orbit in diseases classified elsewhere

139

1.60

1.24

1.3

1.2

2.63

4.96

u/ml

0.56

Impacted maxillary molar

547

1.29

1.24

1.3

4.74

4.37

u/ml

0.08

258

Other acute skin changes due to ultraviolet radiation

171

1.53

1.23

1.2

2.00

6.19

u/ml

1.37

Benign neoplasm of other and unspecified intrathoracic organs

1.99

1.23

1.3

1.2

1.00

4.23

u/ml

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

212

1.47

1.23

1.3

1.2

2.30

8.01

u/ml

1.96

102

Malignant neoplasm of eye, brain and central nervous system

237

1.44

1.23

1.1

1.2

4.85

6.05

u/ml

0.19

114

Malignant neoplasm of anus and anal canal, including Hilmo

2.06

1.22

1.3

1.2

2.80

6.19

u/ml

—

Foreign body entering into or through eye or natural orifice

530

1.29

1.22

1.4

1.2

3.38

4.58

u/ml

0.47

253

Habit and impulse disorders

116

1.66

1.22

1.4

1.3

6.13

3.95

u/ml

—

Contact with other hot fluids

196

1.49

1.22

1.2

1.3

2.12

4.99

u/ml

1.44

Vitamin D deficiency

116

1.65

1.22

1.4

1.3

4.30

6.11

u/ml

—

Thyroiditis, unspecified

1.74

1.22

1.7

1.2

5.00

2.94

u/ml

—

Flat foot [pes planus] (acquired)

548

1.28

1.22

1.2

1.3

5.96

3.84

u/ml

0.53

256

Specific development disorders of scholastic skills

324

1.37

1.21

1.6

1.4

3.90

4.61

u/ml

0.23

162

Congenital deformities of feet

164

1.54

1.21

1.4

1.3

3.80

5.25

u/ml

0.37

Conduct disorder

156

1.55

1.21

1.2

1.3

3.17

5.99

u/ml

0.90

Hodgkin lymphoma, hilmo

164

1.54

1.21

1.3

1.2

2.23

5.09

u/ml

1.26

Benign neoplasm: Skin of lower limb, including hip

156

1.55

1.21

1.3

1.2

1.75

6.82

u/ml

—

Chronic iridocyclitis

297

1.39

1.20

1.3

1.2

2.65

4.40

u/ml

0.98

134

Paralytic strabismus

374

1.34

1.20

1.2

5.33

5.39

u/ml

0.01

176

Other specified disorders of muscle

148

1.56

1.20

1.3

1.2

2.08

3.25

u/ml

0.90

Pure hyperglyceridaemia

101

1.70

1.20

1.2

2.88

3.70

u/ml

—

Diabetic neuropathy

564

1.27

1.20

1.4

1.3

3.43

4.88

u/ml

0.69

274

Glucosamine medication

285

2019

1.13

1.20

1.2

3.84

4.08

u/ml

0.14

132

912

Haemorrhagic and haematological disorders of fetus and newborn

104

1.67

1.19

1.1

1.3

11.36

3.24

u/ml

0.97

Strabismus

234

2051

1.14

1.19

1.3

3.56

4.13

u/ml

0.56

114

969

Atopic conjunctivitis

298

1.38

1.19

1.1

1.3

2.67

4.30

u/ml

1.11

148

Basal cell carcinoma, including Hilmo

319

1929

1.12

1.19

1.3

1.2

3.86

3.87

u/ml

0.01

154

896

Seronegative juvenile rheumatoid arthritis

149

1.56

1.18

1.2

1.3

3.82

5.04

u/ml

0.23

Hypermetropia

462

1.30

1.18

1.3

2.21

4.37

u/ml

2.04

217

Migraine without aura, drug-induced

1.80

1.18

1.2

1.3

1.57

7.72

u/ml

—

Other injuries of lower limb, level unspecified

1.96

1.18

2.0

1.2

3.80

2.34

u/ml

—

Arthropathy in ulcerative colitis

1.79

1.18

1.3

7.14

4.11

u/ml

—

Twin gestation

775

1.23

1.18

1.3

3.87

3.50

u/ml

0.15

334

Carcinoma in situ of rectum

1.95

1.18

1.6

1.1

1.67

4.04

u/ml

—

Osteomalacia

2.03

1.17

1.1

1.2

5.60

3.83

u/ml

—

Malignant neoplasm of other and ill-defined digestive organs, including Hilmo

2.01

1.17

1.4

1.2

2.60

5.43

u/ml

—

Follicular cysts of skin and subcutaneous tissue

152

1297

1.17

1.16

1.3

3.11

4.19

u/ml

1.17

595

Toxic effect of other and unspecified substances

1.75

1.16

1.5

1.3

4.20

4.19

u/ml

—

Other specified and unspecified strabismus

1.83

1.16

1.3

1.2

5.14

3.50

u/ml

—

Burn and corrosion of trunk

174

1.51

1.16

1.3

1.2

7.23

3.58

u/ml

0.51

Nummular dermatitis

473

1.29

1.15

1.2

2.46

5.32

u/ml

1.80

217

Use of glatiramer acetate

126

1.61

1.15

1.0

1.3

2.83

5.60

u/ml

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

482

1.29

1.15

1.3

1.2

3.21

4.54

u/ml

0.60

204

Prurigo nodularis

118

1.62

1.15

1.4

1.2

2.18

6.80

u/ml

0.98

Sub-endpoint used in defining T1D endpoints

237

2056

1.14

1.15

1.4

1.3

4.72

4.04

u/ml

0.37

126

971

Volvulus

118

1.62

1.15

1.3

1.2

1.78

6.78

u/ml

—

Viral conjunctivitis

134

1.58

1.15

1.4

1.2

11.40

3.23

u/ml

—

Malignant neoplasm of endocrine gland

456

1.30

1.15

1.3

1.2

4.77

4.61

u/ml

0.03

191

Any dementia, excluding more controls

139

1125

0.85

1.15

1.1

1.2

3.50

4.37

u/ml

0.46

513

Benign neoplasm: Skin of eyelid, including canthus

107

886

1.21

1.15

1.1

1.2

2.77

4.92

u/ml

2.10

390

Postpartum haemorrhage due to anatomy

129

1088

1.19

1.14

1.3

2.84

4.07

u/ml

1.18

475

Manic episode

191

1.48

1.14

1.2

1.3

3.63

3.86

u/ml

0.05

Benign neoplasm of breast

733

1.23

1.14

1.3

1.2

3.55

4.06

u/ml

0.15

311

Biguanides

813

5249

0.93

1.14

1.2

4.89

3.76

u/ml

0.93

364

2466

Other and unspecified injuries of shoulder and upper arm

183

1.48

1.13

1.2

8.00

4.87

u/ml

0.39

Crohn's disease of large intestine

335

1.35

1.13

1.5

1.2

3.58

4.62

u/ml

0.43

152

Impingement syndrome of shoulder

166

1430

1.16

1.13

1.2

3.23

3.60

u/ml

0.35

667

Contact with other sharp object(s)

519

1.28

1.13

1.3

2.89

4.42

u/ml

1.28

236

HSIL lesion of the vulva

111

1.64

1.13

1.3

1.2

2.10

5.19

u/ml

—

Other epidermal thickening

225

1.43

1.12

1.4

1.2

6.76

4.50

u/ml

0.28

102

Burns and corrosions

122

1026

1.19

1.12

1.4

1.3

5.21

4.27

u/ml

0.30

489

Presbycusis

504

1.28

1.12

1.2

2.30

4.96

u/ml

2.21

237

Malignant neoplasm of heart, mediastinum and pleura

1.98

1.12

1.0

1.2

2.40

4.88

u/ml

—

Other and unspecified abdominal hernia

192

1.47

1.11

1.3

1.2

4.00

4.27

u/ml

0.07

Renal agenesis and other reduction defects of kidney, including avohilmo

2.30

1.11

1.3

—

4.64

—

Otitis externa, unspecified

100

826

1.21

1.11

1.3

4.79

4.01

u/ml

0.16

374

Dementia, including avohilmo

204

1588

0.87

1.10

1.2

5.25

4.21

u/ml

0.37

735

Blood alcohol or alcohol intoxication level

168

1.50

1.10

1.1

1.3

2.55

5.64

u/ml

1.14

Polycystic ovarian syndrome

548

1.27

1.10

1.2

1.3

2.37

3.72

u/ml

1.50

252

Diseases caused by chlamydiae, including avohilmo

104

1.65

1.10

1.2

3.18

5.32

u/ml

0.36

Status post-ami

137

881

1.18

1.10

1.3

1.2

8.95

3.47

u/ml

0.98

397

D07AA Corticosteroids, weak (group I)

142

1210

1.17

1.10

1.3

5.67

4.50

u/ml

0.43

574

Clubfoot

1.84

1.10

1.2

1.3

2.43

5.00

u/ml

—

Other diseases caused by chlamydiae

1.75

1.10

1.1

3.56

6.22

u/ml

—

Malignant neoplasm of other connective and soft tissue

104

1.65

1.10

1.1

1.2

5.13

6.02

u/ml

—

Malignant neoplasm of other connective and soft tissue, including Hilmo

193

1.46

1.09

1.1

1.2

5.38

7.51

u/ml

0.31

Other disorders of nervous system

355

1.33

1.09

1.5

1.2

3.11

4.11

u/ml

0.45

161

Ulcerative rectosigmoiditis

558

1.26

1.08

1.2

1.3

3.32

4.10

u/ml

0.35

263

Lichen ruber planus, wide definition including periferal and oral lichen planus

171

1483

1.16

1.08

1.4

1.2

3.42

4.27

u/ml

0.55

670

Deep endometriosis

666

1.24

1.08

1.3

4.03

u/ml

0.00

283

Sacroiliitis, not elsewhere classified

356

1.33

1.07

1.2

3.37

3.68

u/ml

0.16

161

Xerosis cutis

1.77

1.07

1.2

14.20

7.41

u/ml

—

Abnormality of white blood cells, not elsewhere classified

1.95

1.07

1.3

1.2

2.80

3.36

u/ml

—

Melanocytic naevi of other and unspecified parts of face

391

1.31

1.07

1.2

1.3

4.30

4.21

u/ml

0.03

174

Eustachian salpingitis and obstruction

649

1.24

1.07

1.3

1.2

4.59

3.77

u/ml

0.33

307

Motor neuron disease (with DMD)

1.93

1.06

1.0

1.1

2.00

3.21

u/ml

—

Medial epicondylitis

203

1.44

1.05

1.1

1.2

5.62

3.63

u/ml

0.37

Perioral dermatitis

170

1.48

1.05

1.3

1.2

3.90

3.29

u/ml

—

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

1.80

1.05

1.1

1.2

2.33

10.00

u/ml

—

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

597

1.24

1.04

1.3

1.2

2.97

3.95

u/ml

0.52

239

Other benign neoplasms of connective and other soft tissue

606

1.24

1.04

1.1

1.2

3.16

4.55

u/ml

0.86

273

Other congenital malformations, not elsewhere classified

1.86

1.04

1.1

1.2

8.67

2.42

u/ml

—

Placental disorders

1.76

1.04

1.2

1.3

1.83

3.93

u/ml

—

Mixed specific developmental disorders

127

1.54

1.04

1.5

1.3

5.19

4.65

u/ml

0.08

Family history of other conditions

114

1.60

1.03

1.4

1.3

3.57

6.19

u/ml

—

Accidental poisoning by and exposure to alcohol

114

1.59

1.03

1.3

1.4

8.10

4.94

u/ml

—

Loose body in joint

114

1.59

1.03

1.1

1.3

1.57

4.05

u/ml

—

UC patients in KELA-register (code 208), prior to 1994

238

1.39

1.03

1.3

1.2

5.20

5.43

u/ml

0.03

104

Other specified/unspecified hearing loss

500

1.26

1.02

1.2

2.63

4.68

u/ml

1.01

230

Hypertrophy of breast in women and men

174

1519

1.15

1.02

1.2

4.50

3.90

u/ml

0.27

672

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

456

1.28

1.02

1.2

4.97

5.42

u/ml

0.09

218

HSIL lesion of the cervix uteri

158

1816

0.87

1.01

1.3

5.80

4.16

u/ml

0.24

785

Other disorders of central nervous system

1.78

1.01

1.2

3.00

3.30

u/ml

—

Other and unspecified myopathies

439

1.28

1.01

1.1

1.2

2.92

5.30

u/ml

1.29

210

Parkinson's disease

698

0.79

1.01

1.2

2.33

4.99

u/ml

2.37

322

Other and unspecified glaucoma

273

1.36

1.00

1.1

1.2

2.94

6.20

u/ml

1.18

144

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

274

0.65

1.00

1.1

1.2

2.67

4.79

u/ml

—

117

Chondromalacia

172

1.46

1.00

1.4

1.2

7.80

6.39

u/ml

—

Sequelae of injuries of neck and trunk

172

1.46

1.00

1.1

1.2

3.13

4.92

u/ml

—

Asthma mixed form (mode), excluding more controls

239

1.39

1.00

1.2

1.3

2.92

3.02

u/ml

0.04

109

Hypertrophy of breast

157

1364

1.15

1.00

1.2

4.37

3.66

u/ml

0.29

588

205

1.41

0.99

1.1

1.2

2.45

7.93

u/ml

1.61

Early lumbar disc prolapse operation

111

939

1.19

0.99

1.2

1.3

3.14

4.10

u/ml

0.71

446

Malignant neoplasm of head and neck

396

1.29

0.99

1.4

1.2

2.40

6.05

u/ml

2.09

184

Tonsillectomy and adenotomy

652

4233

1.07

0.99

1.3

4.18

4.01

u/ml

0.15

319

2025

Benign neoplasm of urinary organs

223

1.40

0.98

1.2

3.82

6.72

u/ml

0.64

104

Late syphilis, including avohilmo

1.68

0.98

1.5

1.2

2.33

4.18

u/ml

—

Crossbite

479

1.25

0.98

1.3

2.37

4.52

u/ml

3.09

244

Frontotemporal dementia, wide, incl. Pick's disease

0.00

0.98

0.0

1.2

—

5.33

—

Congenital iodine-deficiency syndrome/hypothyroidism

140

1.51

0.98

1.7

1.2

3.09

2.22

u/ml

0.30

Pilonidal cyst

666

1.22

0.97

1.3

3.19

4.21

u/ml

0.68

318

Other diseases caused by chlamydiae, including avohilmo

108

1.59

0.97

1.2

3.18

5.21

u/ml

0.34

Other congenital malformations of tongue, mouth and pharynx

1.67

0.97

2.4

1.3

13.78

4.38

u/ml

—

Paralytic ileus

165

1.46

0.97

1.5

1.2

6.64

5.87

u/ml

0.07

Hypertrichosis

182

1.44

0.97

1.2

1.4

1.43

4.20

u/ml

—

Biological medicines for asthma

157

1.48

0.97

1.2

6.13

5.34

u/ml

0.09

Congenital malformations of breast, including avohilmo

149

1.49

0.96

1.3

1.4

25.10

5.66

u/ml

—

Lichen sclerosus et atrophicus

658

1.22

0.96

1.3

1.2

3.95

3.93

u/ml

0.00

286

Contact with heat and hot substances

328

1.32

0.96

1.3

1.2

6.17

4.86

u/ml

0.23

151

Other specified/unspecified dorsopathies

199

1.41

0.96

1.3

1.2

5.36

3.36

u/ml

0.29

Acute nasopharyngitis (common cold)

109

916

1.18

0.96

1.3

4.00

3.65

u/ml

0.11

435

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

695

1.21

0.96

1.4

1.2

2.11

4.33

u/ml

3.19

290

Fracture of forearm

490

4074

1.08

0.95

1.2

1.3

3.29

4.27

u/ml

1.81

234

1915

Non-small cell lung cancer, including Hilmo

617

1.22

0.95

1.2

3.18

4.74

u/ml

1.05

284

Primary angle-closure glaucoma

149

1.48

0.95

1.1

1.2

2.62

4.74

u/ml

0.82

Alcohol use disorder, Swedish definition

472

3968

1.08

0.94

1.3

4.14

3.78

u/ml

0.28

229

1909

Malignant neoplasm of small intestine

1.62

0.94

1.3

1.2

3.29

3.42

u/ml

—

Parkinson's disease, including avohilmo

724

0.80

0.94

1.2

2.43

5.00

u/ml

2.41

333

Intrahepatic Cholestasis of Pregnancy (ICP)

606

1.23

0.94

1.4

1.2

1.97

4.45

u/ml

3.25

253

Subacute thyroiditis

234

1.38

0.94

1.3

1.2

3.58

2.66

u/ml

0.39

Malignant neoplasm of thyroid gland, including Hilmo

471

1.26

0.93

1.3

1.2

4.79

4.42

u/ml

0.08

203

Viral meningitis, including avohilmo

260

1.35

0.93

1.3

1.2

4.33

4.82

u/ml

0.11

109

Psychotic depression

374

1.29

0.92

1.2

3.78

3.69

u/ml

0.02

177

Multiple gestation

808

1.19

0.92

1.3

3.87

3.44

u/ml

0.18

352

Enteropathic arthropathies

134

1.50

0.92

1.5

1.3

5.55

3.66

u/ml

0.27

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

608

1.22

0.91

1.4

1.2

1.97

4.33

u/ml

3.12

252

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

699

1.21

0.91

1.4

1.2

2.11

4.21

u/ml

3.01

287

Excessive earwax

454

4439

0.93

0.91

1.3

1.2

4.48

3.73

u/ml

0.67

208

2120

Other disorders of conjunctiva

818

1.19

0.91

1.3

1.2

4.28

4.71

u/ml

0.12

369

Asthma mixed form (mode)

244

1.36

0.90

1.2

1.3

2.92

3.46

u/ml

0.27

112

Non-Hodgkin lymphoma, all

151

1.46

0.90

1.2

2.20

7.08

u/ml

—

Fracture of femur

149

1171

1.15

0.90

1.3

1.2

3.58

4.47

u/ml

0.50

519

Allergic colitis

151

1.47

0.90

1.2

1.3

3.00

3.62

u/ml

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

310

1912

1.10

0.90

1.3

1.2

4.67

3.88

u/ml

0.51

150

891

Non-small cell lung cancer, adenocarcinoma, helper endpoint

253

1.35

0.90

1.2

2.27

7.15

u/ml

1.76

117

Behavioural disorders

160

1.45

0.89

1.2

1.3

3.17

5.60

u/ml

0.76

Melanoma in situ of trunk

1.70

0.89

1.2

2.80

6.97

u/ml

—

Primary open-angle glaucoma

134

1482

0.87

0.89

1.3

1.2

3.32

4.28

u/ml

0.71

686

Coeliac disease

802

1.19

0.89

1.4

1.3

4.60

4.66

u/ml

0.02

357

Other and unspecified corneal deformities and disorders

194

1.40

0.88

1.7

1.2

3.70

4.60

u/ml

—

Graves ophthalmopathy

152

1.46

0.88

1.3

1.2

2.62

4.66

u/ml

0.55

Benign neoplasm: Other/unspecified site

1.66

0.88

1.5

1.1

2.57

3.22

u/ml

—

Paraplegia, diplegia of upper limbs

119

1.52

0.88

1.2

3.75

3.38

u/ml

—

Other and unspecified trigeminal disorders

1.66

0.88

1.2

2.86

6.23

u/ml

—

Malignant neoplasm of urinary organs

439

1.26

0.88

1.2

5.39

5.55

u/ml

0.03

211

HSIL lesion of the cervix uteri, vagina or vulva

173

1953

0.88

1.3

5.46

4.15

u/ml

0.20

845

Helminthiases, including avohilmo

298

1.32

0.88

1.4

1.3

1.56

4.41

u/ml

2.83

140

Acute laryngitis and tracheitis

112

945

1.17

0.87

1.3

4.57

3.96

u/ml

0.22

448

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

395

1.27

0.87

1.1

1.3

5.25

5.71

u/ml

0.09

190

Scissor bite

159

1.44

0.87

1.1

1.3

4.83

3.63

u/ml

0.16

Alzheimer’s disease (Late onset)

681

0.82

0.87

1.1

1.2

4.58

5.09

u/ml

0.13

308

Pustular psoriasis

281

1.32

0.87

1.2

1.3

2.88

5.29

u/ml

1.02

112

Inguinal hernia

485

2993

1.08

0.86

1.3

4.34

3.73

u/ml

0.46

238

1454

Parkinson's disease, strict definition, excluding more controls

378

1.26

0.85

1.2

2.28

3.53

u/ml

1.05

171

Personal history of certain other diseases

137

1.47

0.84

1.2

1.4

7.38

6.18

u/ml

0.14

Malignant neoplasm of kidney, except renal pelvis

415

1.26

0.84

1.2

5.37

5.63

u/ml

0.04

198

Parkinson's disease, strict definition

636

0.80

0.84

1.2

2.28

5.22

u/ml

2.45

292

Vulvovaginal ulceration/inflammation in other diseases

560

1.22

0.84

1.2

2.86

4.05

u/ml

0.70

234

Hyperkinetic disorders (excl. ADHD)

119

1.50

0.83

1.2

1.4

4.92

3.60

u/ml

0.24

Vascular dementia

239

1.33

0.83

1.1

1.2

1.70

6.20

u/ml

—

119

Congenital deformities of feet, including avohilmo

266

1.32

0.83

1.3

3.55

4.78

u/ml

0.47

116

Malignant neoplasm of brain, including Hilmo

266

1.32

0.82

1.1

1.2

4.46

6.17

u/ml

0.31

125

Primary coxarthrosis, bilateral

171

1520

1.13

0.81

1.2

4.72

4.10

u/ml

0.16

697

Benign neoplasm of male genital organs

1.62

0.81

1.1

1.4

8.57

6.78

u/ml

—

Other secondary coxarthrosis

172

1.40

0.81

1.1

1.2

2.00

5.16

u/ml

1.47

Barrett oesophagus

267

1.32

0.81

1.3

1.2

5.27

4.22

u/ml

0.21

118

Chronic suppurative otitis media, including avohilmo

454

1.24

0.81

1.2

2.44

4.37

u/ml

1.05

214

Hirsutism in women

164

1.41

0.80

1.2

1.3

1.43

3.90

u/ml

—

Kela-code for severe mental illness

278

3041

0.91

0.80

1.3

1.2

3.31

3.89

u/ml

0.49

133

1447

All dysplastic lesions of the vagina

181

1.39

0.80

1.1

1.2

2.27

4.36

u/ml

0.69

Hypertrophy of bone

0.00

0.80

0.0

1.2

—

4.75

—

Other vitreous opacities

224

1.35

0.80

1.1

1.2

1.75

5.18

u/ml

1.54

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

473

1.23

0.80

1.4

1.3

2.19

3.84

u/ml

1.60

222

Malignant neoplasm of digestive organs, including Hilmo

287

1927

1.10

0.79

1.2

2.64

3.96

u/ml

3.11

143

897

Coronary artery bypass grafting

129

834

1.15

0.79

1.2

7.22

3.58

u/ml

0.66

379

Tibial collateral bursitis [Pellegrini-Stieda]

1.68

0.79

1.4

1.1

3.33

3.85

u/ml

—

Fitting and adjustment of other devices

181

1781

0.89

0.79

1.1

1.2

4.89

4.24

u/ml

0.19

813

Gestational [pregnancy-induced] hypertension

269

2451

1.10

0.79

1.3

1.2

3.95

4.01

u/ml

0.02

123

1100

Frontotemporal dementia

0.00

0.79

0.0

1.2

—

5.50

—

Gluteal tendinitis

242

1.33

0.79

1.2

2.85

3.82

u/ml

0.47

Thiamine deficiency

0.00

0.79

0.0

1.3

—

5.33

—

Inflammatory diseases of prostate (prostatitis)

702

1.18

0.78

1.2

1.3

5.27

3.83

u/ml

0.20

357

Psoriasis (vulgaris), strict definition

211

0.66

0.78

1.6

1.2

2.29

4.52

u/ml

—

Laparoscopic left hemicolectomy

1.60

0.78

1.4

1.2

1.71

6.50

u/ml

—

Cyst of Bartholin Gland

281

0.71

0.78

1.2

1.3

2.44

5.43

u/ml

—

110

Corneal degeneration

1.60

0.78

1.0

1.1

3.29

6.30

u/ml

—

Benign neoplasm: Pancreas

123

1.47

0.78

1.0

1.2

2.13

6.36

u/ml

—

Juvenile osteochondrosis

208

1.35

0.78

1.1

1.3

2.44

5.31

u/ml

—

Congenital malformations of breast

140

1.44

0.77

1.4

1.3

25.10

5.22

u/ml

—

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

208

1.35

0.77

1.3

1.2

2.35

7.60

u/ml

1.78

103

Other salmonella infections

191

1.37

0.77

1.4

1.2

8.38

4.97

u/ml

0.38

Other disorders of the genitourinary system

676

1.19

0.77

1.2

2.97

4.82

u/ml

1.19

282

Colon adenocarcinoma, helper endpoint

575

1.20

0.77

1.1

1.2

2.68

5.42

u/ml

1.59

264

Injury of intra-abdominal organs

157

1.41

0.77

1.6

1.2

3.88

6.32

u/ml

—

Granulomatous disorders of skin and subcutaneous tissue

157

1.41

0.77

1.6

1.2

2.30

3.87

u/ml

—

Benign neoplasm: Kidney

174

1.39

0.77

1.3

1.2

3.93

5.44

u/ml

0.33

Palmar fascial fibromatosis [Dupuytren]

658

1.19

0.76

1.3

1.2

7.76

3.92

u/ml

0.36

319

Malignant neoplasm of small intestine, including Hilmo

132

1.45

0.76

1.3

1.2

2.90

7.87

u/ml

—

Persistent delusional disorders

449

0.78

0.75

1.2

3.64

4.54

u/ml

0.28

208

Other acute viral hepatitis

1.58

0.75

1.2

2.88

4.69

u/ml

—

Poisoning by medicine, drug-induced

1.58

0.75

1.2

1.3

5.00

7.31

u/ml

—

Mental and behabioural disorders of puerperum, not classified elsewhere, excluding more controls

1.62

0.75

1.3

1.2

5.67

5.24

u/ml

—

Absence of one kidney, including avohilmo

2.13

0.75

1.0

1.4

—

5.64

—

Erythema multiforme

124

1.46

0.75

1.2

5.10

5.73

u/ml

—

Other menopausal disorders

215

1081

1.11

0.75

1.2

2.82

4.72

u/ml

2.59

103

478

Viral conjunctivitis, including avohilmo

262

1.30

0.75

1.7

1.3

11.71

3.45

u/ml

1.23

115

Benign neoplasm: Other and unspecified parts of mouth

175

1.38

0.75

1.3

1.2

6.70

6.09

u/ml

—

Wide developmental disorders, excluding more controls

213

1.33

0.74

1.2

1.3

5.00

3.93

u/ml

0.19

110

Abrasion of teeth

313

2887

1.09

0.74

1.2

2.87

3.86

u/ml

1.43

151

1339

Other articular cartilage disorders

108

1.49

0.74

1.4

1.2

1.86

4.45

u/ml

—

Alcohol-induced acute pancreatitis

219

1.33

0.73

1.2

4.73

4.88

u/ml

0.03

111

Malignant neoplasm of brain

193

1.35

0.73

1.1

1.2

3.11

5.01

u/ml

—

Polyhydramnios

397

1.24

0.73

1.2

1.3

2.33

3.71

u/ml

1.36

175

Certain zoonotic bacterial diseases

100

1.51

0.73

1.1

1.2

2.33

6.52

u/ml

—

Sequelae of other and unspecified infectious and parasitic diseases

370

1.25

0.73

1.2

4.26

3.99

u/ml

0.08

167

Otosclerosis

406

1.24

0.73

1.2

2.58

4.20

u/ml

1.10

174

Benign neoplasm of other and unspecified sites

176

1.37

0.73

1.6

1.2

7.58

5.78

u/ml

0.14

Galactorrhea

1.57

0.72

1.5

1.2

3.13

6.28

u/ml

—

Trigger finger

102

885

1.15

0.72

1.4

1.2

6.52

3.73

u/ml

1.09

395

Malignant neoplasm of head and neck, including Hilmo

488

1.21

0.72

1.3

1.2

3.13

5.50

u/ml

0.98

226

Benign neoplasm: Spinal cord

1.59

0.72

1.0

1.2

2.67

4.03

u/ml

—

Other congenital malformations of tongue, mouth and pharynx, including avohilmo

108

1.48

0.72

2.2

1.3

12.60

4.61

u/ml

—

Congenital malformations of ovaries, fallopian tubes and broad ligaments

453

1.22

0.71

1.2

1.3

4.21

4.04

u/ml

0.03

188

Thyrotoxicosis with toxic multinodular goitre

282

1.28

0.71

1.2

3.37

5.17

u/ml

0.54

110

Pleural plaque without asbestos

109

1.47

0.71

1.1

1.2

2.22

8.67

u/ml

—

Alzheimer’s disease (Late onset), excluding more controls

310

1.22

0.71

1.1

1.2

4.93

3.91

u/ml

0.26

141

Nontoxic single thyroid nodule

435

1.22

0.71

1.2

6.77

4.73

u/ml

0.35

165

Sequelae of other and unspecified infectious and parasitic diseases, including avohilmo

372

1.24

0.70

1.2

4.26

3.99

u/ml

0.08

167

Panniculitis affecting regions of neck and back

212

1.33

0.70

1.4

1.2

3.73

3.57

u/ml

0.05

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

221

1.32

0.70

1.2

3.43

5.38

u/ml

0.66

Superficial injury of forearm

749

1.16

0.69

1.2

1.3

2.41

4.60

u/ml

1.81

350

Nonalcoholic steatohepatitis

1.66

0.69

1.9

1.2

2.20

8.46

u/ml

—

Thalassaemia

1.88

0.69

1.6

1.2

1.60

4.92

u/ml

—

Respiratory tuberculosis, not confirmed

135

1.41

0.69

1.4

1.2

1.90

8.33

u/ml

—

Other obstetric trauma

437

1.22

0.68

1.4

1.3

5.76

3.17

u/ml

0.35

186

Other noninflammatory disorders of uterus, except cervix

146

867

1.12

0.68

1.3

1.2

3.21

4.64

u/ml

1.70

385

Malignant neoplasm of urinary organs, including Hilmo

519

1.20

0.68

1.2

4.88

4.98

u/ml

0.02

249

Non-small cell lung cancer, adenocarcinoma

266

1.28

0.68

1.2

2.27

7.22

u/ml

2.05

124

Intentional self-harm by unspecified means

102

1.48

0.68

1.4

1.3

3.25

4.13

u/ml

—

Other obstructed labour

562

0.82

0.67

1.2

1.68

3.29

u/ml

4.01

241

Lichen planus

779

1.16

0.67

1.3

1.2

2.34

3.98

u/ml

2.40

330

Sequelae of infectious and parasitic diseases, including avohilmo

438

1.21

0.67

1.2

3.64

5.25

u/ml

0.59

203

Nontoxic diffuse goitre

153

1.38

0.67

1.3

1.2

2.11

2.24

u/ml

—

Respiratory tuberculosis, not confirmed, including avohilmo

136

1.40

0.67

1.4

1.2

1.90

8.23

u/ml

—

Other noninflammatory disorders of cervix uteri

285

1.27

0.66

1.3

1.2

4.68

4.53

u/ml

0.02

125

Basal cell carcinoma

292

1838

1.08

0.66

1.3

1.2

4.07

3.92

u/ml

0.08

137

858

Congenital malformations of the nervous system

162

1.37

0.66

1.1

1.3

5.00

5.95

u/ml

0.11

Superficial injuries involving multiple body regions

162

1.37

0.66

1.4

1.3

2.43

4.80

u/ml

—

Chronic suppurative otitis media

348

1.24

0.66

1.2

2.78

4.74

u/ml

0.66

162

Evidence of alcohol involvement determined by level of intoxication

1.55

0.66

1.3

3.80

4.33

u/ml

—

Other strabismus

190

1719

1.10

0.66

1.3

3.46

4.18

u/ml

0.75

814

Vertical strabismus

206

1.32

0.65

1.2

4.22

5.49

u/ml

—

Mouth breathing

326

3028

1.08

0.65

1.3

3.25

3.88

u/ml

0.91

144

1455

Other disorders of bladder

605

1.18

0.65

1.4

1.2

4.84

3.90

u/ml

0.27

264

Malnutrition

103

1.46

0.65

1.3

1.2

2.00

3.46

u/ml

—

Crohn disease (strict definition, require KELA)

459

1.20

0.64

1.5

1.3

3.67

4.81

u/ml

0.59

213

Autism

198

1.32

0.64

1.3

4.92

3.90

u/ml

0.16

Crohn disease (strict definition, require KELA, min 2 HDR)

450

1.20

0.64

1.4

1.3

3.66

4.52

u/ml

0.41

206

Schizophrenia, schizotypal and delusional disorders

240

2606

0.92

0.64

1.3

3.25

3.83

u/ml

0.57

114

1233

Psoriasis vulgaris

145

1302

1.12

0.63

1.3

4.37

4.30

u/ml

0.03

595

Failed induction of labour

561

1.18

0.63

1.3

4.04

2.98

u/ml

0.31

250

Schizophrenia or delusion

240

2605

0.92

0.63

1.3

3.24

3.83

u/ml

0.60

116

1231

malignant neoplasm of female genital organs, including Hilmo

111

934

1.13

0.63

1.1

1.2

2.86

3.74

u/ml

0.88

400

Alopecia areata

190

1.32

0.63

2.0

1.3

4.73

3.95

u/ml

0.12

Superficial injury of neck

138

1.39

0.63

1.6

1.3

11.60

3.42

u/ml

—

Alcohol withdrawal state with delirium

414

0.79

0.63

1.2

3.82

5.23

u/ml

0.35

207

malignant neoplasm of female genital organs

813

1.14

0.62

1.1

1.2

2.82

3.84

u/ml

0.98

351

Sequelae of infectious and parasitic diseases

433

1.20

0.62

1.2

3.71

5.25

u/ml

0.54

203

Parkinson's disease, excluding more controls

423

1.20

0.62

1.2

2.33

3.44

u/ml

1.00

195

Other disorders of cornea

590

1.17

0.62

1.3

1.2

2.91

4.28

u/ml

1.23

271

Disorders of iron metabolism

1.47

0.62

1.4

1.2

6.67

3.89

u/ml

—

Malignant neoplasm of tongue

1.47

0.62

1.5

1.3

3.17

4.72

u/ml

—

Craniosynostosis EXCLUDE syndromes

0.00

0.61

0.0

1.1

—

3.20

—

Malignant neoplasm of cervix uteri, including Hilmo

156

1.35

0.61

1.1

1.2

1.67

5.00

u/ml

—

Malignant neoplasm of digestive organs

252

1778

1.08

0.61

1.2

2.65

3.97

u/ml

2.78

128

828

Other disorders of prostate

156

1.35

0.61

1.0

1.3

2.00

4.84

u/ml

2.19

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

307

1.24

0.61

1.1

1.3

2.50

3.71

u/ml

0.66

119

Burn and corrosion confined to eye and adnexa

165

1.34

0.61

1.6

1.2

2.11

5.19

u/ml

—

Benign neoplasm: Female genital organ, unspecified

0.00

0.60

0.0

1.0

—

4.20

—

Defect, injury or illness of lumbar spine

0.00

0.60

0.0

1.1

—

3.33

—

Hypospadias

0.00

0.60

0.0

1.2

—

2.00

—

Blepharochalasis

185

1688

1.10

0.60

1.2

3.39

4.29

u/ml

0.71

755

Osteogenesis imperfecta

0.00

0.60

0.0

1.0

—

3.40

—

Diabetes, insulin treatment (Kela reimbursement)

872

5409

0.96

0.60

1.3

1.2

4.95

3.69

u/ml

1.28

408

2548

Personality and behavioural disorders due to brain disease, damage and dysfunction

1.51

0.60

1.7

1.3

7.17

4.63

u/ml

—

Other specified and unspecified disorders of iris and ciliary body

0.00

0.60

0.0

1.2

—

5.20

—

Autism spe

192

1.31

0.59

1.3

1.4

5.17

3.84

u/ml

0.20

Generalized epilepsy, mode (most common among epilepsy diagnosis)

201

1.30

0.59

1.1

1.3

2.22

5.43

u/ml

—

Mental and behavioural disorders due to use of volatile solvents

0.00

0.59

0.0

1.3

—

4.77

—

Changes in corneal membranes

0.00

0.59

0.0

1.2

—

5.00

—

Spinal enthesopathy

1.53

0.58

1.2

1.1

6.80

5.06

u/ml

—

Benign neoplasm: Pituitary gland, craniopharyngeal duct

327

1.23

0.58

1.5

1.2

11.94

4.89

u/ml

0.70

152

Single delivery by forceps and vacuum extractor

151

996

0.90

0.58

1.2

1.3

4.32

5.17

u/ml

0.23

497

Foreign body in respiratory tract

309

1.23

0.58

1.2

1.70

5.00

u/ml

—

133

Carcinoma in situ of skin of upper limb, including shoulder

1.47

0.58

1.2

2.67

6.45

u/ml

—

Primary open-angle glaucoma, strict

112

1252

0.89

0.58

1.2

3.32

4.46

u/ml

0.74

570

Other and unspecified acute skin changes due to ultraviolet radiation

106

1.42

0.58

1.2

1.86

6.09

u/ml

—

Secondary and unspecified malignant neoplasm of lymph nodes

465

1.19

0.57

1.3

1.2

2.25

5.35

u/ml

2.31

220

Pediculosis, acariasis and other infestations

410

1.20

0.57

1.4

1.2

5.12

4.65

u/ml

0.05

190

Arthropathic psoriasis

754

1.14

0.57

1.3

1.2

6.82

4.42

u/ml

0.63

341

Familial hypercholesterolemia

679

1.15

0.57

1.2

3.24

4.28

u/ml

0.55

320

Pustulosis palmaris et plantaris

265

1.25

0.57

1.2

1.3

2.71

5.44

u/ml

1.18

107

Benign neoplasm: Skin of trunk

247

1.26

0.57

1.2

2.38

5.08

u/ml

1.28

106

Anti-inflammatory and antirheumatic products, non-steroids

246

1143

1.08

0.57

1.3

7.39

3.86

u/ml

0.99

110

593

Leisure time condition

113

1263

0.89

0.56

1.3

2.39

4.38

u/ml

2.66

596

Ankylosing spondylitis, ICD10

615

1.16

0.56

1.2

3.03

4.46

u/ml

0.84

286

124

1.38

0.56

1.2

1.4

2.22

3.22

u/ml

—

Benign lipomatous neoplasm of other sites/unspecified

440

0.82

0.56

1.2

3.75

5.44

u/ml

0.48

199

Disturbance of activity and attention

143

1264

1.11

0.56

1.3

4.26

4.55

u/ml

0.12

623

L02BX Other hormone antagonists and related agents

229

0.74

0.56

1.5

1.3

16.25

6.28

u/ml

—

110

Effects of foreign body entering through natural orifice

201

1851

1.09

0.55

1.3

3.06

4.18

u/ml

1.12

881

500

4237

1.05

0.55

1.3

4.22

3.78

u/ml

0.37

240

2048

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

284

1.24

0.55

1.3

1.2

2.27

6.87

u/ml

2.18

137

Childhood allergy (age < 16)

161

1210

1.10

0.54

1.2

1.3

3.81

4.53

u/ml

0.46

644

Pedestrian injured in collision with pedal cycle

186

1.30

0.54

1.2

2.00

5.79

u/ml

—

Bronchitis, not specified as acute or chronic

505

1.17

0.54

1.1

1.2

3.79

4.55

u/ml

0.27

246

Pneumonia due to Streptococcus pneumoniae

231

1.26

0.54

1.3

1.2

4.75

3.98

u/ml

0.12

Hereditary corneal dystrophies

160

1.32

0.53

1.1

1.2

3.11

4.79

u/ml

—

Female genital prolapse

214

1097

1.09

0.53

1.2

3.25

4.65

u/ml

1.14

482

Parapsoriasis

108

1.40

0.53

1.4

1.3

4.38

4.26

u/ml

—

Hidradenitis suppurativa

295

1.23

0.53

1.4

1.3

2.92

3.94

u/ml

0.28

129

Malignant neoplasm of bronchus and lung, including Hilmo

108

805

1.12

0.53

1.2

3.68

4.58

u/ml

0.51

378

531

4397

1.05

0.53

1.3

4.06

3.77

u/ml

0.23

256

2126

Embedded teeth, including avohilmo

788

1.13

0.53

1.2

1.3

8.46

3.81

u/ml

0.45

381

Mixed hyperlipidaemia

196

1.28

0.52

1.1

1.2

1.87

5.54

u/ml

1.23

Postpartum haemorrhage due to retained placenta

133

1206

1.11

0.52

1.3

1.2

2.66

3.99

u/ml

1.89

527

Schizotypal disorder

169

0.71

0.52

1.3

1.2

2.20

3.92

u/ml

—

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

480

1.17

0.51

1.2

2.83

5.39

u/ml

1.57

227

Contact with machinery

693

0.86

0.51

1.1

1.3

4.41

4.94

u/ml

0.11

336

Benign neoplasm: Long bones of lower limb

215

1.26

0.51

1.1

1.2

2.71

4.75

u/ml

0.85

Hyperkinetic disorders

150

1336

1.10

0.51

1.3

4.25

4.47

u/ml

0.10

660

Adenocarcinoma and papilloma adenocarcinoma of rectum

462

1.17

0.51

1.2

2.82

5.56

u/ml

1.61

215

Discitis, unspecified

1.47

0.51

1.1

6.20

4.11

u/ml

—

Benign neoplasm: Larynx

144

1.32

0.50

1.4

1.2

1.91

5.40

u/ml

1.47

Deficiency of other B group vitamins

1.42

0.50

1.5

1.2

3.75

5.39

u/ml

—

Alzheimer disease, excluding more controls

400

1.15

0.50

1.1

1.2

4.77

3.57

u/ml

0.38

174

Corns and callosities

352

1.20

0.50

1.4

1.2

3.30

4.30

u/ml

0.24

164

Chronic conjunctivitis

171

1.29

0.50

1.4

1.3

4.22

4.83

u/ml

—

Transient global amnesia

454

1.17

0.50

1.2

5.43

5.56

u/ml

0.02

199

Burn and corrosion of wrist and hand

252

1.23

0.50

1.5

1.3

5.50

4.64

u/ml

0.15

114

Perforation of tympanic membrane

585

1.15

0.49

1.2

4.42

5.06

u/ml

0.16

270

Disorders in reading

110

1.37

0.49

2.2

1.4

5.22

3.20

u/ml

—

Intermittent heterotropia

399

1.18

0.48

1.3

3.27

4.52

u/ml

0.59

187

Wet age-related macular degeneration

628

1.14

0.48

1.1

1.2

4.24

4.50

u/ml

0.07

292

Malignant neoplasm of other and unspecified parts of tongue, including Hilmo

1.40

0.48

1.3

1.20

4.94

u/ml

—

Unspecified maternal hypertension

102

1.38

0.48

1.2

8.38

5.36

u/ml

—

Later onset COPD

120

873

1.10

0.47

1.2

3.45

4.42

u/ml

0.63

398

Dermatitis herpetiformis

102

1.38

0.47

1.1

1.2

3.71

7.91

u/ml

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

260

2438

1.07

0.47

1.3

5.02

3.94

u/ml

0.22

116

1163

Dronedarone medication

102

1.38

0.47

1.9

1.1

4.00

2.84

u/ml

—

Injury of other and unspecified intrathoracic organs

364

1.18

0.47

1.3

1.2

3.62

5.73

u/ml

0.62

165

Ectropion of eyelid

111

1.35

0.46

1.2

2.00

9.45

u/ml

—

Premenstrual syndrome

120

1.34

0.46

1.5

1.3

12.86

5.43

u/ml

—

Evidence of alcohol involvement determined by blood alcohol level

1.39

0.46

1.0

1.3

1.50

4.57

u/ml

—

Multiple delivery

707

0.87

0.46

1.3

1.2

2.56

3.46

u/ml

1.17

327

Obstructed labour due to maternal pelvic abnormality

1034

0.90

0.46

1.2

3.90

3.40

u/ml

0.18

443

Pediculosis, acariasis and other infestations, including avohilmo

158

1457

1.09

0.45

1.3

3.64

4.15

u/ml

0.18

693

Pathological resorption of teeth

237

1.23

0.45

1.2

2.00

5.24

u/ml

—

107

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

487

1.15

0.45

1.5

1.3

3.67

4.61

u/ml

0.48

228

Burns and corrosions confined to eye and internal organs

192

1.26

0.45

1.5

1.2

2.00

4.95

u/ml

—

Benign neoplasm: Skin of ear and external auricular canal

183

1.26

0.45

1.1

1.2

2.27

8.06

u/ml

1.43

Malignant neoplasm of tonsil and base of tongue, including Hilmo

112

1.34

0.45

1.3

1.2

2.86

4.71

u/ml

—

Malignant neoplasm of thyroid gland

422

1.16

0.45

1.3

1.2

5.00

4.79

u/ml

0.03

179

Late syphilis

1.46

0.44

1.4

1.2

2.20

4.39

u/ml

—

Beningn neoplasm: Meninges, unspecified

1.46

0.44

1.4

1.1

3.80

7.52

u/ml

—

Other and unspecified nerve root and plexus disorders, also in other diseases

170

1575

1.08

0.44

1.3

1.2

6.14

4.03

u/ml

0.68

727

Abnormal findings on antenatal screening of mother

799

0.89

0.44

1.1

1.3

3.30

5.60

u/ml

1.12

360

Benign neoplasm: Lip

1.37

0.44

1.4

1.2

1.20

4.44

u/ml

—

Disorders of acoustic nerve

139

1.30

0.44

1.3

1.2

1.60

3.52

u/ml

—

Noise effects on inner ear

230

0.78

0.43

1.2

1.83

4.04

u/ml

—

117

Use of galantamine

220

1.23

0.43

1.2

3.56

6.53

u/ml

—

113

Muscle strain

193

1.25

0.43

1.6

1.2

3.07

3.21

u/ml

0.07

Endometriosis in cutaneous scar

1.58

0.42

1.0

1.1

—

2.38

—

Benign neoplasm of bone and articular cartilage

565

1.14

0.42

1.2

1.3

3.06

4.83

u/ml

1.29

253

Non-small cell lung cancer

419

1.16

0.42

1.2

2.90

5.88

u/ml

1.67

192

Familial hypercholesterolemia, with ischemic heart disease

382

0.84

0.42

1.3

1.2

4.27

3.92

u/ml

0.10

185

Burn and corrosion of ankle and foot

1.39

0.42

1.2

1.3

2.86

4.41

u/ml

—

Psoriatic arthropathies, ICD10

707

1.12

0.42

1.3

1.2

7.42

4.20

u/ml

0.79

326

Polydactyly

0.00

0.42

0.0

1.0

—

3.71

—

Syphilis, including avohilmo

149

1.28

0.42

1.5

1.2

3.50

3.56

u/ml

—

Syphilis

149

1.28

0.42

1.5

1.2

3.50

3.56

u/ml

—

Duodenal ulcer

481

1.14

0.42

1.5

1.2

3.34

5.21

u/ml

0.88

213

conjunctival scars

0.00

0.42

0.0

1.1

—

2.50

—

Intentional self-harm by jumping or lying before moving object

0.00

0.42

0.0

1.1

—

6.25

—

Cyst of spleen

0.00

0.41

0.0

1.5

—

5.20

—

Oesophagitis, drug-induced

0.00

0.41

0.0

1.1

—

6.67

—

Benign neoplasm: Respiratory system, unspecified

0.00

0.41

0.0

1.0

—

2.20

—

Marasmic kwashiorkor

0.00

0.41

0.0

1.2

—

5.22

—

Other salmonella infections, including avohilmo

249

1.21

0.41

1.4

1.2

7.19

4.44

u/ml

0.38

Benign neoplasm: Other specified/unspecified intrathoracic organs (+ respiratory system NOS of Icd-9)

0.00

0.41

0.0

1.3

—

3.71

—

Erythema in diseases classified elsewhere

0.00

0.41

0.0

1.0

—

3.00

—

Labyrinthine fistula

0.00

0.41

0.0

1.4

—

4.63

—

Disorder of mineral metabolism, other/unspecified

0.00

0.41

0.0

1.1

—

6.43

—

Small plaque parapsoriasis

0.00

0.41

0.0

1.1

—

5.44

—

Congenital myopathies

0.00

0.41

0.0

1.1

—

6.60

—

Trisomy 21 (Down syndrome) due to meiotic nondisjunction

0.00

0.41

0.0

1.1

—

1.75

—

Disorders of globe

105

1.34

0.41

1.1

1.2

1.67

7.47

u/ml

—

Other and unspecified psoriasis

407

1.16

0.41

1.6

1.2

8.30

5.06

u/ml

0.53

185

Retinal breaks without detachment

111

1014

1.10

0.41

1.2

3.15

4.11

u/ml

0.44

443

Delivery

302

1681

0.95

0.41

1.3

5.64

4.65

u/ml

0.34

121

811

Benign neoplasm: Carotid body

0.00

0.41

0.0

1.2

—

4.88

—

Neuroendocrine tumor and carcinoma of rectum

0.00

0.41

0.0

1.2

—

6.14

—

Other symptoms and signs involving the urinary system

567

1.13

0.41

1.3

1.2

4.23

4.09

u/ml

0.03

258

Abscess of Bartholin gland

204

1.23

0.41

1.2

3.40

4.93

u/ml

—

Malignant neoplasm of corpus uteri, including Hilmo

426

1.15

0.41

1.2

2.62

4.06

u/ml

0.92

173

Endometriosis of intestine

123

1.31

0.40

1.6

1.3

2.56

4.79

u/ml

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

389

1.16

0.40

1.2

3.77

4.71

u/ml

0.21

173

Mental and behavioural disorders due to use of other stimulants, including caffeine

232

1.21

0.40

1.4

1.3

3.00

3.56

u/ml

0.32

111

Microtia (small ears)

0.00

0.39

0.0

1.2

—

5.00

—

Upper arm

0.00

0.39

0.0

1.2

—

5.10

—

Drug-induced myopathy

0.00

0.39

0.0

1.2

—

6.00

—

Other specified/unspecified deforming dorsopathies

106

1.33

0.39

1.1

1.44

3.83

u/ml

—

Hair colour and hair shaft abnormalities

0.00

0.39

0.0

1.2

—

5.22

—

Additional codes for the location of defect, injury or illness

353

1.16

0.39

1.2

4.20

5.06

u/ml

0.20

157

Organic, including symptomatic, mental disorders

279

2070

0.95

0.38

1.3

1.2

3.82

4.03

u/ml

0.12

131

963

Other infestations, including avohilmo

1.35

0.38

1.2

3.33

6.95

u/ml

—

Divergent concomitant strabismus

505

1.13

0.37

1.3

3.36

4.61

u/ml

0.54

227

Other abnormal uterine and vaginal bleeding

166

1112

1.07

0.37

1.3

1.2

3.47

4.40

u/ml

0.51

503

Malignant neoplasm of prostate

142

906

0.93

0.37

1.2

1.3

3.00

4.27

u/ml

0.86

459

Benign neoplasm: salivary glands, exclude unknown (D119)

477

1.13

0.37

1.3

1.2

4.63

4.70

u/ml

0.01

213

Malignant neoplasm of tongue, including Hilmo

125

1.28

0.37

1.4

1.2

2.86

4.84

u/ml

—

Crohn disease (strict definition, all UC cases excluded)

356

1.15

0.36

1.4

1.3

4.23

4.54

u/ml

0.09

158

Contact with sharp object, undetermined intent

171

1.23

0.36

1.4

1.2

3.82

6.16

u/ml

0.42

Special screening examination for other diseases and disorders

668

1.11

0.35

1.2

3.23

3.83

u/ml

0.33

313

Mental retardation, excluding more controls

227

1.19

0.35

1.2

4.67

4.62

u/ml

0.01

Other psoriatic arthropathies

688

1.11

0.35

1.3

1.2

7.42

4.13

u/ml

0.82

320

Oral lichen planus and hypothyroidism or thyroxine medication

108

1.30

0.35

2.0

1.2

11.43

5.33

u/ml

—

Exposure to other and unspecified man-made environmental factors

135

1.27

0.35

1.3

1.2

2.38

3.88

u/ml

—

Assault by sharp object

117

1.29

0.35

1.3

1.2

4.90

4.05

u/ml

—

Benign neoplasm: Cranial nerves

144

1.25

0.35

1.3

1.2

1.60

5.19

u/ml

—

Other and unspecified epidermal thickening

135

1.26

0.35

1.6

1.2

2.40

5.78

u/ml

—

Alzheimer’s disease (Atypical or mixed), excluding more controls

175

0.81

0.35

1.1

2.60

4.44

u/ml

—

L02BA Anti-estrogens

1056

0.92

0.35

1.1

1.2

3.03

3.67

u/ml

0.50

451

False labour

322

1906

1.05

0.35

1.3

3.50

4.56

u/ml

0.98

147

886

Pleural plaque

320

1.16

0.34

1.1

1.2

5.04

6.35

u/ml

0.19

141

Postmenopausal atrophic vaginitis

177

904

1.07

0.34

1.2

2.90

4.75

u/ml

2.09

394

Melanocytic naevi, other sites/unspecified

585

1.11

0.34

1.4

1.3

5.39

4.39

u/ml

0.22

264

Puerperal sepsis

877

0.91

0.34

1.3

1.2

3.35

3.95

u/ml

0.29

373

Alcohol use disorder, ICD-based

340

3256

1.04

0.34

1.3

4.33

3.84

u/ml

0.28

155

1566

Maternal care for known or suspected disproportion

329

0.85

0.33

1.1

1.2

6.00

2.69

u/ml

0.56

137

Disorder of the sleep-wake schedule

118

1.28

0.33

1.5

1.3

12.43

3.18

u/ml

—

Sexual dysfunction

118

1.28

0.33

1.7

1.2

4.71

4.82

u/ml

—

Pedal cyclist injured in transport accident

189

1783

1.06

0.33

1.2

1.3

3.25

4.17

u/ml

0.72

835

Leiomyoma of uterus

538

2913

1.04

0.33

1.2

4.29

3.80

u/ml

0.37

224

1286

Anomalies of dental arch relationship, including avohilmo

180

1533

1.06

0.33

1.2

1.3

3.29

4.20

u/ml

0.93

738

Unspecified mental disorder

335

3493

0.96

0.32

1.3

1.2

3.83

3.99

u/ml

0.09

161

1660

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

313

1.15

0.32

1.7

1.2

6.06

4.42

u/ml

0.20

122

Acute alcohol intoxication ICD-9

165

0.79

0.32

1.2

4.33

5.88

u/ml

—

Hypogonadotropic hypogonadism

220

1.19

0.32

1.3

5.08

3.79

u/ml

0.29

117

Open wound of shoulder and upper arm

119

1.27

0.32

1.3

1.2

1.80

5.88

u/ml

—

Injury of nerves and spinal cord at neck level

119

1.27

0.32

1.7

1.2

5.37

4.02

u/ml

—

Disorders of eyelid in diseases classified elsewhere

183

1.21

0.32

1.4

1.2

3.55

6.30

u/ml

0.62

Convalescence

304

1.15

0.32

1.2

3.94

4.70

u/ml

0.15

128

Non-invasive ventilation

125

1005

1.07

0.31

1.2

3.12

3.81

u/ml

0.72

475

Use of biperiden

316

0.85

0.31

1.3

1.2

2.80

4.97

u/ml

0.81

139

Other and unspecified mononeuropathies of upper limb

174

1.21

0.31

1.5

1.2

6.44

5.06

u/ml

—

Rubella [German measles]

239

1.18

0.31

1.2

1.3

1.92

4.24

u/ml

2.06

114

Rubella [German measles], including avohilmo

239

1.18

0.31

1.2

1.3

1.92

4.24

u/ml

2.06

114

Mental and behavioural disorders due to alcohol

430

3948

1.04

0.31

1.3

4.13

3.77

u/ml

0.25

199

1916

Campylobacter enteritis

165

1.22

0.31

1.5

1.2

10.30

5.31

u/ml

—

Conductive hearing loss, unspecified

538

0.89

0.31

1.3

5.76

4.68

u/ml

0.14

242

Sudden idiopathic hearing loss

618

1.10

0.31

1.2

3.09

4.51

u/ml

0.77

271

Type1 diabetes, definitions combined, early onset

535

0.89

0.31

1.4

1.3

5.11

4.39

u/ml

0.17

261

Normotensive glaucoma

371

1.13

0.30

1.3

1.2

2.06

5.92

u/ml

2.19

183

Malignant neoplasm of bronchus and lung

701

1.09

0.30

1.2

3.95

4.67

u/ml

0.30

322

Diabetes medication

1026

5851

1.02

0.30

1.3

4.83

3.89

u/ml

0.95

475

2772

Malignant neoplasm of rectum, including Hilmo

571

1.10

0.30

1.2

3.09

5.11

u/ml

1.26

263

Other diseases of biliary tract

457

1.12

0.30

1.4

1.2

4.73

4.06

u/ml

0.14

198

Presbyopia

543

1.11

0.30

1.3

1.2

3.67

4.66

u/ml

0.35

232

Other osteochondropathies

467

1.12

0.30

1.2

3.05

4.47

u/ml

0.66

215

Benign neoplasm: Parotid gland

429

1.12

0.29

1.3

1.2

4.95

4.65

u/ml

0.04

191

Other acquired deformities of musculoskeletal system and connective tissue

278

1.15

0.29

1.3

1.2

5.79

4.89

u/ml

0.19

120

Necrosis of pulp, including avohilmo

572

5484

1.03

0.29

1.3

3.74

3.98

u/ml

0.19

253

2620

Sixth [abducent] nerve palsy

157

1.21

0.29

1.0

1.2

2.88

4.97

u/ml

—

Benign neoplasm: Skin of scalp and neck

152

0.79

0.29

1.1

1.2

2.20

5.52

u/ml

—

Adenocarcinoma and ductal carcinoma of pancreas

141

0.78

0.29

1.1

1.2

1.83

7.87

u/ml

—

Non-small cell lung cancer, squamous, helper endpoint

152

0.79

0.29

1.1

1.2

3.71

7.17

u/ml

—

Intentional self-harm by sharp object

185

1.19

0.29

1.7

1.3

4.55

4.41

u/ml

0.02

Mandibular retrognathia

476

1.11

0.29

1.2

1.3

4.32

3.98

u/ml

0.10

217

Calcific tendinitis of shoulder

307

1.14

0.29

1.1

1.2

4.33

3.60

u/ml

0.21

136

Testicular dysfunction

279

1.15

0.28

1.6

1.3

2.18

3.89

u/ml

1.81

147

167

1.20

0.28

1.1

1.2

3.25

4.85

u/ml

0.46

Pedal cyclist injured in noncollision transport accidents

824

1.08

0.28

1.2

1.3

3.40

4.25

u/ml

0.34

383

Mental and behavioural disorders due to cannabinoids

223

1.17

0.28

1.5

1.4

5.38

4.49

u/ml

0.15

114

Complications following abortion and ectopic and molar pregnancy

195

1.18

0.28

1.1

1.2

4.50

2.78

u/ml

0.56

Mental and behavioural disorders of puerperium, not classified elsewhere

1.28

0.28

1.3

1.2

5.67

2.70

u/ml

—

Wide developmental disorders

250

1.16

0.28

1.2

1.3

5.00

3.87

u/ml

0.20

123

Delivery, wide proxy

263

1334

1.05

0.28

1.3

4.97

4.87

u/ml

0.03

109

650

Open bite

412

1.12

0.28

1.3

2.35

4.04

u/ml

1.77

189

Benign neoplasm of ovary

1032

0.93

0.28

1.1

1.2

3.02

3.89

u/ml

0.60

449

Burn and corrosion of hip and lower limb, except ankle and foot

149

1.21

0.28

1.4

1.2

1.80

3.40

u/ml

—

Propionic acid derivatives

238

1142

1.05

0.28

1.2

1.3

7.51

3.84

u/ml

0.96

103

592

Sequelae of injuries of upper limb

671

1.09

0.27

1.4

1.3

3.66

4.11

u/ml

0.13

314

Spontaneous rupture of synovium and tendon

422

1.12

0.27

1.1

1.2

2.39

3.91

u/ml

1.86

187

Viral infections of central nervous system, not elsewhere classified/unspecified

1.25

0.27

1.3

—

4.37

—

Malignant neoplasm of corpus uteri

384

1.12

0.27

1.2

2.74

4.15

u/ml

0.80

156

Other disorders of iris and ciliary body

140

1.22

0.27

1.4

1.2

6.00

5.81

u/ml

—

Nontoxic multinodular goitre

116

1087

1.07

0.27

1.2

5.64

3.95

u/ml

0.38

475

Secondary uncertain malignant neoplasm

662

1.09

0.27

1.2

2.20

4.65

u/ml

2.59

313

Inflammatory disease of cervix uteri

353

0.88

0.27

1.3

1.2

3.33

4.99

u/ml

—

134

Other obstructive and reflux uropathy

243

1.15

0.27

1.3

4.86

5.49

u/ml

0.08

104

Mental and behavioural disorders associated with the puerperium

1.27

0.26

1.3

1.2

5.67

6.86

u/ml

—

Failed attempted abortion

1.27

0.26

1.1

1.3

10.00

4.43

u/ml

—

Car occupant injured in noncollision transport accident

253

1.15

0.26

1.3

1.2

6.50

4.54

u/ml

0.24

115

Benign neoplasm of major salivary glands

529

1.10

0.26

1.2

4.35

5.27

u/ml

0.16

233

Malignant neoplasm of bone and articular cartilage, including Hilmo

1.28

0.26

1.1

1.3

1.50

7.38

u/ml

—

Nystagmus and other irregular eye movements

1.30

0.26

1.3

5.40

4.63

u/ml

—

Acute appendicitis, with complications

140

1323

1.06

0.26

1.2

1.3

5.19

4.35

u/ml

0.20

612

Chronic hepatitis NAS

0.67

0.26

1.0

1.2

3.60

4.32

u/ml

—

Other and unspecified injuries of ankle and foot

291

1.14

0.26

1.1

1.3

2.64

5.70

u/ml

1.28

125

Calculus of lower urinary tract

225

1.16

0.26

1.5

1.2

1.75

4.91

u/ml

2.37

105

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

132

1.22

0.26

1.1

1.2

2.40

7.11

u/ml

—

Malignant neoplasm of stomach, including Hilmo

235

0.85

0.25

1.3

1.2

2.07

7.19

u/ml

1.93

114

FESS (DNB20)

893

0.93

0.25

1.4

1.2

4.82

4.02

u/ml

0.29

409

Use of levodopa decarboxylase inhibitor

613

0.91

0.25

1.2

2.19

5.30

u/ml

2.81

284

Burn and corrosion of head and neck

123

1.22

0.25

1.5

1.2

14.13

3.74

u/ml

—

Serous carcinoma of ovary, including Hilmo

160

1.19

0.25

1.2

4.50

5.26

u/ml

—

Fracture of neck

301

1.13

0.25

1.4

1.2

3.87

6.02

u/ml

0.47

145

Anisometropia and aniseikonia

188

1.17

0.25

1.2

3.18

6.27

u/ml

0.91

Open wound of abdomen, lower back and pelvis

207

1.16

0.25

1.9

1.2

4.93

5.01

u/ml

0.01

Deep bite

745

1.07

0.25

1.2

1.3

4.06

4.59

u/ml

0.23

361

Mental retardation

252

1.14

0.25

1.2

1.3

6.14

4.84

u/ml

0.26

115

Struck by thrown, projected or falling objec

361

0.88

0.25

1.2

2.18

4.92

u/ml

1.66

172

Maltreatment syndromes

397

1.11

0.24

1.2

1.3

3.15

4.02

u/ml

0.48

182

Spermatocele

382

0.89

0.24

1.1

1.3

4.06

4.36

u/ml

0.05

196

Scabies

321

1.12

0.24

1.4

1.2

6.82

4.95

u/ml

0.15

147

Traumatic ischaemia of muscle

1.29

0.24

2.4

1.3

10.60

4.49

u/ml

—

All dysplastic lesions of the cervix uteri

258

2636

0.96

0.23

1.3

4.61

4.08

u/ml

0.11

123

1169

Ankylosing spondylitis, strict definition

313

1.12

0.23

1.3

1.2

4.19

4.15

u/ml

0.01

136

Malignant neoplasm of ovary

256

1.13

0.23

1.1

1.2

4.00

4.48

u/ml

—

Thiazolidinediones

609

0.92

0.23

1.3

1.2

5.28

4.02

u/ml

0.29

269

Unspecified urinary incontinence

476

1.09

0.23

1.3

1.2

3.00

3.79

u/ml

0.49

192

Use of disulfiram, acamprosate or naltrexone

650

0.92

0.23

1.1

1.2

3.23

4.07

u/ml

0.42

307

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

877

0.93

0.22

1.2

2.03

4.48

u/ml

3.72

415

Granuloma annulare

1.25

0.22

1.7

1.2

2.00

3.64

u/ml

—

Alcoholic liver disease

592

1.08

0.22

1.3

1.2

3.59

5.07

u/ml

0.78

279

Graves disease, strict definition

763

0.93

0.22

1.3

1.2

3.41

3.93

u/ml

0.25

319

Benign neoplasm: Skin of other and unspecified parts of face

573

1.08

0.22

1.1

1.2

4.73

5.58

u/ml

0.15

254

Vasomotor rhinitis (mode)

448

1.10

0.22

1.3

1.2

3.09

4.84

u/ml

0.96

191

Schizoaffective disorder

566

0.92

0.22

1.2

1.3

2.74

4.85

u/ml

1.68

261

LeFortI or BSSO operation

305

0.88

0.22

1.2

1.3

2.56

4.62

u/ml

—

131

Explicit viral Sepsis

0.00

0.22

0.0

1.3

—

2.00

—

Hyperplasia of prostate

220

1289

0.96

0.22

1.3

5.49

4.02

u/ml

0.34

108

652

Combined immunodeficiency, unspecified

0.00

0.22

0.0

1.3

—

1.80

—

Edwards' syndrome and Patau's syndrome

0.00

0.22

0.0

1.1

—

4.00

—

Juvenile dermatomyositis

0.00

0.21

0.0

1.2

—

2.60

—

Huntington disease

0.00

0.21

0.0

1.2

—

2.20

—

Fusion of the labia, including avohilmo

0.00

0.21

0.0

1.2

—

2.67

—

Occupant of three-wheeled motor vehicle injured in other and unspecified transport accidents

0.00

0.21

0.0

1.1

—

2.33

—

Benign neoplasm: Penis

0.00

0.21

0.0

1.3

—

6.80

—

Medullary carcinoma of thyroid gland, including Hilmo

0.00

0.21

0.0

1.2

—

8.60

—

Disorders of sexual preference

0.00

0.21

0.0

1.3

—

6.33

—

Sequelae of injuries involving multiple and unspecified body regions

0.00

0.21

0.0

1.4

—

6.40

—

Traumatic spondylopathy

0.00

0.21

0.0

1.1

—

3.83

—

Other acantholytic disorders

0.00

0.21

0.0

1.2

—

2.20

—

Ulcer of oesophagus, drug-induced

0.00

0.21

0.0

1.2

—

6.67

—

Brain mixed glioma

0.00

0.21

0.0

1.2

—

3.50

—

Other combined immunodeficiencies

0.00

0.21

0.0

1.0

—

2.83

—

Pectus carinatum

0.00

0.21

0.0

1.2

—

2.00

—

Erythema annulare centrifugum

0.00

0.21

0.0

1.0

—

3.80

—

Supernumerary ureter

0.00

0.21

0.0

1.3

—

2.00

—

Intentional self-harm by smoke, fire and flames

0.00

0.21

0.0

1.2

—

2.83

—

Familial benign pemphigus (Hailey-Hailey disease)

0.00

0.21

0.0

1.2

—

7.80

—

Explicit viral Sepsis, including avohilmo

0.00

0.21

0.0

1.2

—

2.00

—

Induced delusional disorder

0.00

0.21

0.0

1.4

—

6.57

—

Clear cell adenocarcinoma of kidney

220

1.14

0.21

1.1

1.2

9.00

7.22

u/ml

0.15

111

Other specified/unspecified disorders of bone/cartilage

154

1.17

0.21

1.3

1.2

12.25

4.88

u/ml

—

Dislocation, sprain and strain of joints and ligaments of elbow

440

1.09

0.21

1.2

1.3

4.57

3.82

u/ml

0.18

202

Pectus carinatum, including avohilmo

0.00

0.21

0.0

1.2

—

2.17

—

Other cranial nerve disorders in other disorders

0.00

0.21

0.0

1.2

—

2.20

—

Acute otitis externa, noninfective

1.24

0.21

1.0

1.3

1.80

6.69

u/ml

—

Biliary cirrhosis, NAS

0.00

0.21

0.0

1.0

—

3.00

—

ICD 8 haemorrhage (epidural, subarachnoid, subduralis)

0.00

0.21

0.0

1.2

—

6.67

—

Other disorders following mastoidectomy

0.00

0.21

0.0

1.3

—

6.29

—

Primary ovarian failure

145

1.18

0.20

1.2

5.00

3.59

u/ml

—

Foreign body on external eye

116

1101

1.05

0.20

1.3

3.09

3.91

u/ml

0.49

547

Insulin, fast-acting (human)

112

1062

1.06

0.20

1.5

1.3

5.47

3.97

u/ml

0.64

502

Other ulcerative colitis

383

1.10

0.20

1.1

1.3

5.96

4.73

u/ml

0.30

179

Brain mixed glioma, helper endpoint

0.00

0.20

0.0

1.1

—

3.14

—

Lichen striatus

0.00

0.20

0.0

1.0

—

4.60

—

Other changes in lacrimal passages

0.00

0.20

0.0

1.0

—

4.50

—

Drug-induced fever

0.00

0.20

0.0

1.2

—

6.14

—

Tympanosclerosis

0.00

0.20

0.0

1.4

—

5.75

—

Carcinoma in situ of lip, oral cavity and pharynx

0.00

0.20

0.0

1.1

—

2.83

—

Chronic constrictive pericarditis

0.00

0.20

0.0

1.4

—

4.78

—

Malignant neoplasm of oral cavity

164

1.16

0.20

1.4

1.2

2.80

4.70

u/ml

—

Amblyopia ex anopsia

240

1.13

0.20

1.4

1.3

2.82

4.35

u/ml

0.75

110

Malignant neoplasm of prostate, including Hilmo

152

938

0.96

0.20

1.2

1.3

4.34

4.22

u/ml

0.03

480

Bilateral sagittal split ramus osteotomy operation

250

0.88

0.20

1.2

1.3

2.83

5.05

u/ml

—

107

Mental and behavioural disorders due to alcohol, excluding acute intoxication

361

3480

1.03

0.20

1.3

4.30

3.82

u/ml

0.30

166

1672

Other and unspecified disease of Bartholin gland

155

1.16

0.20

1.6

1.2

4.09

4.64

u/ml

0.10

Other fall from one level to another

180

1729

1.04

0.19

1.3

3.79

4.32

u/ml

0.31

824

Infective dermatitis

684

1.07

0.19

1.3

1.2

2.41

5.17

u/ml

2.41

312

Malignant neoplasm of bladder, including Hilmo

436

1.09

0.19

1.4

1.3

7.57

5.76

u/ml

0.22

210

Other ill-defined and unspecified causes of mortality

375

0.91

0.19

1.4

1.2

5.40

5.10

u/ml

0.05

186

Contusion of ankle

279

1.11

0.19

1.5

1.3

4.33

5.85

u/ml

0.42

117

Congenital malformations of eye, ear, face and neck

462

1.08

0.19

1.1

1.3

3.29

4.31

u/ml

0.52

209

Guillain-Barre syndrome

1.24

0.19

1.0

1.2

1.60

4.50

u/ml

—

Placenta praevia

376

1.09

0.18

1.2

1.3

3.12

3.65

u/ml

0.23

161

Motorcycle rider injured in noncollision transport accidents

194

1.14

0.18

1.3

1.2

3.73

3.92

u/ml

0.04

Congenital malformations of the respiratory system, including avohilmo

109

1.20

0.18

1.2

1.1

5.00

5.08

u/ml

—

Inguinal or femoral hernia, bilateral

550

1.07

0.18

1.3

1.2

6.00

4.97

u/ml

0.24

278

Heterophoria

560

1.07

0.18

1.3

3.41

4.59

u/ml

0.59

261

Redundant prepuce, phimosis and paraphimosis

152

1436

1.04

0.18

1.4

1.3

4.37

3.70

u/ml

0.35

762

Other and unspecified intracranial injuries

147

1.16

0.18

1.5

1.2

1.90

5.62

u/ml

—

Early syphilis, including avohilmo

1.21

0.17

1.5

1.2

5.00

4.34

u/ml

—

Type of accident

232

2249

1.03

0.17

1.3

5.28

4.01

u/ml

0.25

106

1075

Malignant neoplasm, without specification of site, including Hilmo

176

1.14

0.17

1.1

1.2

2.33

7.95

u/ml

—

Bacterial meningitis

205

1.12

0.17

1.2

4.67

5.80

u/ml

—

Other contact dermatitis

516

0.93

0.17

1.2

3.65

5.90

u/ml

0.73

235

Benign neoplasm: Skin, unspecified

236

0.89

0.17

1.3

1.2

3.00

5.32

u/ml

—

Other disorders of ear

816

5186

1.02

0.17

1.2

1.3

4.38

3.81

u/ml

0.32

369

2468

Malignant neoplasm of breast, HER-negative

119

1094

1.04

0.16

1.2

3.29

3.57

u/ml

0.17

465

Hydrocephalus

311

1.09

0.16

1.3

1.2

2.41

4.21

u/ml

1.30

145

Attention to artificial openings

177

1.13

0.16

1.2

8.67

7.20

u/ml

—

Simple and mucopurulent chronic bronchitis

177

1.13

0.16

1.5

1.2

4.31

6.95

u/ml

0.47

malignant neoplasm of male genital organs

156

975

0.96

0.16

1.3

3.41

4.17

u/ml

0.40

503

Other disorders of amniotic fluid and membranes

132

1325

0.96

0.16

1.2

1.3

3.29

4.77

u/ml

0.58

610

LSIL lesion of the vulva

187

1.13

0.16

1.2

2.09

3.85

u/ml

0.60

Injury of muscle and tendon at ankle and foot level

161

0.87

0.15

1.1

1.2

1.60

5.34

u/ml

—

Mixed conductive and sensorineural hearing loss

708

0.95

0.15

1.2

2.24

4.40

u/ml

2.33

310

Benign leiomyoma with endometriosis

918

1.05

0.15

1.3

1.2

3.92

4.06

u/ml

0.04

395

Spasmodic torticollis

188

1.12

0.15

1.3

1.2

2.17

4.47

u/ml

—

Secondary parkinsonism+Parkinsonism in other disease

112

1.16

0.14

1.1

1.2

6.13

5.08

u/ml

—

Malignant neoplasm of breast, ER-positive, including Hilmo

227

1642

1.03

0.14

1.2

3.83

3.69

u/ml

0.08

704

Pedal cyclist injured in other and unspecified transport accidents

782

1.05

0.14

1.2

1.3

4.57

4.05

u/ml

0.14

365

Occupational exposure to risk-factors

181

0.88

0.14

1.1

1.2

4.00

6.34

u/ml

—

Macular cyst

118

0.85

0.14

1.0

1.2

5.20

5.96

u/ml

—

Erosion and ectropion of cervix uteri

160

0.87

0.14

1.1

1.2

2.17

5.45

u/ml

—

Cervical polyps

626

1.06

0.14

1.2

2.55

4.03

u/ml

1.62

286

Anankastic personality disorder

295

1.09

0.14

1.3

2.46

3.98

u/ml

1.33

125

Assault by blunt object

103

1.17

0.14

1.3

1.2

4.00

4.11

u/ml

—

Malignant neoplasm of other and unspecified female genital organs, including Hilmo

128

0.86

0.13

1.0

1.2

4.60

3.72

u/ml

—

Mental retardation, wide definition

264

1.09

0.13

1.2

1.3

6.14

4.75

u/ml

0.29

120

Ill-defined and unknown causes of mortality

418

0.93

0.13

1.4

1.2

5.12

5.60

u/ml

0.09

204

Disorder of external ear, unspecified

199

1.11

0.13

1.3

1.2

1.80

5.82

u/ml

1.64

Dysplastic lesion of unknown severity in the cervix uteri, vagina or vulva

1.17

0.13

1.0

1.2

1.40

5.94

u/ml

—

Malignant neoplasm of breast, ER-negative, including Hilmo

132

1193

1.04

0.13

1.2

3.47

3.48

u/ml

0.01

511

Inflammation of lacrimal passages (acute and unspecified)

1.17

0.13

1.5

1.2

5.83

4.14

u/ml

—

Malignant neoplasm, without specification of site

1.17

0.13

1.1

1.2

2.20

8.38

u/ml

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

379

2915

1.02

0.12

1.3

1.2

5.05

3.69

u/ml

0.63

177

1378

Unspecified chronic bronchitis

142

1.13

0.12

1.1

1.2

5.20

6.16

u/ml

—

Certain zoonotic bacterial diseases, including avohilmo

171

1.11

0.12

1.1

1.2

2.00

6.39

u/ml

—

Impacted cerumen

619

1.05

0.12

1.3

1.2

3.86

4.98

u/ml

0.30

283

Other mental disorders due to brain damage and dysfunction and to physical disease

590

0.95

0.12

1.2

2.33

5.10

u/ml

2.09

272

Inguinal hernia, bilateral

541

1.05

0.12

1.2

6.17

4.98

u/ml

0.26

277

Alcohol abuse, main dg, excluding more controls

110

1062

1.04

0.12

1.4

1.3

3.61

4.29

u/ml

0.24

517

Alcohol abuse, main dg

110

1139

0.97

0.12

1.4

1.3

3.61

4.12

u/ml

0.18

544

Other protozoal intestinal diseases, including avohilmo

137

0.87

0.12

1.3

1.2

2.50

5.56

u/ml

—

Malignant neoplasm of breast, HER2-negative

302

1987

0.98

0.12

1.2

3.14

3.64

u/ml

0.62

131

855

Open wound of hip and thigh

220

1.09

0.12

1.4

1.2

3.00

4.58

u/ml

0.50

Other assisted single delivery

168

0.89

0.11

1.2

1.3

1.71

3.91

u/ml

—

Scabies, including avohilmo

130

1260

1.03

0.11

1.4

1.3

4.02

3.79

u/ml

0.06

594

Tooth agenesis EXCLUDE clefts and syndromes

288

1.08

0.11

1.2

1.4

2.21

4.65

u/ml

1.49

140

Other benign neoplasm of uterus: Other parts/unspecified

124

1.13

0.11

1.0

1.2

2.13

3.55

u/ml

—

Keratoconus

157

0.89

0.11

1.3

1.2

2.14

4.82

u/ml

—

Periodontal disease, other/unspecified

157

0.89

0.11

1.0

1.2

2.71

4.29

u/ml

—

Other specified disorders of external ear

188

0.90

0.11

1.2

4.63

6.39

u/ml

—

Viral infections of central nervous system, not elsewhere classified/unspecifie, including avohilmod

1.17

0.11

1.2

—

6.62

—

Lesion of plantar nerve

332

0.93

0.11

1.2

2.33

3.67

u/ml

0.75

126

Pedal cyclist injured in collision with motor vehicle

198

0.91

0.10

1.1

1.3

2.00

5.23

u/ml

—

Glaucoma-related operations

231

1.08

0.10

1.4

1.2

2.70

4.88

u/ml

—

109

Congenital deformities of hip, including avohilmo

134

1.12

0.10

1.1

1.2

1.89

4.67

u/ml

—

Gonococcal infection

208

0.91

0.10

1.2

3.09

4.84

u/ml

0.69

Premature rupture of membranes

227

1581

1.02

0.10

1.3

3.97

4.59

u/ml

0.21

739

Testicular hypofunction

261

1.07

0.10

1.6

1.3

1.80

3.97

u/ml

3.60

138

Other renal tubulo-interstitial diseases

135

1.11

0.09

1.5

1.2

2.00

5.09

u/ml

—

Schizophrenia or delusion, excluding more controls

240

2325

1.02

0.09

1.3

1.2

3.24

4.01

u/ml

0.78

116

1140

Motorcycle rider injured in other and unspecified transport accidents

418

1.05

0.09

1.3

13.67

4.58

u/ml

0.38

196

Effects of other external causes

203

1.09

0.09

1.1

1.3

2.42

5.28

u/ml

1.45

malignant neoplasm of male genital organs, including Hilmo

170

997

1.02

0.09

1.3

4.48

4.15

u/ml

0.09

513

L02BB Anti-androgens

340

0.94

0.09

1.3

1.2

4.80

5.88

u/ml

0.20

159

Other (not insulin) diabetes medications

894

5292

0.99

0.09

1.3

1.2

4.85

3.80

u/ml

0.92

402

2487

135

1130

1.03

0.09

1.3

1.2

4.48

4.29

u/ml

0.08

514

Postprocedural musculoskeletal disorders, not elsewhere classified

350

1.06

0.09

1.2

6.67

5.26

u/ml

0.20

151

Benign neoplasm of middle ear and respiratory system

421

0.95

0.09

1.3

1.2

1.95

5.63

u/ml

2.40

190

Congenital malformations of the respiratory system

1.14

0.09

1.2

1.1

5.60

3.23

u/ml

—

Benign neoplasm: Anus and anal canal

134

0.89

0.09

1.4

1.2

2.67

7.09

u/ml

—

Ethmoidectomy

928

0.97

0.09

1.4

1.3

4.59

3.99

u/ml

0.22

426

Thyrotoxicosis with diffuse goitre

106

1031

1.03

0.08

1.3

1.2

3.05

3.87

u/ml

0.66

441

Dyshidrosis [pompholyx]

107

1.12

0.08

1.2

1.3

4.00

6.51

u/ml

—

Carcinoma in situ, bladder

144

0.90

0.08

1.3

1.2

12.43

8.28

u/ml

—

Lesion of sciatic nerve

144

0.90

0.08

1.0

1.2

6.83

7.97

u/ml

—

Malignant neoplasm of oral cavity, including Hilmo

224

1.07

0.08

1.3

1.2

2.64

6.20

u/ml

1.10

110

Other appendicitis

568

1.04

0.08

1.2

2.71

4.66

u/ml

1.66

254

Stenosis and insufficiency of lacrimal passages

511

0.96

0.08

1.2

3.14

4.84

u/ml

0.95

218

Arthropod-borne viral fevers and viral haemorrhagic fevers

588

1.04

0.08

1.1

1.2

2.52

5.06

u/ml

1.99

274

Presence of other devices

123

1239

0.98

0.08

1.2

3.37

4.10

u/ml

0.40

556

Glucagon-like peptide-1 (GLP-1) analogues

249

2452

1.02

0.07

1.3

1.2

5.28

3.63

u/ml

0.37

1168

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

249

2452

1.02

0.07

1.3

1.2

5.28

3.63

u/ml

0.37

1168

Abnormalities of forces of labour

854

0.97

0.07

1.3

1.2

3.23

3.30

u/ml

0.03

365

Anxious personality disorder

143

0.91

0.07

1.1

1.3

3.57

4.50

u/ml

—

Benign neoplasm of thyroid gland

184

0.92

0.07

1.2

10.14

4.53

u/ml

—

Dislocation, sprain and strain of joints and ligaments of head

286

0.94

0.07

1.3

9.90

5.38

u/ml

—

125

Tularaemia, including avohilmo

112

0.89

0.07

1.2

2.20

6.04

u/ml

—

Pleural plaque with presence of asbestos

235

1.06

0.07

1.0

1.2

6.11

7.02

u/ml

0.10

113

Lichen planus, including avohilmo

125

1223

1.02

0.07

1.4

1.2

2.74

4.52

u/ml

2.28

556

Assault by unspecified means

153

0.91

0.07

1.6

1.2

3.11

3.71

u/ml

—

Melanocytic naevi of upper limb, including shoulder

153

0.91

0.07

1.1

1.2

1.17

6.91

u/ml

—

Benign neoplasm: Vulva

118

1.10

0.07

1.3

1.1

2.50

2.58

u/ml

—

Benign mammary dysplasia

802

0.97

0.07

1.3

1.2

2.97

4.11

u/ml

1.07

347

Acute and transient psychotic disorders

852

0.97

0.06

1.2

1.3

4.54

4.30

u/ml

0.09

394

Malignant neoplasm of bladder

216

1.06

0.06

1.1

1.2

5.56

6.96

u/ml

—

108

Dislocation, sprain and strain of joint and ligaments of hip

177

1.07

0.06

1.1

1.2

2.17

6.02

u/ml

—

Use of selegiline

183

0.93

0.06

1.3

1.2

1.14

4.92

u/ml

—

Malignant neoplasm of breast, HER-positive

223

1636

1.01

0.06

1.2

3.81

3.70

u/ml

0.06

701

Use of rivastigmine

540

1.03

0.06

1.2

2.46

5.14

u/ml

2.10

257

Alcohol dependence

185

1879

0.98

0.06

1.2

1.3

4.21

3.98

u/ml

0.07

904

Foreign body in alimentary tract

315

1.05

0.06

1.2

2.19

5.15

u/ml

1.84

149

Other and unspecified mononeuropathies of lower limb

148

1.08

0.06

1.5

1.1

8.50

4.89

u/ml

—

Infections of genitourinary tract in pregnancy

750

1.03

0.06

1.3

3.33

4.14

u/ml

0.43

318

Urethral stricture

256

1.06

0.06

1.3

1.2

2.73

4.32

u/ml

0.75

115

Convergence insufficiency and excess

109

1.10

0.06

1.0

1.3

5.17

6.85

u/ml

—

Malignant neoplasm of rectum

473

1.04

0.06

1.2

3.07

5.47

u/ml

1.30

222

Malignant neoplasm of breast

305

1988

0.99

0.06

1.2

3.17

3.64

u/ml

0.57

133

856

Non-small cell lung cancer, squamous

131

0.92

0.05

1.1

1.2

3.71

7.90

u/ml

—

Communicating hydrocephalus

100

1.10

0.05

1.4

1.1

1.83

6.00

u/ml

—

Foreign body in ear

120

1.08

0.05

1.5

1.3

4.57

3.58

u/ml

—

Contact with nonpowered hand tool

272

0.96

0.04

1.2

2.82

5.19

u/ml

0.90

129

Torsion of testis

1.10

0.04

2.0

1.2

7.40

3.98

u/ml

—

Carcinoma in situ of breast, intraductal

493

0.97

0.04

1.4

1.2

4.28

3.73

u/ml

0.12

190

Secondary parkinsonism

111

1.08

0.04

1.1

1.2

6.86

5.50

u/ml

—

Allergic contact dermatitis due to drugs in contact with skin

119

0.92

0.04

1.4

1.2

2.00

6.31

u/ml

—

Endometriosis ASRM stages 1,2

154

1522

1.01

0.04

1.4

1.2

3.24

3.68

u/ml

0.20

657

Systemic atrophies primarily affecting the central nervous system

200

1.05

0.03

1.2

1.89

5.55

u/ml

—

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

210

0.95

0.03

1.3

1.2

2.00

5.66

u/ml

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

836

4977

1.00

0.03

1.3

1.2

5.02

3.70

u/ml

1.31

393

2341

Long labour

236

1982

1.01

0.03

1.3

3.90

4.22

u/ml

0.16

115

900

Suppurative otitis media, unspecified

149

0.94

0.03

1.4

1.3

4.44

5.23

u/ml

—

Mumps, including avohilmo

159

0.94

0.03

1.1

1.2

2.30

3.44

u/ml

—

Contact with sharp glass

280

1.04

0.03

1.4

1.3

3.14

4.73

u/ml

0.67

129

Malignant neoplasm of breast, including Hilmo

318

2023

1.01

0.03

1.2

3.03

3.68

u/ml

1.07

137

874

Type 1 diabetes, strict definition

650

0.98

0.03

1.4

1.3

4.30

3.80

u/ml

0.16

303

Malignant neoplasm of ovary, including Hilmo

340

1.03

0.03

1.1

1.2

4.17

3.60

u/ml

0.14

138

837

1.01

0.03

1.5

1.2

4.65

4.60

u/ml

0.01

362

Malignant neoplasm of breast, HER2-negative, including Hilmo

318

2024

1.01

0.03

1.2

3.03

3.68

u/ml

1.06

137

875

Gonococcal infection, including avohilmo

229

0.96

0.03

1.3

1.2

5.85

4.58

u/ml

0.17

104

Other blood glucose lowering drugs, excl. Insulins

852

0.99

0.02

1.2

7.72

3.74

u/ml

0.44

392

Type 1 diabetes, strict definition, subgroup 1

618

1.02

0.02

1.4

1.3

4.33

3.88

u/ml

0.13

286

Benign neoplasm: Choroid

341

1.03

0.02

1.2

1.87

4.70

u/ml

2.30

151

Mandibular retrognathia AND surgery (BSSO)

188

0.96

0.02

1.2

1.3

2.83

5.57

u/ml

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified

491

1.02

0.02

1.1

1.2

2.50

4.22

u/ml

1.52

232

Dermatitis due to ingested food

222

1.03

0.02

1.3

9.33

3.82

u/ml

0.66

114

Glaucoma suspect

224

2226

1.01

0.02

1.3

1.2

4.05

4.19

u/ml

0.08

103

1024

Malignant neoplasm of pancreas

308

0.97

0.02

1.0

1.2

2.36

6.51

u/ml

1.98

146

Burns and corrosions of multiple and unspecified body regions

137

0.95

0.01

1.1

1.3

1.57

3.65

u/ml

—

Torsion of ovary, ovarian pedicle and fallopian tube

163

1.04

0.01

1.4

1.3

3.00

4.92

u/ml

—

Use of interferon beta-1a

167

0.96

0.01

1.3

2.00

5.41

u/ml

—

Overjet

166

0.96

0.01

1.2

1.3

7.88

4.27

u/ml

—

Dementia in other diseases classified elsewhere

183

1.04

0.01

1.1

1.2

1.50

6.91

u/ml

—

Herpesviral keratitis and keratoconjunctivitis

237

0.97

0.01

1.3

1.2

2.11

4.22

u/ml

—

108

Other conjunctival vascular disorders and cysts

116

0.95

0.00

1.1

1.2

3.80

6.50

u/ml

—

Pedestrian injured in collision with car, pick-up truck or van

144

1.04

0.00

1.3

7.14

3.69

u/ml

—

Traumatic amputation of wrist and hand

224

1.03

0.00

1.3

1.2

1.90

4.86

u/ml

—

116

Cholesteatoma of middle ear

234

1.03

0.00

1.2

3.00

6.90

u/ml

—

111

Carpal tunnel syndrome

504

4358

1.00

0.00

1.3

1.2

4.71

3.69

u/ml

1.24

226

2029

Alcohol-induced chronic pancreatitis

384

1.02

0.00

1.2

4.63

4.43

u/ml

0.05

189

Glaucoma

355

3019

1.00

0.00

1.3

1.2

3.84

4.00

u/ml

0.11

154

1412

Other and unspecified nonorganic psychotic disorders

162

1614

1.00

0.00

1.4

1.3

3.29

3.83

u/ml

0.43

762

Malignant neoplasm of pancreas, including Hilmo

388

1.01

0.00

1.1

1.2

2.88

6.26

u/ml

1.66

183

Distal bite

258

1.00

0.00

1.1

1.3

3.54

4.54

u/ml

0.26

122

Cleft lip, lip and palate or palate

111

0.99

0.00

1.3

2.40

4.08

u/ml

—

Carcinoma in situ of other and unspecified genital organs

115

1.04

0.00

1.2

1.1

2.50

5.02

u/ml

—

Type 1 diabetes, definitions combined

769

1.00

0.00

1.3

3.93

4.04

u/ml

0.04

363

Other and unspecified injuries of abdomen, lower back and pelvis

1.04

0.00

1.0

1.3

2.20

5.22

u/ml

—

Family history of other specific disorders

106

1.04

0.00

1.7

1.2

1.83

6.19

u/ml

—

Injury of muscle and tendon at forearm level

124

0.97

0.00

1.6

1.2

6.00

5.75

u/ml

—

Mild mental retardation

156

1.03

0.00

1.1

1.3

5.64

4.95

u/ml

0.11

Other congenital malformations of face and neck

204

0.98

0.00

1.3

3.43

4.91

u/ml

—

Other otitis externa (chronic)

414

0.99

0.00

1.2

1.3

3.67

4.78

u/ml

0.26

189

Fall on and from ladder

424

0.99

0.00

1.2

3.06

5.68

u/ml

0.88

200

Epiphora

112

0.98

0.00

1.2

1.1

4.40

7.42

u/ml

—

Rheumatic fever incl heart disease

122

0.98

0.00

1.7

1.2

6.71

5.34

u/ml

—

Other facial nerve disorders

162

0.99

0.00

1.3

1.2

2.17

4.47

u/ml

—

Infliximab

162

0.99

0.00

1.1

1.2

2.20

5.82

u/ml

—

Follicular lymphoma, hilmo

188

1.01

0.00

1.2

2.00

5.06

u/ml

—

All dysplastic lesions of the cervix uteri, vagina or vulva

297

2891

1.00

0.00

1.3

4.29

4.08

u/ml

0.04

143

1284

Type 1 diabetes, strict (exclude DM2)

771

1.00

0.00

1.3

3.93

4.02

u/ml

0.03

367

Infections of breast associated with childbirth

302

0.99

0.00

1.1

1.3

5.14

4.01

u/ml

0.24

124

Unknown and unspecified causes of morbidity

349

1.00

0.00

1.3

1.2

2.19

5.03

u/ml

1.88

151

Acute alcohol intoxication

179

1792

1.00

0.00

1.3

3.46

4.04

u/ml

0.34

861

Acute alcohol intoxication, ICD10

152

1519

1.00

0.00

1.3

3.55

4.35

u/ml

0.40

720

Peritonsillar abscess

182

1819

1.00

0.00

1.3

1.2

2.82

3.86

u/ml

1.51

842

Benign neoplasm of other and unspecified female genital organs

238

1.01

0.00

1.5

1.2

3.38

4.08

u/ml

0.23

Adenocarcinoma of pancreas

103

0.97

0.00

1.1

1.2

2.00

8.00

u/ml

—

Exposure to other specified electric current

167

1.02

0.00

1.5

1.2

4.70

5.20

u/ml

—

Enterobiasis, including avohilmo

187

1.02

0.00

1.3

1.4

1.86

4.16

u/ml

—

Congenital deformities of hip

116

1.03

0.00

1.1

1.2

2.14

5.02

u/ml

—

Glycogen storage disease

0.00

0.0

1.0

—

Ménière disease

520

1.00

-0.00

1.2

2.55

4.80

u/ml

1.43

222

Polyglandular hyperfunction

0.00

-0.00

0.0

1.0

—

2.60

—

Carcinoma in situ of other and unspecified sites

160

1.00

-0.00

1.3

1.2

9.89

7.47

u/ml

—

Other neonatal haemorrhages

0.00

-0.00

0.0

1.0

—

3.00

—

Other benign neoplasms of uterus

220

1.00

-0.00

1.1

1.2

3.00

4.40

u/ml

0.50

Disorders of urea cycle metabolism

0.00

-0.00

0.0

1.0

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS